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Abbrivations 
Å angstrom 
Ac acetate 
Anal. analytical 
bpy 2,2'-Bipyridine 
bpzm bis(3,5-dimethylpyrazol-1-yl)methane 
br.  broad 
BSSE basis set superposition error 
bu butyl 
°C degrees centigrade 
calc. calculated 
CID collision-induced dissociation 
cod 1,5-cyclooctadiene 
d doublet 
dbd  N,N-dimethyl-2-diphenylphosphinoaniline 
DFT density functional theory 
diop O-isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane 
DMF N,N-dimethylformamide 
DMF-DMA  N,N-dimethylformamide dimethyl acetal 
DMSO dimethyl sulfoxide 
e.e. enantiomeric excess 
eq equivalent 
eq. equation 
ESI  electrospray ionisation 
ESI-MS electrospray mass spectrometry 
Et ethyl 
Et2O  diethyl ether 
EtOH  ethanol 
FT-IR fourier transform infrared spectroscopy 
g gram 
GC gas chromatography 
H H2-hydrogenation 
h hour 
  
Hz  hertz 
IMes 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene 
iPr isopropanol 
IR  infrared 
J  couplings constant 
kcal kilocalorie 
M molar 
m multiplet 
Me methyl 
MeCN  acetonitrile 
mg milligram 
min  minute 
mL millilitre 
mm millimetre 
mw microwave 
NMR  nuclear magnetic resonance 
n-Pr  n-propyl 
OTf trifluoromethanesulfonate 
PCy3 tricyclohexylphosphine 
pdpm 2-amino-4-(2-pyridinyl)pyrimidine 
Ph  phenyl 
por porphyrin 
ppm parts per million 
ref. reference 
refl. reflux 
RNA ribonucleic acid 
RT  room temperatur 
s  singlet 
T transfer hydrogenation 
T  temperature in Kelvin 
t triplet 
TBD triazabicyclodecene 
tBu  tert-Butyl 
  
temp. temperature in °C 
Tf  triflate group (CF3SO2-) 
TH transfer hydrogenation 
THF  tetrahydrofuran 
TOF turn over frequency 
TON turn over number 
Tp trispyrazolylborate 
Tp*  hydridotris(3,5-dimethylpyrazolyl)borate 
TS transition state 
Tsdpen N-tosylated  1,2-diphenyl-1,2-ethylenediamine 
ʋ͂  wave number in cm-1 
ZPE zero-point energy 
δ  chemical shift in ppm 
∆G Gibbs energy 
∆Hf standard enthalpy of formation of a chemical compound 
λ  wavelength in Å 
ρ density in g cm-3 
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1 Introduction 
1.1 Catalysis 
 Catalysis is the science of accelerating and directing chemical transformations.1 In 
general, more complex molecules are produced from readily attainable starting materials for 
versatile applications. These conversions allow the creation of a large range of products which 
are further required in industry or are directly commercialized for the consumer. Catalysts 
ensure that these reactions proceed in a highly efficient manner, giving optimum yields and 
avoiding unwanted by-products. Significantly, they allow a much more economical production 
compared to classical stoichiometric procedures and have opened up an access to yet unknown 
transformations.  
 More than 80% of all chemical products come into contact with catalysts during their 
synthesis, thus catalysts are necessary for the needs of today’s society and so, they are a key 
factor for profitability and sustainability of chemical production processes. As Beller 
mentioned in his article on catalysis, 15-20% of the economies of the developed western 
nations depend directly or indirectly on catalytic processes, according to the North American 
Catalysis Society.1 Therefore, it is not surprising that without catalysis lots of things which we 
take for granted in everyday’s life – petrol or plastics, dyes and clothing, automobiles or 
airplanes, mobile phones or computers, medicines or cosmetics – would either not be possible 
or suffer in quality.  
 Even now, classical organic reactions that are more than 100 years old are used for 
syntheses of chemical products. These include nitrations, Friedel-Crafts reactions, and 
halogenations. One of the main disadvantage of many of them is the occurrence of 
stoichiometric – frequently even overstoichiometric – quantities of side products (e. g. salts) 
which must be separated as waste. Additionally complicated protective group techniques, are 
frequently required for the specific activation of a function moity being in presence of other 
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functional groups. This is why often several metric tonnes of waste per metric tonne of target 
product are produced by conventional production processes for fine chemicals. Given these 
facts, there is no doubt about the necessity of inventive and versatile catalytic methods for new 
environmentally benign chemical processes.  
1.2 Catalysts 
 Wilhelm Ostwald, who was awarded the Nobel prize for chemistry in 1909 has 
introduced the following definition for a catalyst:  
"A catalyst is a compound which increases the rate of a chemical reaction without being 
consumed by itself and without changing the thermodynamic equilibrium of the reaction". 
  Up to now different kinds of catalysts have been improved and applied in all fields of 
chemistry. Since the 1950ies almost all of the important base chemicals are produced by using 
catalytic procedures. The importance of catalysis in the modern chemistry is highlighted by 
awarding the Noble Prize for catalytic investigations to: 
 Noyori, Knowles and Sharpless , 2001 for asymmetric catalysts 
 Chauvin, Grubbs and Schrock, 2005 for olefin-metatheses 
 Ertl, 2007 for investigations in surface catalysis 
 Heck, Negishi and Suzucki, 2010 for palladium catalyzed cross coupling reactions  
to name just the laureates of the last decade. 
1.3 Hydrogenation of Ketones 
 Reduction of ketones to secondary alcohols is a core reaction for the synthesis of 
alcohols including chiral ones. A number of homogeneous catalytic systems based on Ru, Rh, 
Ir, and more recently Os complexes have been developed for ketone hydrogenation2 and 
transfer hydrogenation (TH)3 reactions. One of the most significant breakthroughs in this field 
was done by Noyori and co-workers, leading to systems such as trans-[RuCl2(PP)(1,2-
diamine)] (PP = diphosphine) and [(η6-arene)RuCl(Tsdpen)] for efficient ketone hydrogenation 
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and TH reactions, respectively (Scheme 1).4 They discovered, that both, activities and 
selectivities can be improved by the presence of a N-H functionality in the ligand being in 
close proximity to the metal site and named this effect "bifunctional catalysis".5 According to 
this improvement, others have investigated ligands containing amino alcohol,6 aminoamide,7 
and aminocarboxylate groups8 with at least one hydrogen atom bound to nitrogen for the 
bifunctional ruthenium catalyzed hydrogenation and transfer hydrogenation. The in-situ 
generation of metal hydrido species was proposed for the hydrogenation mechanism (see below 
for mechanistic details).9  
 
Scheme 1. Noyori's catalysts. 
 
 Baratta et al.10,11 have developed an access to arene-free catalysts which turned out to 
be extremely active in the transfer hydrogenation of acetophenone with NaOH as the base.10 
From a mechanistic point of view, the main difference between the Baratta and the Noyori 
systems is, that in the former ones the alcohol and the ketone coordinate to the metal center 
during the catalytic process (so-called “inner-sphere“ mechanism), for more details see the 
mechanism section, whereas in Noyori’s system the substrate does not coordinate to the metal 
site but interacts with the ligands (so-called “outer-sphere mechanism).11 In contrast to direct 
hydrogenation, the hydrogen in the transfer hydrogenation is from a source other than gaseous 
H2. Transfer hydrogenation of ketones is the main topic of this work and will be discussed in 
the next sections. 
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1.3.1 Transfer Hydrogenation 
 Transfer hydrogenation (TH) is the addition of hydrogen (H2; dihydrogen in inorganic 
and organometallic chemistry) to a molecule from a source other than gaseous H2. In the 
catalytic transfer hydrogenation of ketones the substrates are reduced to alcohols mainly with 
2-propanol or formic acid as the hydrogen source.3,12 Highly active catalytic systems make this 
approach attractive for the preparation of alcohols since the direct hydrogenation process often 
requires handling of dangerous dihydrogen under elevated pressure. The most active systems 
are based on Ru, Rh, and Ir and the catalytically active metal site is coordinated by nitrogen 
and/or phosphorus ligands. Especially ruthenium complexes containing suitable combinations 
of P- and N- or mixed P,N-ligands turned out to be efficient catalysts for the hydrogenation and 
transfer hydrogenation of carbonyl compounds. Thus, bi-, tri-, and tetradentate achiral and 
chiral ligands have successfully been used for the preparation of these catalysts. A few general 
types should be mentioned here: (P)2(NN)RuCl2 and (PP)(NN)RuCl2 (P = phosphine ligand; 
PP = diphosphine ligand; NN = diamine, dipyridine ligand),13 (P)2(PN)RuCl2 (PN = amino- or 
iminophosphine ligands, oxazolinylferrocenylphosphine),14 (PN)2RuCl2,14a,15 [(η6-p-
cymene)(PN)RuCl][BF4] (PN = phosphole-pyridine),16 [(η6-p-cymene)(NN)RuCl][BF4],17 
(P)(NPN)RuCl2,18 (NPN)RuCl2),19 (P)(NNN)RuCl2 (NPN and NNN = oxazoline based 
ligands),20 [RuCl(CNN)(PP)] (PP = Josiphos diphosphine and CNN = amin/aryl/pyridine based 
ligands)21 and (PNNP)RuCl2 systems (PNNP = diphosphine/diamine ligands).22 
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 Aliphatic and aromatic nitrogen donors have emerged as important ligands in 
homogeneous and heterogeneous catalysis.23,24 Among them tridentate aromatic nitrogen 
donors have been used for nickel-catalyzed asymmetric Negishi cross couplings25 or for 
iron/cobalt catalyzed ethylene polymerization.26 Furthermore polydentate imino and amino 
ligands have provided a considerable improvement on the catalyst performance in the catalytic 
transfer hydrogenation of ketones.27 
1.4 Mechanisms of the Hydrogenation 
 Catalytic hydrogenation of polar bonds and their asymmetric variant are key reactions 
in fine chemical and pharmaceutical synthesis. Homogeneous hydrogenation catalysts based on 
ruthenium have been known nearly for 40 years28 and became the most useful catalysts for 
these reactions. Ruthenium complexes exhibit promising reactivity and selectivity, especially 
in the catalytic reduction of polar bonds, that often transcend those of the common stars of 
hydrogenation, complexes of rhodium and iridium.29 In a series of review articles the role of 
some ruthenium hydrido30 and dihydrogen complexes31 as precatalysts or intermediates in 
catalytic cycles was discussed. 
 In this section the proposed mechanisms for the H2-hydrogenation (H) and the transfer 
hydrogenation (T) of carbonyl bonds will be discussed in details according to Morris 
classification12d with a focus on ruthenium hydrido complexes which are engaged as catalysts 
or precatalysts (equation 1). 
H:
OR2
R1
+ H2
[Ru]H OHR2
R1
(1)
 
 Equation 1. Direct hydrogenation of a carbonyl group (H). 
OR2
R1
+ DH2
OHR2
R1
+ D (2)T: [Ru]H
 
Equation 2. Transfer hydrogenation of a carbonyl group (T). 
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 Catalytically active species containing ruthenium hydrido units are marked as [Ru]H, 
where in [Ru] indicates the ruthenium center with its other ligands. The hydrogen sources DH2 
in equation 2 are generally secondary alcohols, especially 2-propanol, or formic acid, often 
applied as ammoniumformate, [NEt3H][CO2H].  
 Generally the catalytic cycles include two main steps. In the first step the hydride will 
react with the unsaturated compound, and in the second step the hydride will be regenerated 
from H2 (in H) or a hydrogen donor (in T). The classification of the catalytic cycles discussed 
in the next sections mechanism is according to the proposed pathway for the first step as 
Morris has done it in his article.9e,12d 
1.4.1 Classification of Catalytic Cycles According to the Hydride Transfer Mechanism 
 The classical mechanisms of transition metal homogeneous catalysis include the 
reactants being bound to the central metal. Therefore, it is usually supposed that in the 
hydrogenation of polar bonds by ruthenium hydrides, the ketone will coordinate to 
ruthenium(II) at a vacant site that is opened-up by dissociation of a ligand or a solvent 
molecule. The carbon atom of the carbonyl group will be electrophilically activated by 
coordination in the inner (I) or primary coordination sphere of ruthenium (Lewis-acid) so that a 
cis coordinated hydrido ligand is able to migrate to this carbon atom (Figure 1). 
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C
O[Ru]
H(I) C
O[Ru]
H(IL)
L E
δ+δ-
δ-
δ-
δ-
δ+
δ+
δ+
 
Figure 1. Attack of a hydrido ligand to the coordinated unsaturated carbonyl group in the 
primary coordination sphere. This is supposed to be part of the HI or TI mechanism. The [Ru] 
notation indicates the ruthenium ion (normally Ru(II)) and its ancillary ligands. The IL (right) 
notation shows additional activation by an electrophile (E = H+, M+) on an ancillary ligand. 
This is a part of the HIL or TIL catalytic cycles. 
 
 Mechanisms with these features will be named as HI or TI mechanisms. They are 
usually characterized by the dissociation of an ancillary ligand providing a vacant site for 
coordination of the carbonyl group. Often this vacant site is attainable by dissociation of a 
weakly coordinating solvent molecule. Noyori and Ohkuma30a have shown that a drastic 
geometric change of ground state structures is necessary to obtain the essential interactions 
between the Ru–H bond and the π face of the carbonyl group in the inner sphere mechanism 
which can lead to a high activation barrier. Additional activation of the carbonyl group towards 
hydride attack can be provided by a coordinated ancillary ligand, L, which contains an acidic 
group as shown in Figure 1. Following Morris' notation,12d an L is added to the end of the 
abbreviation in this case. For instance, HIL would refer to the hydrogenation of an unsaturated 
substrate with ligand assistance in the inner sphere.  
 The catalysts that work by an inner sphere hydride transfer have the disadvantage that 
they are not very selective for C=O bonds over C=C bonds, e.g. in the reduction of α,β-
unsaturated ketones and aldehydes.32 This can be caused by a competition of C=C and C=O 
bonds for the vacant site cis to the hydrido ligand. Additionally monohydrides are known to 
accelerate the isomerization of olefins33 and imines,34 which is another unwanted side reaction. 
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 Recently Noyori’s group has introduced a non-classical mechanism for the reduction of 
polar bonds by ruthenium complexes which is proposed to work by the transfer of a hydride to 
the substrate in the second, or outer coordination sphere of the ruthenium complex. Therefore, 
this mechanism is called outer sphere (O) hydrogenation mechanism (Figure 2). An 
electrophilic activation is required either by an external electrophile (HO or TO) or by an 
internal electrophile bounded to an ancillary ligand (HOL or TOL) for the carbon atom of 
carbonyl group with a low hydride affinity. 
C
O[Ru]
H(O)
C
O
[Ru]
H
(OL)
L
E
δ+
δ-
δ-
δ-
δ-
δ+
δ+
δ+
E
δ+ δ-δ
+
 
Figure 2. The outer sphere (O) attack of hydride on the unsaturated aldehyde or ketone. 
Usually, an electrophile (E) assists in these reactions and usually also an ancillary ligand (OL 
mechanism) is involved. This is part of the HO, HOL, TO or TOL catalytic cycles. 
 
 The term “metal–ligand bifunctional catalysis”4b was created by Noyori to refer to the 
catalytic systems that are involving the HOL or TIL mechanisms. In these cases usually the 
ancillary ligand contains a proton (E = H in Figure 2) that can be transferred to the oxygen 
atom simultaneously with the hydride transfer to the carbon atom. This results in a preferred 
reaction of the polar C=O bond over the unpolar C=C bonds. Having a primary amine as the 
ancillary ligand, the “N–H effect”, the ligand geometry and a hydridic–protonic attraction 
arrange the Ru–H and N–H bonds precisely.  
 The existence of an ancillary ligand cis to the hydrido ligand with an NH or OH group 
or an electrophile, like a K+ ion is required for catalysts following the ligand-assisted 
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Yes 
Yes 
Yes 
No 
No 
No 
Yes 
No 
Yes 
No 
Yes 
No  
Yes 
No 
mechanism. The flowchart shown in scheme 2 summarizes the classification of hydrogenation 
catalysts. 
 
Scheme 2. Classification of the mechanisms related to the reduction of polar bonds; H = 
hydrogenation; T = transfer hydrogenation; I = inner sphere; O = outer sphere; L = ligand 
assisted.  
 
 Since this work is focused on the transfer hydrogenation, the mechanism of this 
reaction will be discussed in details in the next sections. 
1.4.2 Homogeneous Transfer Hydrogenation of Substrates with Polar Bonds (T 
Mechanism) 
 The transfer hydrogenation and asymmetric hydrogenation of ketones is a useful 
method in organic synthesis.29c,30e-h,35 Among all metals, ruthenium complexes have shown the 
best activities in these reactions (Table 1). Naota et al. have reviewed the general catalytic 
chemistry of ruthenium including ruthenium hydrides and their application in catalytic 
hydrogenation and transfer hydrogenation in 1998.30f A chapter of a book is also dedicated to 
transfer hydrogenations.36 
Q3 Ligand assists
in the H-transfer?
Q2 H- transferred
to a substrate that
is coordinated to
the metal (in the
inner sphere)?
Q1 Source of
"H+/H-"is H2 (g)?
Q1
H (H2-
hydrog.) Q2
HI Q3
HIL
HI
HO Q3
HOL
HO
T (transfer 
hydrog.) Q2
TI Q3
TIL
TI
TO Q3
TOL
TO
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 Different mechanisms have been proposed for these reactions but in many cases they 
can be divided to two types: (1) The TI mechanism in which a hydride is transfered to the 
coordinated substrate and (2) the TO mechanism in which a hydride is transfered in the second 
coordination sphere. In Table 1 typical conditions for the hydrogenation of C=O bonds by 
some of the TI and TO catalysts are listed. 
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Table 1. Typical conditions for the transfer hydrogenation of aldehydes and ketones.12d 
 precatalyst (Ru) substerate (S) H donor (DH2) additives (A) Ru: DH2:A solvent 
conversion 
(%) 
time 
(h) 
temp. 
(° C) 
TOF 
(h-1) cycle ref. 
1 Ru(H)2(H2)(PPh3)3 4-methylcyclo-hexanone iPrOH  1:100:300 iPrOH 91 1 25 91 TI [37a] 
2 RuH2(PPh3)4 4-methylcyclo-hexanone iPrOH  1:100:300 iPrOH 33 24 25 1 TI [37a] 
3 RuH2(PPh3)4 PhMeC = O iPrOH  1:200:neat iPrOH 93 3 85 62 TI [39b] 
4 RuH2(PPh3)4 hexanal PhCH2OH   C6H5Br   80 30 TI [37b] 
5 RuCl2(PPh3)3 PhMeC = O iPrOH  1:200:neat iPrOH 0 3 85 0 TI [39b] 
6 RuCl2(PPh3)3 cyclohexanone iPrOH NaOH 1:1000:neat:24 iPrOH 89 1 82 1800 TI [37c] 
7 RuHCl(PPh3)3 PhMeC = O HCOOH   PhMeC = O/HCOOH 46 3 125  TI [37d] 
8 [RuH(H2){P(CH2CH2PPh2)3}]BPh4 PhMeC = O iPrOH  1:250:12000 THF 96 5 60 50 TI [37e] 
9 [RuH(H2){P(CH2CH2PPh2)3}]BPh4 cyclohexanone iPrOH  1:250:12000 THF 100 1 60 250 TI [37e] 
10 RuH2(CO)(PPh3)3 PhMeC = O HCOOH   PhMeC = O/HCOOH 28 3 125  TI [37d] 
11 RuHCl(CO)(PPh3)3 PhHC = O HCOOH  1:760:1760 PhHC = O/HCOOH 47 3 Reflux 280 TI [37f] 
12 RuHCl(CO)(PPh3)3 PhHC = O HCOOH  1:760:1760 PhHC = O/HCOOH 23 0.27 mwa 860 TI [37f] 
13 Ru4H4(CO)8((-)-diop)2 PhMeC = O iPrOH  Ru:1:2 [Ru] 1 mM PhMeC = O/iPrOH 37 111 120  TI [37g] 
14 Ru4H4(CO)8((-)-diop)2 PhMeC = O iPrOH NaOiPr Ru:1:2 [Ru] 1 
mM PhMeC = O/iPrOH 67 24 120  TI [37g] 
15 [Ru4H3(CO)12]- EtMeC = O iPrOH  1:100 [Ru] 1 mM iPrOH 95 6 82 16 TI [45] 
16 RuH(OTf)(bpzm)(cod) cyclohexanone iPrOH NaOH 1:2100:neat:10 iPrOH  3 80 880 TI [41] 
17 RuH(Tp*)(cod) PhMeC = O iPrOH NaOH 1:500:neat:500 iPrOH   70 30 TI [42] 
18 RuH(Tp*)(cod) cyclohexanone iPrOH NaOH 1:500:neat:500 iPrOH 95 1.7 70 400 TI [42] 
19 RuH(Tp*)(H2)2 cyclohexanone iPrOH NaOH 1:500:neat:500 iPrOH 95 3.7 70 200 TI [42] 
20 Ru(pcp)(OTf)(PPh3) cyclohexanone iPrOH KOH 1:1000:neat:20 iPrOH   82 27000 TI [37h] 
21 RuCl2(PPh3)(oxferphos)  PhMeC = O iPrOH NaOiPr 1:200:neat:4 iPrOH 94 (>99% e.e.) 2 20 100 TI [37i] 
22 [Ru(C5H5)(NCMe)(pn)]CF3SO3 PhMeC = O iPrOH NaOiPr 1:200:neat:2 iPrOH 99 24 25 8 TI [40] 
23 [Ru(C5H5)(NCMe)((R)-ppfa)]CF3SO3 PhMeC = O iPrOH NaOiPr 1:200:neat:2 iPrOH <5 (0 e.e.) 2.5 82 80 TI [40] 
24 RuCl2(Lpr)(PPh3) PhMeC = O iPrOH KOH 1:100:neat:1.5 iPrOH 85 72 83 1.2 TI [44] 
25 RuCl2{PPh2(C6H4SO3Na)}2 PhHC = O NaO2CH PPh2(C6H4SO3Na) 1:100:excess:10 H2O/aldehyde 99.5 1.5 80 67 TI [37j] 
26 RuH(NHCOMe)(OHiPr)(PCy3)2(CO) PhMeC = O iPrOH  1:200 iPrOH >95 6 80 32 TIL [46] 
27 [Ru(C6Me6)(bpy)(OH2)](PF6)2 cyclohexanone NaO2CH  1:200:6000 H2O pH 4 99 4 70 98 TO [47] 
28 [Ru(C6Me6)(bpy)(OH2)](PF6)2 (NaSO3-4-C6H4)MeC = O NaO2CH  1:200:6000 H2O pH 4 98 3 70 103 TO [47] 
29 [RuCl2(C6H6)]2 PhMeC = O iPrOH NH2CH2CH2OH/KOH 1:200:neat:5 iPrOH   28 227 TOL [30e] 
30 [RuCl2(C6H6)]2 PhMeC = O iPrOH NH2CH2CH2NHTs/KOH 1:200:neat:5 iPrOH   28 86 TOL [30e] 
31 RuCl((S,S)-NH2CHPhCHPhNTs)(mesitylene) PhMeC = O HCOOH/NEt3  1:200:neat HCOOH:NEt3 = 5:2 99 (98% S) 20 28 10 TOL [30e] 
32 [RuCl2(C6H6)]2 tBuOOCCH2COMe iPrOH/KOH (1S,2R)-OCHPhCHMeNHCH2C6H4Ph 1:100:neat:2 iPrOH 
99 (67% 
e.e. S) 2.5 20 46 TOL [37k] 
33 [RuCl2(p-cymene)]2 PhMeC = O iPrOH/KOH (1R,2S)-aminoindanol 1:400:neat:4 iPrOH 72 (91% 4 20 72 TOL [37l] 
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e.e.) 
34 RuCl2((R R)-P-NH-cy-NH-P) PhMeC = O iPrOH KOiPr 1:200:neat:0.5 iPrOH 91 (97% e.e. S) 25 23 7 TOL [37m] 
35 RuHCl(PPh3)3 PhiPrC = O HCOOH/NEt3 Amine 1:100:neat:5 HCOOH/NEt3 100 (86% e.e. S) 120 60 0.8 TOL [37n] 
36 Ru2(µ-H)(µ5-Ph2(C6H4OMe)2OH···OC5Ph2(C6H4OMe)2)(CO)4 cyclohexanone HCOOH NaO2CH 1:7200:7200:1400 HCOOH/H2O/ketone 100 3 100 3800 TOL [49] 
a
mw: microwave heating. 
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1.4.2.1 Hydride Transfer to the Substrate in the Primary or Inner Coordination Sphere (TI) 
  The mechanism shown in Scheme 3 is a commonly accepted one for transition metal 
TI catalysts.35b,38 In the first step ketone 1 adds to the coordinatively unsaturated Ru(II) hydrido 
species (A) giving the complex (B). Normally the hydride species (A), which is not isolated, is 
formed from a catalyst precursor. In the second step a hydride migrates to the carbon atom and 
the new unsaturated ruthenium species (C) will be formed. The hydrogen transfer agent cleaves 
the coordinated alkoxide by protonation in the third step and subsequently transfers a hydride 
to the metal by a β-hydride elimination. In the last step the oxidized hydrogen donor will be 
eliminated. A ruthenium hydrido species could only be detected in some cases.30h,34,39 
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Scheme 3. The inner sphere transfer hydrogenation mechanism (TI). 
 
 Allowing the TI mechanisn, ruthenium complexes with bidentate ligands containing 
phosphorus and nitrogen donors (P–N) have shown high activities in transfer hydrogenation. 
Complexes of the type [Ru(C5H5)(NCMe)(P–N)](CF3SO3) shown in Scheme 4 catalyze the TI 
of acetophenone in 2-propanol (Table 1, entries 22, 23).40 Although chiral ligands were used no 
e.e. was observed. This proves that the nitrogen end of the chelating ligand is hemilabile and 
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will dissociate from the metal center during the hydride transfer to the ketone (Scheme 4). The 
dbd ligand (dbd = N,N-dimethyl-2-diphenylphosphinoaniline) has a rigid structure and is not 
able to dissociate. Therefore the ruthenium complex has a low activity. A much more active 
precatalyst is realized with [Ru(C5H5)(PPh3)(NCMe)2]CF3SO3 which possesses more vacant 
coordination sites.40 
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O C
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Scheme 4. TI of ketones catalyzed by complexes RuH(C5H5)(P–N). 
 
 Chelating nitrogen ligands also have shown activity in the transfer hydrogenation of 
ketones in the presence of a base, e. g. NaOH. For instance RuH(OTf)(bpzm)(cod) (bpzm = 
bis(pyrazol-1-yl)methane, cod = cycloocta-1,5-diene, Figure 3), was reported to catalyze the 
transfer hydrogenation of cyclohexanone by propan-2-ol at 80 °C (Table 1, entry 16).41 The 
complex RuH(Tp*)(cod) with a tridentate nitrogen-donor ligand (Tp* = hydridotris(3,5-
dimethylpyrazolyl)borate) was found to be active for the transfer hydrogenation of 
cyclohexanone and acetophenone in 2-propanol (Table 4, entries 17 and 18).42 RuH(Tp*)(cod) 
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is formed from RuH(Tp*)(H2)2 in the presence of NaOH and COD (Table 1, entry 19) and 
catalyzes the transfer hydrogenation of cyclohexanone.  
RuN
N
H
OTf
N
NH
H
 
Figure 3. Structure of RuH(OTf)(bpzm). 
 
 The complex RuCl2(PPh3)L with a tridentate ligand L containing P, N and O donor 
sites (Scheme 5) is another activate catalyst for the transfer hydrogenation of cyclic ketones 
and acetophenone (TOF: 118800 h-1) in basic media.43 In this case no ruthenium(II) hydrides 
have been observed. 
N
H PPh2
O
Me
iPr
 
Scheme 5. Tridendate ligand containing P, N and O donor sites.  
 
 However the trans-RuCl2L(PPh3) complexes of the tridentate PNP ligands 
PPh2CH2CH2NRCH2CH2PPh2 (R = n-Pr (Lpr), n-Bu (Lbu), n-Hex (Lhex), CH2Ph (Lbz)) were 
poor transfer hydrogenation catalysts (Table 1, entry 24) and their activities decreased as the 
size of the R group on L increases.44 In this reaction also no ruthenium(II) hydrides were 
detected. 
 Bhaduir et al.45 have reported that the anionic hydrido carbonyl cluster [Ru4H3(CO)12]- 
can catalyze the transfer of hydrogen from 2-propanol to methylethylketone (Table 1, entry 15) 
or 2-cyclohexenone at 82 ◦C but this reaction suffers from poor selectivity of C=O over C=C 
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bond hydrogenation which was explained by a radical mechanism for the hydrogen transfer. 
Transfer hydrogenation of ketones ceased by using precisely purified isopropanol as the 
hydrogen donor. Adding hydroperoxide HOOtBu, the reaction started. The authors believe that 
the ruthenium cluster fragmentates and thus can initiate a radical chain propagating by 2-
propoxy radicals and cyclohexenone-derived radicals. 
1.4.2.1.1 Hydride Transfer to the Substrate in the Inner Coordination Sphere with 
Ancillary Ligand Assistance (TIL) 
 The ruthenium - acetamido complex RuH(NHCOMe)(HOiPr)(PCy3)2(CO) is an 
effecient precatalyst for the TIL of both aryl- and alkyl-substituted ketones and imines (Table 
1, entry 26).46 Following the proposed mechanism (Scheme 6), a PCy3 ligand will dissociate 
from the precatalyst which activates it to the catalyst, RuH(NHCOMe)(HOiPr)(PCy3)(CO). 
Addition of phosphine inhibited the reaction which is a strong evidence for the dissociation 
equilibrium.  
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Scheme 6. The TIL hydrogenation of acetophenone by RuH(NHCOMe)(HOiPr)(PCy3)2(CO) in 
iPrOH. 
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1.4.2.2 Hydride Transfer to the Substrate in the Outer Coordination Sphere (TO) 
 The 2,2'-bipyridine ligand (bpy) in the complex [Ru(C6Me6)(bpy)(OH2)](PF6)2 was 
found to promote TO catalysis in water or water/organic biphasic systems.47 For the 
hydrogenation of water-soluble as well as water insoluble ketones, TOFs range from 20 to 150 
h-1 at 70 °C for the hydrogen transfer from sodium formate (e.g. entries 27–28 in Table 1) and 
the reaction reaches its maximum rate at pH 4. The formate complex 
[Ru(O2CH)(C6Me6)(bpy)]+ and the hydrido complex [RuH(C6Me6)(bpy)]+ are two observed 
intermediates in the catalytic cycle. The later complex could be identified by a resonance at -
7.45 (s) in its 1H NMR spectrum. Although the hydride is stable within the pH range of 5 to 9 
at temperatures greater than 40 °C, the maximum rate of the hydrogenation occurred at pH 4 
which was explained in terms of acid assistance in the hydride transfer step (see Figure 4). The 
narrow pH range for this catalysis can be explained as follows: Since the pKa of HCOOH is 
3.6, the rate maximum occurs in the presence of the formate ligand HCOO-. The pKa of the 
aqua complex [Ru(C6Me6)(bpy)(OH2)]2+/[Ru(C6Me6)(bpy)(OH)]+ is 7.3 which means that 
below pH 7.3, the aqua ligand can be displaced by formate while the hydroxide complex is 
present above pH 7.3 which it is not reactive towards formate. 
Ru
HN
N
C O
R2
R1
H
 
Figure 4. Acid assisted hydride transfer to ketones from [RuH(bpy)(C6Me6)]+.  
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1.4.2.2.1 Hydride Transfer to the Substrate in the Outer Coordination Sphere with 
Ancillary Ligand Assistance (TOL) 
 The discovery of Noyori and coworkers that the ligand can play a critical role in the 
hydrogen transfer to unsaturated compounds strongly influenced the strategies for catalyst 
design. Morris12d described the role of the ligand as follows (Scheme 7): (1) activation of the 
carbon atom of the unsaturated substrate for a nucleophilic hydride attack via performing a 
hydrogen bond to the oxygen or nitrogen atom of the substrate, (2) allowing a cyclic transition 
state for H+/H- transfer via a correct hyperconjugation with the metal, (3) serving as a source of 
the proton to be transferred along with the hydride from the metal, and (4) providing a point of 
interaction for enantioselective recognition of a prochiral substrate. Usually, the substrate does 
not coordinate to the metal and is located within the second coordination sphere of the catalyst 
complex. 
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Scheme 7. TOL mechanism involving a hydrogen on a co-ligand. 
 
 Noyori’s discovery of the NH effect was a revolution in transfer hydrogenation 
catalysis.30e,4b,38,48 A highly efficient catalyst system is produced by mixing chelating ligands 
with NH2 groups, such as 2-aminoethanol or the mono-N-tosylated diamine TsNHCH2CH2NH2 
with a base and [RuCl2(benzene)]2 in 2-propanol (Table 1, entries 29–30). Using N,N-
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dimethylated compounds, totally inactive ruthenium complexes were synthesized. This was the 
first evidence for the “NH effect” in the hydrogenation of polar bonds. 
 The mechanism shown in Scheme 8 is proposed for the action of these catalysts in the 
hydrogenation of ketones providing an example for the TOL mechanism shown in Scheme 
7.30e,4b ,38,48a Forming a hydrogen bond with the NH hydrogen atom on the axial tosylated 
diamine ligand, the ketone orients in the second coordination sphere. The hydride (δ-) to 
substrate sp2-carbon (δ+) contact and a substrate aromatic ring to η6-ring interaction are two 
chiral points to cause enantioselectivity.48a An alcohol in the (S)-configuration is produced via 
a concerted H-/H+ transfer and then the hydrido-amine complex is regenerated by reaction with 
2-propanol or formic acid.  
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Scheme 8. TOL of arylketones catalyzed by RuH(NH2CHPhCHPhNTs)(η6-arene) and 
Ru(NHCHPhCHPhNTs)(η6-arene) (arene = C6H6, MeC6H4iPr, C6H3Me3, Ts = SO2C6H4Me). 
 
 Shlov’s catalyst benefits from a hydroxyl group on the ligand and catalyzes the ketone 
or aldehyde transfer hydrogenation using formic acid (Figure 5).49 
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Figure 5. Shlov’s catalyst. 
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1.5 C-H Bond Activation  
 A prevalent topic in transition metal chemistry is the controlled activation of small and 
relatively inert molecules. Its development began in the late 1950s.50 A yet unsolved problem 
in this area which is usually referred is the activation of alkanes. Until now, the reactivity of a 
variety of molecules has been changed by binding them to metal centers due to changes in the 
relative energies of their orbitals or their polarity. For instance, upon coordination to a metal 
centre olefins and carbon monoxide are more prone to a nucleophilic attack,51 while 
coordinated dioxygen often reacts with electrophiles.52 Even classic inert small molecules like 
dinitrogen participate in chemical transformations when coordinated to a transition metal.53 
Principally, activating inert C–H bonds should be possible in the same way, but it should not 
be forgotten that the small molecules mentioned above all possess lone electron pairs and/or π 
orbitals to interact with empty orbitals of the metals. Alkanes have none of them. 
 In fact, before 1980s, most of the reactions of C–H bonds coordinated to transition-
metal centers ran successfully only through the participation of the π orbitals of aromatic C–H 
units (Scheme 9, equation (3) 54) and/or engagement of an intramolecular reaction, wherein the 
moiety with the C–H bond to be activated is attached to the metal (Scheme 9, equation (4) 55 & 
equation (5) 56).  
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Scheme 9. Assisted C–H bond activation at transition-metal centers. 
 
1.5.1 Classification of C-H Activation Reactions 
 In this section the C–H activation at metal centers leading to bond formation between a 
metal and an alkane carbon atom will be discussed. Bercaw50 has classified these reactions 
according to their overall stoichiometry into five classes. In four classes, stable organometallic 
species are formed but usually just two of these happen. In the fifth class, transient 
organometallic species are considered to be reaction intermediates. 
1.5.1.1 Oxidative addition 
 Low valent complexes of ‘late’ transition elements such as Re, Fe, Ru, Os, Rh, Ir, Pt 
are electron-rich and can undergo oxidative addition reactions (equation (6)). In some cases the 
reactive coordinatively unsaturated species [LnMx] is generated from a suitable precursor by 
thermal or photochemical decomposition. For instance, (η5-C5Me5)(PMe3)IrIIIH2 loses H2 under 
photoirradiation to give the (unobserved) intermediate (η5-C5Me5)(PMe3)IrI (equation (7)).57 
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[LnMx] + RH LnMx+2
H
R
(6)
hv
-H2
Ir HMe3P
(7)Ir HHMe3P
 
Scheme 10. CH bond activation via oxidative-addition. 
 
1.5.1.2 Sigma-bond metathesis 
 Alkyl or hydrido complexes of ‘early’ transition metals from group 3 of the periodic 
table (sometimes also metals of groups 4 and 558) with d0 electron configurations may undergo 
a reversible reaction according to equation (8a).59  
 
Scheme 11. Sigma-bond metathesis. 
 
 Mainly R and R' are both alkyl groups and instead of a total alkane activation, an 
interchange of alkyl fragments will occur. Although interconversions of dihydrogen and metal 
alkyl with alkane and metal hydride (equation (8c)) are observed60, C–C single bonds 
formation through the alternative exchange shown in equation (8b) is not known yet. 
1.5.1.3 Metalloradical activation 
 Alkane C–H bonds can be broken reversibly by rhodium(II) porphyrin complexes 
which exist in a monomer–dimer equilibrium (equation (9)). The most reactive hydrocarbon 
for this class of reaction is methane. According to the fact that the Rh–H bond strength is low 
(around 60 kcal mol-1 compared to the 105 kcal mol-1 C–H bond of methane) the generation of 
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the free alkyl radicals through the abstraction of a hydrogen atom from methane by the Rh 
centre is prohibitively endothermic. This excludes the mechanism involving free alkyl radicals 
in agreement with inferences from experimental observations.61 
[(por)RhII]2 2 (por)RhII (por)RhIII-CH3 + (por)RhIII-H (9)
 
 
1.5.1.4 1,2-Addition 
 The addition of an alkane to a metal-nonmetal double bond is a 1,2-addition reaction. 
For instance methane is added to a Zr–N double bond (equation (10)),62 however just benzene 
is activated by a similar system and not methane.63 Despite the unclear scope of alkane 
additions across M = N and M = C double bonds, this type of reaction is reported for other 
early and middle transition-metal centers.64 
(R'NH)3ZrR heat
-RH
(R'NH)2Zr=NR'
CH4 (10)(R'NH)2ZrCH3
 
 
1.5.1.5 Electrophilic activation 
 Although organometallic species are not observed as intermediates in certain reactions 
with functionalized alkanes as the product, these types of reactions (equation (11)) are 
classified as electrophilic activation reactions. Usually, this occurs in strongly polar media for 
late- or a post-transition metals (Pd2+, Pt2+ and/or Pt4+, Hg2+, Tl3+).65 The assumed 
organometallic species [LnMx+2(R)(X)] is formed by electrophilic activation via substitution of 
a metal by a proton as shown in equation (12a). A possible route leading to the product is 
shown in equation (12b). 
LnMX+2X2 + R-H [LnMX] + RX + HX (11)
[LnMX+2(R)(X)] + HX (12a)
[LnMX+2(R)(X)] [LnMX] + RX (12b)
LnMX+2X2 + R-H
 
Scheme 12. Electrophilic activation. 
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1.6 Coupling Reactions 
 The usefulness of palladium-based catalysts is certainly revealed by the number of 
articles published in any recent organic chemistry journal.66 Cross-coupling reactions catalyzed 
by palladium seem to be the most powerful methods for C-C bonds formation. Generally 
palladium assists the C-C bond formation between less-reactive organic electrophiles e. g. aryl 
halides, and different carbon nucleophiles. 
 Stoichiometric reactions of reactive nucleophiles with electrophiles or pericyclic 
reactions were the common methods for C-C bond formation about 50 years ago. Actually, 
today's carbon–carbon bond-forming methods were started by oxidation catalysis: An 
important revelation was the application of palladium(II) catalysts in the oxidation of olefins to 
carbonyl compounds. The Wacker process67 is the master example. In the late 1960s, coupling 
reactions of arylmercury compounds in the presence of either stoichiometric or catalytic 
amounts of palladium(II) were developed by Richard Heck.68 In 1972, the well-known “Heck 
reaction” 69 was established by him based on the reaction of phenylmercuric acetate and lithium 
tetrachloropalladate under an atmosphere of ethylene.68a Tsutomo Mizoroki had described a 
similar reaction in 1971.70 
 Using organometallic catalysis for the coupling between aryl halides and olefins was a 
breakthrough in organic synthesis which made further applications possible. Therefore, during 
the 1970s palladium-catalyzed coupling reactions were investigated incessantly (Scheme 13). 
Sonogashira coupling of aryl halides with alkynes is an example in which catalytic amounts of 
palladium and copper salts are used.71 
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Scheme 13. Some examples of palladium-catalyzed C-C coupling reactions. 
 
 Arylzinc and arylmagnesium were used by Negishi72 and Murahashi73, respectively in 
palladium-catalyzed coupling reactions instead of alkenes or alkynes. Recently, the famous 
Negishi and Kumada coupling reactions have found extensive applications. Despite the fact 
that nickel can catalyze similar cross-coupling reactions concerning reactivity, selectivity, and 
functional-group tolerance palladium has found wider application. Palladium-catalyzed 
coupling of arylboronic acids and esters with aryl halides were discovered by Suzuki and 
Miyaura74 for the synthesis of symmetric and unsymmetric biaryls. The use of air-stable and 
readily accessible arylboronic acids is the main advantage of the Suzucki-Miyaura coupling. In 
the same way, the palladium-catalyzed coupling of aryltin and arylsilanes were investigated by 
Stille75 and Hiyama76. Nowadays, highly efficient C-O and C-N bond formations are also 
known. The Buchwald–Hartwig amination is the most remarkable one.77 
 After their discovery, palladium-catalyzed cross-coupling reactions became rapidly 
popular. There are several reasons for their success: The tolerance of the methods to a wide 
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range of functional groups on both coupling partners is their noticeable feature. This allows the 
efficient construction of the complex organic building blocks in few steps. Additionally, a fine-
tuning of the reactivity is possible by the development of ligands and co-catalysts. In the last 
two decades there has been no other organometallic method that has a broader investigation in 
academic laboratories and application in industry.78 Their significance and superiority in 
organic chemistry is highlighted by awarding the Noble prize to the Heck, Negishi and Suzuki 
in 2010.  
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2  Motivation 
 The good results of the previous studies on the catalytic activity of ruthenium 
complexes in transfer hydrogenation done in Prof. Werner R. Thiel’s group79,80 were our 
motivation to optimize the structure of these complexes to obtain better catalysts working 
under milder conditions. These studies have shown that bidentate or tridentate pyrazole-based 
ligands such as bispyrazole and bispyrazolylpyridine are suitable for the ruthenium catalyzed 
hydrogenation and transfer hydrogenation of ketones. Changing the substituent on the 1-, 4- or 
5 position of the pyrazole ring, the steric and electronic characteristics of the pyrazole 
containing ligands can be controlled (Scheme 14). This makes these ligands potentially suitable 
for applications in catalysis.  
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Scheme 14. Different possibilities for modifications at the pyrazole ring. 
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Scheme 15. The desired bispyrazolylpyridine with different substituents at the pyrazole rings. 
 
 The discovery of Noyori and coworkers that activities and selectivities can be improved 
by the presence of a N-H functionality in the ligand being in close proximity to the metal site 
(bifunctional catalysis)5 was a significant breakthrough in hydrogenation catalysis and later on 
strongly influenced the strategies for catalyst design. Previous studies in Prof. Thiel’s group 
have shown that the NH group of the pyrazole ring act in this way.79,80 Another aim of this 
work was to find methods to substitute the pyrazole against a 2-aminopyrimidine ring hoping 
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that with the NH2 group of this new ligands a bifunctional mechanism might be realizable 
(Schema 16). The ruthenium complexes of these ligands had to be examined for transfer 
hydrogenation of ketones. Also, the mechanism of the reaction had to be investigated. 
N N
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N N
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Scheme 16. Replacing the pyrazole against a 2-aminopyrimidine. 
 
 The NH2 group of the new ligands is a potential site for the introduction of new 
substituents leading to multidentate ligands. Multidentate ligands, having pyrimidine groups as 
relatively soft donors for late transition metals and possessing simultaneously a binding 
position for a hard Lewis-acid are matter of interest in the SFB/TRR-88 (3MET) at the TU 
Kaiserslautern. Synthesis and characterization of such ligands were another aim of this work 
(Scheme 17). 
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Scheme 17. Introducing substituents on the amino group to obtain soft and hard donor sites. 
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3 Results and Discussion 
3.1 Ligand Synthesis 
 The development of new ligands bearing donor atoms other than phosphorus has 
aroused increasing interest in coordination chemistry, homogeneous catalysis, and organic 
synthesis. Mixed-donor ligands have been widely used as a result of the versatility arising from 
the different stereoelectronic properties of the multiple coordination sites, providing a unique 
reactivity of their metal complexes.81 Ligand lability is an important feature of many efficient 
catalysts since ligand dissociation steps are often involved in catalytic cycles. However, too 
much lability may lead to catalyst decomposition. Thus, at least one strongly coordinating 
donor is certainly required for a ligand to be used for the preparation of a transition-metal 
catalyst, especially when other labile sites are present. In general, a balance between the 
stability of the organometallic catalysts and the need to incorporate dissociable ligands is 
desirable for highly efficient catalysts relying on ligand dissociation in their catalytic reaction. 
Bidentate pyridine-derived ligands are commonly present in coordination chemistry and 
homogeneous catalysis, while recently symmetric tridentate planar N3 ligands with pyridine 
backbones such as 2,2':6',2''-terpyridines82, 2,6-bis(imino)pyridines83, and 2,6-
bis(oxazolinyl)pyridines84 have been investigated. 
3.1.1 Synthesis of NNN Ligands 
 The chemistry of pyrazole, pyrimidine and their derivatives has been studied for more 
than 100 years.85-88 A wide bunch of synthetic routes leading to these structures have been 
worked out, since some members of the pyrazole and pyrimidine family play economically 
prominent roles in pharmacy and agrochemistry.83 However, there are only two routes of 
general importance:81,89 the five-membered pyrazole ring system can either be formed by 
combining a diazomethane derivative and an acetylene in a 1,3-dipolar cycloaddition or by ring 
closure using hydrazine and a β-diketone or a derivative of similar reactivity (Scheme 18). The 
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latter strategy also allows the access to pyrimidines when formamidines, ureas, thioureas or 
guanidines are applied for the ring closure instead of hydrazine. This method is obviously 
favorable since the substitution pattern of the resulting 1H-pyrazole/pyrimidine can readily be 
determined by the starting materials. A large number of syntheses of pyrimidines82 and 
bispyrimidines83 have been described in the literature but there are just a few reports on 
pyridylpyrimidines.84 
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Scheme 18. Formation of five/six-membered ring systems. 
 
3.1.1.1 Synthesis of Ligands with a Bispyrazolylpyridine Backbone 
 Symmetrical tridentate planar bispyrazolylpyridines ligands have been synthesized and 
investigated in the recent years in Thiel’s group90, but further modifying of these ligand was 
requested to get optimized ligands suitable for the ruthenium catalyzed transfer hydrogenation.  
3.1.1.1.1 Synthesis of the Precursors 
 Bispyrazolylpyridine are used as the backbone of the new ligands and synthesized as 
follows: 
3.1.1.1.1.1 Synthesis of 2,6-di(1H-pyrazol-3-yl)pyridine 
 Starting from 1,1'-(pyridine-2,6-diyl)diethanone, 2,6-di(1H-pyrazol-3-yl)pyridine can 
be synthesized easily in two steps according to the literature.26h In the first step 1,1'-(pyridine-
2,6-diyl)diethanone is refluxed with 1,1-dimethoxy-N,N-dimethylmethanamine. The product is 
(2E,2'E)-1,1'-(pyridine-2,6-diyl)bis(3-(dimethylamino)prop-2-en-1-one) which will condense 
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in the second step with hydrazinhydrate under reflux conditions in ethanol as the solvent to 
obtain 2,6-di(1H-pyrazol-3-yl)pyridine (Scheme 19). 
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Scheme 19. Synthesis of 2,6-di(1H-pyrazol-3-yl)pyridine. 
 
 In addition to the resonance of the AB2-system of the pyridine ring, two characteristic 
doublets at about 6.08 ppm and 6.86 ppm assigned to the protons in the 4- and 5-position of the 
pyrazol rings are observed in the 1H NMR spectra of 2. 
3.1.1.1.1.2  Synthesis of the Bispyrazolylpyridine Backbone with Substituted Pyrazol Rings 
 To synthesize 2,6-di(pyrazol-3-yl)pyridine having alkyl or aryl groups as substituents a 
two step method known from the literature (Scheme 20) was applied.91 
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O
O
N
N NHNHN
R R
 
Scheme 20. Synthesis of 2,6-di(pyrazol-3-yl)pyridine from dimethyl pyridine-2,6-
dicarboxylate. 
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 Here dimethylpyridine-2,6-dicarboxylate is reacted with the proper methylalkyl- or 
methylarylketone. Methylketones are favorably deprotonated regioselectively at the methyl 
group using sodiummethanolate as the base (Schema 21). The best solvent for this reaction is 
tetrahydrofuran (THF). It is required that the solution of the methylketone in THF is added 
dropwise to a suspension of sodiummethanolate and dimethyl pyridine-2,6-dicarboxylate. 
Finally the mixture is refluxed for four hours leading to the sodium salt of the tetraketone 
which can be converted to product by acidifying the reaction medium at the end.  
 
Scheme 21. Synthesis of the tetraketones 3a-e. 
 
 According to the structure of the tetraketones a series of tautomers can be formed via 
keto-enol tautomerization.92 They can be detected in the 1H NMR spectra of these compounds. 
The protons of the hydroxyl group of the enol form of a 1,3-diketon appears at lower field 
between 15 and 16 ppm. In the IR spectrum, intensive absorptions at about 1600 cm-1 and 3100 
cm-1 can be assigned to carbonyl and hydroxyl groups, respectively.  
 The pyrazol rings of the 2,6-di(pyrazol-3-yl)pyridines 4a-e were formed via a 
condensation reaction between the 1,3-diketones (3a-e) and hydrazine (Scheme 22).93 Using 
this method, 2,6-di(pyrazol-3-yl)pyridines with different substituents can be synthesized easily 
and in good yields. 
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Scheme 22. Synthesis of the 2,6-di(pyrazol-3-yl)pyridines 4a-e. 
 
 The solubility of the 2,6-di(pyrazol-3-yl)pyridines without any substituent is poor in 
most organic solvents. By introducing long chain alkyl or aryl groups, the solubility can be 
controlled.82 In the 1H NMR spectra of the compounds 4a-e a characteristic singlet for the 
proton in the 4-position of the pyrazol ring can be observed at about 6.5 ppm in addition to the 
AB2-system of pyridine ring. In the 13C NMR spectra a resonance appearing at about 101 ppm 
can be assigned to the corresponding carbon atom. 
3.1.1.1.2  Synthesis of Allylated Bispyrazolylpyridine Ligands 
 By introducing allylic side chains in the 1- and 1’-positions of the pyrazole rings, the 
2,6-di(pyrazol-3-yl)pyridine is functionalized with substituents of moderate bulkyness. 
Furthermore one could expect the allylic side chains offering chelating π-donating elements, 
that could stabilize a 16VE ruthenium(II) intermediate in a hemilabile manner, but will not be 
hydrogenated itself under the given reaction conditions of the transfer hydrogenation. 
Deprotonation of the pyrazole units with LiH in THF and subsequent allylation with 
allylicbromide gives the 2,6-bis(1-allyl-5-alkyl/aryl-1H-pyrazol-3-yl)pyridines 5 and 6a-e 
(Scheme 23). It should be noted here, that the use of NaH for the deprotonation of 2 or 4a-e 
leads to the formation of quite stable six coordinate sodium complexes, which hamper the 
isolation of the target ligands.  
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Scheme 23. Synthesis of the 2,6-bis(1-allyl-5-alkyl/aryl-1H-pyrazol-3-yl)pyridines 5 and 6a-e. 
 
 By functionalization of the pyrazole ring with an alkyl group (as is shown in Table 2), 
the resonance of H5 on the pyrazole ring changes from a doublet to a singlet and shifts by 
about 1 ppm towards higher field. Also H2 shifts by about 0.5 ppm towards higher field 
compared to 5, indicating an increased electron density in the pyrazol ring, which is also 
reflected in the 13C NMR resonances of these compounds. For the cycloheptyl annulated ligand 
6d, there is no pyrazole proton resonance anymore and the 13C resonance of C5 is shifted to 
lower field, too. (Figure 6 & 7). The methylene protons at the allylic side chains of these 
compounds show doublets between 4.62 and 4.91 ppm indicating that these hydrogen atoms 
are magnetically equivalent. As expected, the two protons H9 which are not magnetically 
equivalent give two doublets slightly shifted upfield when the pyrazole ring is functionalized 
with an alkyl group.  
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Table 2. 1H and 13C NMR shifts of the ligands 
 
R H1 C1 
H2 
C2 
5 H 7.86 143.3 
8.22 
121.4 
6a nbutyl 7.59 144.4 
7.79 
117.9 
6b tbutyl 7.62 150.5 
7.85 
118.5 
6c noctyl 7.65 144.6 
7.83 
118.2 
6d cycloheptyl 7.66 143.6 
7.74 
119.8 
6e npropyl 7.68 143.4 
7.83 
118.2 
 
Figure 6. 1H NMR spectrum of ligand 
5 and 6a-e. 
H3 
C3 
H4 
C4 
H5 
C5 
H6 
C6 
H7 
C7 
H8
C8
----
147.9 
----
144.8 
7.75 
108.9 
----
131.7 
4.85 
55.4 
6.08
5.98
132.0
----
151.8 
----
150.7 
6.76 
103.1 
----
136.5 
4.62 
51.6 
5.95
5.82
133.1
---- 
152.8 
---- 
152.2 
6.81 
 
----
136.9 
4.91 
53.7 
6.00
5.90
134.7
----
152.2 
----
151.1 
6.81 
103.5 
----
136.6 
4.72 
51.9 
5.99
5.92
133.5
----
153.5 
----
147.5 
---- 
120.7 
----
136.4 
4.72 
52.2 
5.99
5.90
133.8
----
152.2 
----
151.2 
6.81 
103.6 
----
136.7 
4.73 
52.0 
6.01
5.91
133.5
6d. 
 
 
H9 
C9 
-
 
 
5.31-5.24 
119.7 
-
 
 
5.05 & 
4.88 
116.5 
-
 
 
5.19 & 
5.01 
116.9 
-
 
 
5.15 & 
4.98 
116.8 
-
 
 
5.15 & 
5.00 
116.6 
-
 
 
5.16 & 
4.98 
116.8 
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Figure 7. 13C NMR spectrum of the ligand 
 
3.1.1.2 Synthesis of Ligands with 
 In proceeding with Thiel
pyrazolyl)pyridines as ligands for homogeneous catalysis,
method to prepare substituted 2
pyrimidyl)pyridines to use them as building blocks for new multidentate ligands. Apart from 
Balavoine et al. who were able to synthesize 2
amino-4-pyrimidyl)pyridine by ring closure with guanidinium nitrate and 1
dimethylaminoprop-2-enone and [2,6
 
6d. 
a Bispyrimidylpyridine Backbone 
’s group studies concerning the synthesis of 
91c,94-100
 I sought a mild and efficient 
-amino-4-(2-pyridyl)pyrimidines and 2,6
-amino-4-(2-pyridyl)pyrimidine and 2,6
-bis(3-dimethylamino-1-oxoprop
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N-alkylated 2-(3-
-bis(2-amino-4-
-bis(2-
-(2-pyridinyl)-3-
-2-en-yl)pyridine] 
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(Scheme 24),93 there is no report on an efficient syntheses of such ligands from a β-diketone or 
a derivative of comparable reactivity. 
N
O O
NN
EtOH, ref lux
N
NH2NH2
NH2
NO3
N NN N
NH2 NH271
 
Scheme 24. Synthesis of 2,6-bis(2-amino-4-pyrimidyl)pyridine. 
 
 The tetraketones 3 are simply accessible by the condensation of methylalkylketones and 
diethyl pyridine-2,6-dicarboxylate in the presence of a base26h as discribed in section 
3.1.1.1.1.2 (Scheme 21). The ring closure of 3c with an excess of guanidinium carbonate is 
carried out under conventional reflux conditions in presence of NaOMe with ethanol as the 
solvent. After removal of the solvent and recrystallisation, 8c is obtained as a yellow solid but 
in just about 9% yields (Scheme 25). Using other solvents such as butanol and DMF101, 
allowing to do the reaction at higher temperatures, did not improve the yields. Moreover 
different type of guanidium salts such as carbonate, nitrate and chloride have been tested, but 
no product was gained. Application of microwave heating also failed.  
 
Scheme 25. Synthesis of the 6,6'-(pyridine-2,6-diyl)bis(4-alkylpyrimidin-2-amine) in a polar 
solvent. 
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+
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20h, RT
CH3CN
24 h, RT
MnO2
10
NN
2
Scheme 26. Different starting materials tested for synthesizing pyrimidine based N,N,N 
ligands. 
 
 Changing the starting material to compounds 9 or 11 was expected to provide a solution 
to this problem. Compound 9 was synthesized according to published procedures via aldol 
condensation (Scheme 26).102 2,6-Diacetylpyridine and two equivalents of a substituted 
arylaldehyde and diethylamine as the catalyst were refluxed overnight in propanol. The orange 
to yellow crystalline precipitate was filtered off and washed with ice-cold methanol. Suitable 
yellow needle like crystals of 9 for X-ray crystallography were obtained from dichloromethane. 
The structure is shown in Figure 8. The bond lengths C(4)-O(1), C(4)-C(5), C(5)-C(6), C(6)-
C(7) are 1.2284, 1.4591, 1.3419, 1.4506 Å, respectively, showing that C(4)-C(5) and C(6)-C(7) 
have more single bond characteristics and C(4)-O(1) and C(5)-C(6) are almost double bonds. 
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Figure 8. Molecular structure of 9 in the solid state. 
 
 According to the mechanism of the aldol condensation (Scheme 27) this method is 
limited to the usage of arylaldehydes. 
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Scheme 27. Aldol condensation mechanism. 
 
 Reacting 9 with different guanidinium salts in refluxing ethanol in the presence of a 
base such as NaOH or NaOEt results in an oily brown substance which was not the product 
according to its 1H NMR spectrum. 
 To obtain 10, hept-1-yn-3-ol was synthesized first according to published methods103 as 
follows: Pentanal was added slowly to a solution of ethynylmagnesium bromide at -78 °C. The 
mixture was stirred for 45 min at -78 °C and then quenched with a saturated solution of 
ammonium chloride. The aqueous layer was separated and extracted with diethyl ether. The 
organic layer was washed with water and then brine, dried over anhydrous magnesium sulfate, 
and filtered. Evaporation of the solvent was followed by a Kugelrohr distillation and yielded 
hept-1-yn-3-ol as a colorless oil. To couple 2,6-dibromopyridine with hept-1-yn-3-ol 2.5 
equivalents of triethylamine were added to a solution of 2 mol % of Pd(PPh3)Cl2, 8 mol % of 
CuI, 2,6-dibromopyridine in dry THF.104 A color change from yellow to orange was observed. 
Then a solution of 2.2 equivalents hept-1-yn-3-ol 2.5 in dry THF was added dropwise, which 
resulted in a color change to brown. In this stage the reaction mixture became warm and if 
needed (depending on the amount) the mixture should be cooled. The reaction mixture was 
stirred at room temperature over night. Evaporating the solvent gave a brown oil, which 
contained 11 and some impurities according to its 1H NMR spectrum. Column chromatography 
on silica gel eluting with ethylacetate did not give a pure product. Attempts to purify the 
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product by sublimation or crystallization also failed. So the reaction was continued with this 
raw product hoping that the final product can be purified. To the solution of 11 in dried 
CH2Cl2, 20 equivalents of activated MnO2 were added. The reaction mixture was stirred for 24 
h at room temperature and then filtered through MgSO4. Evaporating the solvent gives a brown 
solid which was applied to the column chromatography on silica gel eluting with 
hexane:ethylacetate 1:1. The solvent was evaporated leading to a brown oil. In its 1H NMR 
spectrum, the peaks of the product were not detected. According to these results it seems that 
the β-diketone 3 is the only reactant with which the desired product can be obtained. 
 Looking at the reaction mechanism it becomes obvious that the base used to activate 
the guanidinium salt will deactivate the β-diketone (Scheme 28). Moreover there are some 
reports105 showing that using a polar solvent such as ethanol is not suitable for this type of 
reactions. However, non-polar solvents cannot be used since they are not able to dissolve the 
guanidinium carbonate.  
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Scheme 28. Deactivation of the diketone by the base. 
 
 Fusing just the guanidinium salt and the diketone will result in the product but in low 
yield106 (12%). Searching for a base which can activate the guanidinium carbonate but will not 
deactivate the β-diketone, I came up with the idea to use silica or alumina. Silica or alumina, 
guanidinium carbonate and 3 were mixed and ground and the reaction was carried out at 
different temperatures with different ratios of silica and alumina to reactants. The optimized 
conditions were found as follows: the reaction proceeded with two mass equivalents of silica at 
200 °C for 4 h. Using two mass equivalents of silica are essential because the silica is not only 
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the base but also it will absorb the water being released during the reaction (Scheme 29). It is 
noteworthy to mentain that using guanidinium nitrate did not result in product formation. It 
seems that releasing the CO2 gas is necessary as a driving force for the reaction. The resulting 
ligands are too soluble and could not be purified by crystallization. Unfortunately all attempts 
to find a suitable mixture of solvents for column chromatography also failed. Acidifying with 
HCl and trying to perticipate the hexaflourophosphate salt was as well unsuccessful. Only the 
ligand with the tbutyl substituent was pure enough to be applied in the syntheses of 
multidentade ligands (see section 3.1.5). 
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Scheme 29. Mechanism of ring closure and water releasing. 
 
 This method is limited to compounds bearing alkyl groups on the pyrimidine ring and 
all efforts failed to do the reaction with reactants which are functionalized by aryl groups. The 
most visible difference between reactants with alkyl and aryl group is that the alkyl derivatives 
are waxy or oily and can be ground with the other reactants more efficiently than the powdery 
reactants with an aryl group. Even changing the reactant to 9 did not work probably for two 
reasons: first this powdery reactant cannot be ground and mixed well with the other reactants. 
Second, according to the ring closure mechanism (Scheme 30) elimination of H2 is required in 
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the last step which is just possible in the presence of a strong base or an efficient oxidizing 
agent. 
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Scheme 30. Mechanism of ring closure with reactant 9. 
 
 As it is shown in Table 3, functionalizing the pyrimidine ring with different alkyl group 
has no significance effect on the 1H NMR and 13C NMR shifts of ligands 8a-f as it was 
expected. The 1H NMR and 13C NMR spectra of ligand 8b are shown in Figures 9 and 10 as an 
example. 
 
Table 3. 1H NMR and 13C NMR data of ligands 8a-f in CDCl3.  
 
R H1 C1 
H2 
C2 
H3 
C3 
H4 
C4 
H5 
C5 
H6 
C6 
H7 
C7 NH2 
8a nbutyl 7.92 137.9 
8.36 
122.8 
---- 
154.5 
---- 
163.8 
7.60 
107.1 
---- 
173.6 
---- 
163.5 5.63 
8b octyl 7.94 8.42 ---- ---- 7.67 ---- ---- 5.12 
8c tbutyl 
7.96-
7.91 
138.0 
8.40 
122.5 
---- 
154.5 
---- 
163.9 
7.96-7.91 
103.8 
---- 
180.5 
---- 
163.2 5.12 
8d isopropyl 7.94 138.0 
8.41 
122.8 
---- 
154.5 
---- 
164.0 
7.71 
105.1 
---- 
178.4 
---- 
163.4 5.15 
8e npropyl 7.94 138.0 
8.42 
122.9 
---- 
154.5 
---- 
163.8 
7.66 
107.3 
---- 
173.4 
---- 
163.4 5.14 
8f ethyl 7.95 138.0 
8.43 
122.9 
---- 
154.5 
---- 
163.9 
7.70 
106.6 
---- 
174.6 
---- 
163.3 5.12 
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Figure 9. 1H NMR spectrum of ligand 
 
 
 
8b. 
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Figure 10. 13C NMR spectrum of ligand 
 
3.1.2  Synthesis of NN Ligands
 2,2-Bipyridyl is probably the most often used aromatic 
coordination chemistry.107 However, pyridine chemistry makes it difficult to efficiently 
introduce a broad variety of substituents into this system. Since Thiel
N,N'-donor bearing an amino group in close 
combination with other functions to elucidate the influence of these groups on the bifunctional 
catalytic transfer hydrogenation, I became interested in the 2
motif. The chemistry of pyrimidine and its derivatives is well established.
3.1.2.1 Synthesis of the Precursors
 2-Amino-4-(2-pyridinyl)pyrimidines can be obtained in a straightforward syntheses 
starting from versatile 2-acetylpyridine or pyridine
8b. 
 
N,N-chelating ligand in 
’s group was looking for a 
proximity to the coordinating nitrogen atom in 
-amino-4-(2-pyridinyl)pyrimidine 
108
  
 
-2-carboxylicacid ester (Scheme 
 
31). 
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Scheme 31. Synthesis of 12, 13b-e and 14; i) HC(NMe2)(OMe)2, 4 h, refl.; ii) THF, NaH, 
tBuC(O)Me, 12 h, refl.; iii) propanol, NH(Et)2, arylaldehyde, 12 h, refl.. 
 
 As it was mentioned earlier in section 3.1.1.2 I had to choose different types of starting 
materials in order to have different substituents on the pyrimidine ring. 12, 13b-e and 14 were 
synthesized using the methods which are described in sections 3.1.1.1.1.1, 3.1.1.1.1.2 and 
3.1.1.2 for 12, 14 and 13b-e, respectively. Trying to obtain proper crystals of 13e for X-ray 
crystallography I was able to crystallize 15 which is the byproduct of 13e. The crystal structure 
is shown in Figure 11.  
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Figure 11. Molecular structure of byproduct 15 in the solid state.  
 
  Here 13b-e can be used without problems of polymerization as it was discussed in 
section 3.1.1.2. In this case there is just an equilibrium between the monomer and the dimer as 
it is shown in Scheme 32. As the monomer is consumed it will be regenerated according to the 
equilibrium and this will continue until the reaction is completed. 
N
R
O N
O R
R
O
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16
 
Scheme 32. Dimerization equilibrium of 13b-e in solution. 
 
  It is noteworthy to express at this point that the dimerization occurs in the presence of 
light and a color change from yellow to deep green is observed. This process is accelerated in 
solution which is apparent in the 1H NMR spectra of 13d after and before being exposed to the 
sunlight (Figure 12).  
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Figure 12. 1H NMR spectrum of 
sunlight. 
 
 It was not possible to gain suitable crystals of 
was able to separate crystals of dimer 
structure analysis of 16 shows the 
of solid-state photodimerizations of 4
 
13d before (bottom) and after (above) being exposed to 
13c for X-ray crystallography, however I 
16. Its crystal structure is shown in 
syn head-to-head product while generally the major product 
-azachalcones is the syn head-to-tail isomer.
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Figure 13. The X-ray 
109
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Figure 13. Molecular structure of dimer 16 in the solid state. Selected bond lengths [Å] and 
dihedral angles [°]: O1-C5 1.2208(19), O2-C6 1.212(2), C1-C2 1.5556(19), C1-C4 1.578(2), 
C2-C3 1.567(2), C3-C4 1.541(2), C4-C1-C2-C17 104.75(13), C2-C1-C4-C3 18.36(10), C4-
C1-C2-C3 18.04(10), C2-C1-C4-C5 138.91(13), C6-C1-C4-C5 20.69(18), C6-C1-C4-C3 
99.86(13), C6-C1-C2-C3 96.39(14), C6-C1-C2-C17 140.82(14), C17-C2-C3-C28 31.6(2), 
C17-C2-C3-C4 94.62(14), C1-C2-C3-C28 144.70(14), C1-C2-C3-C4 18.48(11), C2-C3-C4-C1 
18.21(10), C2-C3-C4-C5 137.83(13). 
 
3.1.2.2 Synthesis of the Guanidinium Salts 
 Several guanidinium salts could be synthesized by different methods, which are known 
from the literature, depending on the nature of the guanidinium moiety. Generally three 
methods were used for this purpose (Scheme 33). For salts bearing an alkyl group either 
method 1110 or method 2111 were applied. For salts containing aryl groups, method 3112 found 
out to be the best. 
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Scheme 33. Three different methods used to synthesize guanidinium salts. 
 
 Method 1: This method was used for liquid amines. Two equivalents of an alkylamine 
were stirred with 2-methyl-2-thiopseudourea hemisulfate in a little amount of water at room 
temperature over night. The release of methanethiol is a sign that the reaction is occurring. 
After evaporating the water, residual amine can be washed out by ethanol. If there is need to 
change the sulfate to the nitrate ion, the product can be treated with a hot solution of Ba(NO3)2.  
 Method 2: Ammonium hydroxide 30% was added to the alkylamine, followed by the 
addition of 2-methyl-2-thiopseudourea hemisulfate. The mixture was heated to 70 °C and 
stirred vigorously until the reactants dissolved. There was a vigorous evolution of 
methylmercaptane. The mixture was stirred at 70 °C until no effervescence of 
methylmercaptane was detected anymore. The mixture was then cooled to room temperature 
and was evaporated to dryness under reduced pressure in a rotary evaporator. The product can 
be crystallized from water. 
 Method 3: Concentrated nitric acid was added to a solution of an arylamine in ethanol 
followed by a 50% aqueous solution of 1.5 equivalents of cyanamide. The reaction mixture 
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was then heated under reflux for 16 h. The reaction was cooled to 0 °C followed by the 
addition of ether. The contents were then refrigerated overnight, and the resulting solid was 
filtered, affording the product in good yield. 
 The guanidinium salts can be purified by crystallization from water or ethanol. For one 
of them, single crystals suitable for X-ray diffraction studies were obtained, and its molecular 
structures in the solid state are presented in Figure 14. 
 
Figure 14. Molecular structure of one of the guanidinium salt in the solid state possessing a 
sulfate counter anion. Selected bond lengths [Å]: N1-C1 1.3284(19), N2-C1 1.3279(19), N3-
C2 1.464(2), N3-C1 1.3239(18).  
 
3.1.2.3 Synthesis of 2-Amino-4-(2-pyridinyl)pyrimidines 
 The desired ligands 17a-q were obtained in good yields (Scheme 34) either by treating 
the intermediates 12 or 13b-e 113,102b with guanidinium salts in the presence of a NaOEt in 
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refluxing ethanol or by grinding with guanidinium carbonate and silica as it was described in 
section 3.1.1.2.  
N
O
NMe2
12
i-iii N N
R H 1-naphthyl C6H4OnBu
17 a c d e
N
R
R'
17a-q
C6H5 tBu
b f
R' NH2 NH2 NH2 NH2 NH2 NH2
R H
17 g i
tBu
h
R' N(CH2)4 NMe2 N(CH2)4
C6H4OMe C6H4OMe
N
O
tBu
O
N
O
R
14
13b-e
R
H
17
j
l
k
R'
H
H H H
m n o
H
NMe2 N(CH2)5
HN(CH2)2CH3 HN(CH2)3CH3 HN(CH2)7CH3 S-HN(CH)(CH3)(C6H5)
p
H
R-HN(CH)(CH3)(C6H5)
q
H
HN(CH)(CH3)2
 Scheme 34. i) Synthesis of the chelate ligands; for 17a-e: [C(NH2)3]2(CO3), EtOH, refl. 24 h; 
ii) for 17g-q: [XC(NH2)2]2(SO4), EtOH, refl. 24 h; iii) for 17f: [C(NH2)3]2(CO3), SiO2, 200 °C, 
2 h. 
 
 The 1H NMR data of 17a-q are summarized in Table 4. Comparing the chemical shifts, 
it is obvious that functionalizing the pyrimidine ring does not have a big electronic influence. 
Just replacing one hydrogen atom of the NH2 group by an alkyl group causes a down field shift 
for the remaining amino hydrogen atom (see ligands 17l-q in comparison to ligands 17a-f).  
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Table 4. 1H NMR data of ligands 17a-q. 
Ligand H1 H2 H3 H4 H7 H8 NH 
17a 8.68 7.49-7.45 7.93 8.32 7.49-7.45 8.41 6.79 
17b 8.75 8.16-8.13 7.95 8.39 8.06 ---- 6.92 
17c 8.70 7.73-7.51 8.05-7.99 8.42 7.74 ---- 6.97 
17d 8.74 7.50 8.01-7.95 8.36 8.01-7.95 ---- 6.77 
17e 8.74 7.50 8.01-7.95 8.36 8.01-7.95 ---- 6.76 
17f 8.70 7.47 7.93 8.30 7.56 ---- 6.60 
17g 8.67 7.50-7.45 7.92 8.36 7.50-7.45 8.44 ---- 
17h 8.70 7.50 7.96 8.40 7.55 ---- ---- 
17i 8.74 7.52 7.99 8.45 7.99 ---- ---- 
17j 8.67 7.5-7.45 7.93 8.38 7.5-7.45 8.47 ---- 
17k 8.65 7.42 7.87 8.31 7.46 8.44 ---- 
17l 8.67 7.49 7.95 8.33 7.43 8.40 7.24 
17m 8.69 7.50 7.97 8.34 7.44 8.41 7.25 
17n 8.66 7.46 7.90 8.34 7.44 8.40 7.23 
17o 8.66 7.43 7.89-7.92 8.33 7.48-7.51 8.42 7.89-7.92 
17p 8.76 7.43 7.87 8.36 7.66 8.48 7.87 
17q 8.68 7.48 7.95 8.34 7.44 8.41 7.08 
 
 Three members of the 2-amino-4-(2-pyridinyl)pyrimidine series (17d, 17f and 17h) 
could additionally be characterized structurally by single crystal X-ray diffraction (Figures 15, 
16 and 17, respectively). The asymmetric units of 17d and 17h are built up from one molecule 
but for 17f it is built up from two independent molecules. There are no hydrogen bonds in the 
case of 17f and 17h but each NH2 group of 17d is connected through NH---N hydrogen 
interactions with the pyrimidine nitrogen atom of a neighboring molecule. In all cases, the 
nitrogen atoms of the pyridine ring are in the trans position with respect to the nitrogen atoms 
of the pyrimidine rings in order to minimize electronic repulsion between the lone pairs of the 
nitrogen atoms. In 17h and 17d, the pyridine and pyrimidine rings are planar but in the case of 
17f they are twisted along the C(5)-C(6) and C(18)-C(19) bonds resulting in dihedral angles 
163.72° and 150.06°, respectively.  
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Figure 15. Molecular structure of 17d in the solid state. Selected bond lengths [Å] and bond 
angles [°] including hydrogen bonding: N2-C6 1.3482(16), N2-C9 1.3491(16), N3-C8 
1.3428(16), N3-C9 1.3474(16), N4-C9 1.3468(17), N4-H4A 0.88, H4A⋅⋅⋅N 2 2.35, N4⋅⋅⋅N2 
3.1510(16), N4-H4B 0.8800, H4B⋅⋅⋅N3 2.1200, N4⋅⋅⋅N3 2.9847(15), N4-H4A⋅⋅⋅N2 152.00, N4-
H4B⋅⋅⋅N3 167.00.  
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Figure 16. Molecular structure of 17f in the solid state. Selected bond lengths [Å], bond angles 
and dihedral angles [°] including hydrogen bonding: N2-C9 1.3474(19), N3-C8 1.3425(19), 
N3-C9 1.3476(19), N4-C9 1.351(2), N4-H4A 0.875(17), H4A⋅⋅⋅N7 2.238(17), N4⋅⋅⋅N7 
3.1043(18), N4-H4B 0.879(17), H4B⋅⋅⋅N5 2.277(17), N4⋅⋅⋅N5 3.1336(19), N8-H8A 0.870(15), 
H8A⋅⋅⋅N3 2.360(16), N8⋅⋅⋅N3 3.2155(18), N8-H8B 0.882(16), H8B⋅⋅⋅N6 2.251(17), N8⋅⋅⋅N6 
3.1245(18), N4-H4A⋅⋅⋅N7 170.7(16), N4-H4B⋅⋅⋅N5 164.8(15), N8-H8A⋅⋅⋅N3 167.9(16), N8-
H8B⋅⋅⋅N6 170.5(15), N1-C5-C6-N2 -163.72(13).  
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Figure 17. Molecular structure of 17h in solid state. One of the methyl groups at th NMe2 
moity is disordered. Selected bond lengths [Å] and dihedral angles [°]: N2-C9 1.346(2), N3-C8 
1.336(2), N3-C9 1.351(2), N4-C9 1.361(2), N1-C5-C6-N2 180.00.  
 
 The nitrogen atoms of the amino groups are planar in all cases, and the short C-N 
distances (1.361(2) Å for 17h, 1.3511(19) Å for 17f and 1.3469(16) Å for 17d) are within the 
range observed for a carbon-nitrogen double bonds and are slightly longer than the other 
carbon-nitrogen bonds of these compounds (C-N : 1.395 Å and C=N : 1.355 Å).114 This is 
indicative for C=N p-bonding with a delocalization of the nitrogen lone pair into the 
pyrimidine ring. The carbon-nitrogen bond lengths of 17d, 17f and 17h are listed in Table 5.  
 
Table 5. Bond lengths [Å] for 17d, 17f and 17h. 
 17d 17f 17h 
C1-N1 1.3369(18) 1.339(2) 1.339(2) 
C5-N1 1.3440(16) 1.341(2) 1.340(2) 
C9-N2 1.3491(16) 1.3474(19) 1.347(2) 
C9-N3 1.3473(17) 1.348(2) 1.350(2) 
C9-N4 1.3469(16) 1.3511(19) 1.361(2) 
58 
 
3.1.3 Synthesis of 4,4'-Bipyrimidine-2.2'-diamine 
 Precursor 18 was synthesized according to a method published in the literature.115 
Sodium was added to the ethanol under a nitrogen atmosphere. When the reaction of sodium 
and ethanol was completed the guanidinium carbonate was added to the solution which was 
refluxed for 1 h. At the end, precursor 18 was added and the reaction mixture was refluxed 
overnight. After evaporating the solvent, the product was extracted using dichloromethane. The 
product was purified by recrystallization from ethanol. 
N
N
NH2
N
N
NH2
O
O
N
N
guanidinium carbonate (2eq)
Na (2eq)
ethanol, reflux overnight
18 19
 
Scheme 35. Synthesis of 4,4'-bipyrimidine-2.2'-diamine. 
 
 In the 1H NMR spectrum two doublets at 8.42 and 7.37 ppm with a coupling constant 
JHH = 5.0 Hz were assigned to the pymidine hydrogen atoms and a singlet at 6.46 ppm was 
assigned to the hydrogen atoms of the NH2 group. In 13C NMR spectrum four distinguished 
signals at 163.4, 161.8, 159.1 and 106.0 were observed. 
3.1.4 Synthesis of NNC Ligands 
 The desired ligands 20a-e were obtained in good yields (Scheme 36) by treating the 
intermediate 12 with the proper guanidinium nitrates (section 3.1.2.2) in the presence of a 
NaOEt in refluxing ethanol as described in section 3.1.2.3.  
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Scheme 36. Synthesis of the chelating N,N,C ligands. 
 
 As shown in Table 6, functionalization of the phenyl ring in the para position has 
almost no effect on the 1H NMR shifts of the hydrogen atoms in the pyridine ring. However, 
H7 and H8 have shifted to higher field for 20d which is functionalized by an electron donating 
methoxy group and to lower field for 20e with an electron withdrawing cyanide group. In the 
same manner, the protons of the amino group appear at 9.56 ppm for 20d and at 10.34 ppm for 
20e.  
 
Table 6. 1H NMR data for ligand 20a-e.  
 
NH H1 H2 H3 H4 H7 H8 
20a 9.76 8.75 7.57 8.05 8.41 7.73 8.65 
20b 9,79 8.74 7.56 8.03 8.39 7.81 8.63 
20c 9.92 8.75 7.57 8.04 8.40 7.75 8.66 
20d 9.56 8.74 7.56 8.02 8.38 7.66 8.59 
20e 10.34 8.77 7.58 8.06 8.42 7.85 8.74 
 
 
3.1.5 Synthesis of Multidendate Ligands 
 The combination of pyridine and pyrimidine can be used for designing helical 
complexes of multidendate ligands116, but there are just few examples of terpyridine analogue, 
tridentate ligands and their complexes.117 Anslyn and et al. had synthesized complex 21 
(Scheme 37) and used it as a catalyst for RNA hydrolysis.118a It was also applied as a selective 
molecular sensor for aspartate.118b Another hydrolysis catalyst, which was introduced by 
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Hamilton et al., is a binuclear copper complex (complex 22, Scheme 37). It shows high activity 
and selectivity for the cleavage of cyclic ribonucleosid-2´,3´-monophosphate.119 The trinuclear 
complex 23 is as a model for an allosteric enzyme inhibitor.120 There are also some reports on 
the application of multidendate ligands in supramolecular chemistry. One example of this type 
is complex 24 (Scheme 37) which was synthesized by Lehn et al.121  
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Scheme 37. Examples for complexes with multidentate pyridine/pyrimidine ligands. 
 
 Multidentate systems with crown ether units as part of the ligand structure had been 
attended in the recent years. Mainly alkaline metals or alkaline earth metals can be coordinated 
in this type of multidentate ligands according to the size of the ring. Beside the ring size, the 
stability of these complexes depends on the charge of the metal and the solvent which is used. 
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Some ligands of this type and their complexes have been synthesized by Fernández et al.122a,b 
Recently the crystal structure of complex 25 (Scheme 38) was reported by this group.122c 
25
O
O
O
OO
O
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N
NH
NN
Cl
Pd
PPh3
2
 
Scheme 38. A bimetallic complex in which a crown ether is a part of ligand. 
 
 Till now, multidentate ligands, having pyrimidine groups as relatively soft donors for 
late transition metals possessing simultaneously a binding position for a hard Lewis-acid, are 
not known. Such systems are matter of interest in the SFB/TRR-88 (3MET) at the TU 
Kaiserslautern. 
 Since the nitrogen atoms of pyrimidine rings are electron withdrawing, the 
nucleophilicity and the activity of the amino groups of 8c are decreased, so that amidation 
reactions have to be done with acylhalides, which were synthesized according to procedures in 
literature. We here followed a protocol introduced by Reddy123 in which the amine and the acyl 
halide are stirred at 20 °C in pyridine for 16 h. After distillation of the pyridine the 
multidentate ligands 26 and 27 can be crystallized from ethanol.  
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Scheme 39. Synthesis of multidentate ligands starting from diamines. 
 
 As expected, the resonance of the amide group in the 1H NMR spectrum of 26 has 
shifted to lower field, the resonance appears at about 10.83 ppm. The resonance of the carbonyl 
group appears at about 165.74 ppm in the 13C NMR spectrum. In IR spectrum the strong 
absorption at about 1697 cm-1 can be assigned to the carbonyl group (Figure 18).  
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 Figure 18. IR spectrum of 26. 
 
 For 27 the resonance of the amide proton in the 1H NMR spectrum shifted to even 
much lower field, the resonance appears at about 11.70 ppm (Figure 20). Two resonances at 
about 160.3 and 158.3 ppm in 13C NMR spectrum can be assigned to the two different carbonyl 
groups in the molecule. In the IR spectrum, three strong absorptions at about 1769, 1744 and 
1727 cm-1 can be assigned to the carbonyl moieties (Figure 19).  
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 Figure 19. IR spectrum of 27. 
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Figure 20. 1H NMR spectrum of 
 
 Another way to gain multidentate ligands is to start from the mono amine 
diacyl halide or one or two equivalents of a proper acyl halide as shown in 
synthesize compounds 28, 2
and refluxed. After distillation of the 
pyridine, the amine is added and stirred over night at room temperature. Then pyridine was 
evaporated and the residue was dissolved in dichloromethane
over MgSO4. Evaporating the solvent results i
resonance of the hydrogen atom of the amide group shifted to lower field for 
comparison to the starting amine 
the carbonyl absorption of 28
 
27. 
9 and 30 the corresponding acid was dissolved in 
excess of thionylchloride, the residue was dissolved in 
, treated with 
n the products. As expected, the 
17a (10.85, 11.12 and 11.12 ppm, respectively). As predicted, 
 (with an electron donating methoxy group in the ortho
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17a and a 
Scheme 40. To 
thionylchloride 
NaHCO3 and dried 
1H NMR 
28, 29 and 30 in 
-position) 
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appears at a lower energy (about 1658 cm-1) than the corresponding bands of 29 and 30 (1690 
and 1699 cm-1, respectively). 
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Scheme 40. Synthesis of multidentate ligands starting from the monoamine 17a. 
 
 Ligand 31 was synthesized as 28, just here two equivalents of the corresponding acid 
were used. In the 1H NMR spectrum, the peak which was assigned to the NH2 group has 
disappeared. Instead, a peak at about 3.72 ppm appears, belonging to the six hydrogen atoms of 
the two methoxy groups. The two intense bands at about 1725 and 1668 cm-1 in the IR 
spectrum can be assigned to the carbonyl groups. 
 As mentioned before, reacting a mono amine 17a and a diacyl halide is another way to 
obtain multidentate ligands. Ligand 32 was synthesized this way by applying pyridine-2,6-
dicarbonyl dichloride being prepared from pyridine-2,6-dicarboxylic acid. In comparison to 
amine 17a the proton resonance of amide group of 32 has shifted extremely to lower field (6.79 
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ppm for 17a vs. 12.06 ppm for 
and carbon atoms of 32 are shifted a little bit to lower fiel
for 17a vs. 8.79, 8.57, 149.84 and 121.69 ppm for 
absorption at about 1723 cm
Figure 21. 1H NMR spectrum of 
 
3.2 Synthesis of Transition Metal Complexes
 The nitrogen containing ligand
obtain ruthenium and palladium complexes. 
3.2.1 Ruthenium Complexes
 It is well known that c
range of alcohols - including chiral ones 
 
32). In the same manner the resonances of the other hydrogen 
d (8.68, 8.32, 149.41 and 120.75 ppm 
32, respectively). The sharp and strong 
-1
 in IR spectrum is assigned to the carbonyl bond.
32. 
 
s, which were synthesized before, have been used to 
 
 
atalytic transfer hydrogenation of ketons makes accessible a wide 
- which are important in pharmaceutical, 
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agrochemical, flavor, fragrance, materials, and fine chemical industries.4a, 30a-e, 124 Under basic 
conditions and mainly in iPrOH as the solvent, ruthenium(II) complexes turned out to be the 
most active systems. Thus, a broad variety of different ruthenium complexes bearing PP, NN, 
NO, NNN and NPN ligands have been investigated for transfer hydrogenation reactions and 
provided a considerable improvement on the catalyst performance in the catalytic transfer 
hydrogenation of ketones.3e, 18, 27a, 35b, 47, 125 
3.2.1.1 Ruthenium Complexes with Tridendate Ligands 
 Ruthenium complexes containing suitable combinations of P- and N- or mixed P,N-
ligands turned out to be efficient catalysts for the hydrogenation and transfer hydrogenation of 
carbonyl compounds. Thus, some tridentate achiral and chiral ligands have successfully been 
used for the preparation of these catalysts. A few general types should be mentioned here: 
(P)(NPN)RuCl2,18 (NPN)RuCl2),19 (P)(NNN)RuCl2 (NPN and NNN = oxazoline based 
ligands),20 [RuCl(CNN)(PP)] [PP = (R,S)-1-{2-[bis(4-methoxy-3,5-
dimethylphenyl)phosphanyl]ferrocenyl}ethyldicyclohexyl phosphane (Josiphos-type 
diphosphane) and CNN = amin/aryl/pyridine based ligands).21 In this chapter, the synthesis and 
characterization of ruthenium complexes of the type (L)(NNN)RuCl2 (L = PPh3 or CO), bearing 
tridentate dipyrazolpyridines as N,N,N-ligands will be discussed.  
 Treatment of 6a-f with one equivalent of the ruthenium(II) precursor (PPh3)3RuCl2 in 
dichloromethane at room temperature leads to the formation of the corresponding red colored 
ruthenium(II) complexes 33a-f in almost quantitative yields (Scheme 41). Just 33a,b could be 
purified and their structure will be discussed here. Typically for octahedral ruthenium(II) 
monophosphine complexes, the 31P NMR resonances of 33a,b are observed at 44.20 and 42.71 
ppm.126 Recently the reaction of the N,N,N-ligand 4b, having a N-H instead of a N-allyl 
functions, with (PPh3)3RuCl2 was published by Thiel’s group.127 This variation leads to a 
cationic ruthenium(II) complex of the type [(PPh3)2(4b)RuCl]Cl with the two phosphine 
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ligands trans to each other (31P NMR: 25.5 ppm). The ionic structure of this compound is 
stabilized by H⋅⋅⋅Cl interactions between the acidic N-H units at the two pyrazole rings and 
both, the coordinated chloro ligand and the free chloride counter anion. In contrast to 33a,b 
(see catalytic investigations part), [(PPh3)2(4b)RuCl]Cl shows just moderate transfer 
hydrogenation activities, which was assigned to the cationic nature of the active site and to the 
steric hindrance of the two triphenylphosphine ligands. 
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Scheme 41. Formation of the ruthenium(II) complexes 33a-f. 
 
 In the 1H NMR spectra of 33a,b the resonances of the allylic methylene protons, which 
become diastereotopic due to the coordination of the ruthenium centre, are now split into two 
doublets of doublets at 5.80 and 4.76 ppm for 33a and at 6.20 and 4.21 ppm for 33b, which 
requires a cis-coordination of the two chloro ligands. Recrystallization of 33a, 33b and 33e 
from CH2Cl2/Et2O resulted in the formation of single crystals suitable for X-ray analysis. 
Selected geometric parameters are presented in Table 7. As already indicated by the NMR 
spectra, the ruthenium centres are found in a distorted octahedral coordination environment 
with the tridentate N,N,N ligand adopting a meridional geometry and the two chloro ligands in 
a cis-arrangement (Figures 22-24). In contrast to 33b and 33e which crystallize with one 
crystallographically unit, compound 33a crystallizes with two crystallographically independent 
70 
 
units in the solid state. The structural parameters of these two units are almost identical (see 
Index), therefore just one of the two units was taken for the discussion of the geometry. In the 
case of 33b half of the molecule was severely disordered. Since there are little differences in 
the structure of these three complexes (Table 7) solely the structure of 33a will be discussed in 
details in the following. 
 
Table 7. Selected geometric parameters. The numbering is according to figures 22-24.  
 33a 33e 33b 
Distances (Å)    
N(1)-Ru(1) 1.985(3) 1.985(4) 1.974(4) 
N(2)-Ru(1) 2.081(2) 2.081(4) 2.080(3) 
N(4)-Ru(1) 2.093(3) 2.092(4) 2.074(12)-2.100(9) 
P(1)-Ru(1) 2.2800(8) 2.2933(13) 2.2883(10) 
Cl(1)-Ru(1) 2.4576(8) 2.4706(12) 2.4651(10) 
Cl(2)-Ru(1) 2.4664(8) 2.4670(12) 2.4587(11) 
Angles (°)    
N(1)-Ru(1)-N(2) 77.35(10) 78.10(16) 77.82(14) 
N(1)-Ru(1)-N(4) 78.07(10) 77.67(17) 85.3(3)-71.7(3) 
N(2)-Ru(1)-N(4) 154.24(10) 155.16(17) 162.4(4)-149.1(3) 
N(1)-Ru(1)-P(1) 94.37(7) 91.42(12) 92.52(10) 
N(2)-Ru(1)-P(1) 96.08(7) 91.47(12) 94.59(9) 
N(4)-Ru(1)-P(1) 93.34(7) 94.52(12) 91.1(8)-91.7(5) 
N(1)-Ru(1)-Cl(1) 90.40(7) 88.21(12) 89.28(10) 
N(2)-Ru(1)-Cl(1) 83.59(7) 86.59(12) 87.09(9) 
N(4)-Ru(1)-Cl(1) 89.00(7) 87.26(12) 87.7(8)-87.6(5) 
P(1)-Ru(1)-Cl(1) 175.03(3) 178.06(5) 177.76(4) 
N(1)-Ru(1)-Cl(2) 178.65(7) 177.95(12) 178.34(10) 
N(2)-Ru(1)-Cl(2) 103.78(7) 101.52(12) 102.06(8) 
N(4)-Ru(1)-Cl(2) 100.71(8) 102.50(12) 94.6(3)-108.2(3) 
P(1)-Ru(1)-Cl(2) 86.27(3) 90.61(4) 89.14(4) 
Cl(1)-Ru(1)-Cl(2) 88.99(3) 89.75(4) 89.06(4) 
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Figure 22. Molecular structure of the ruthenium(II) complex 33b in the solid state. The 
disordering of one of the butyl side chains is omitted for clarity. 
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Figure 23. Molecular structure of ruthenium complex 33a in solid state.  
 
 
Figure 24. Molecular structure of ruthenium complex 33e in solid state. The two solvent 
molecules in the unit cell are omitted for clarity. 
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 Since pyridines are generally considered to be better donors than pyrazoles, the large 
Ru-N bond length difference of about 10 pm can just be explained by the steric requirements of 
the tridentate ligand.127,128 Bidentate pyrazolylpyridine complexes show less pronounced 
differences in the M-N bond lengths.94,127,129 Due to the tridentate coordination of the N,N,N-
donor, the central nitrogen atom N1 is pushed closer to the ruthenium(II) centre. It therefore 
applies a trans-influence to Cl2 comparable to the trans-influence of the phosphine donor to 
Cl1, which explains the almost identical Ru-Cl bond lengths found in this solid state structure. 
All P-Ru-N angles are larger than 90° showing the steric influence of the bulky 
triphenylphosphine onto the chelating ligand. 
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Scheme 42. Formation of 34a,b by bubbling CO gas through a solution of 33a and 33b. 
 
 Bubbling CO into a solution of 33a,b in refluxing toluene results in the formation of the 
carbonyl complexes 34a,b in quantitative yields (Scheme 42), a colour change from red to 
yellow indicates the end of the reaction. The 31P NMR signals of the triphenylphosphine 
ligands have disappeared proving that the phosphine is substituted by CO which is in contrast 
to previous findings (Figure 25).127 The 1H NMR spectra of 34a and 34b recorded in DMSO-d6 
again show two diastereotopic methylene protons (4a: 6.12, 5.20; 4b: 5.55, 5.03 ppm), which 
means that the chloride ligands are still cis-coordinated. In the 13C NMR spectrum, the 
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resonances of the carbonyl ligand are observed at 191.0 ppm for 
Intense CO absorptions in the infrared spectrum at 1936 cm
confirm the attachment of one carbonyl ligand to the ruthenium centre. The slight difference of 
12 cm-1 can be explained by the steric influence of the bulky butyl chain attached to compound 
34b, which increases the Ru-CO distance
and therefore strengthens the C=O bond. 
Figure 25. 31P NMR spectrum of 
 
34a and at 191.2 ppm for 
-1
 for 34a and at 1948 cm
, decreases the back donation to the carbonyl ligand 
 
33a (top) and 34a (bottom). 
34b. 
-1
 for 34b 
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Figure 26. IR spectra of ruthenium complex 33a (top) and 34a (bottom) 
 
 Attempts to obtain single crystals of 34a suitable for X-ray structure determination by 
crystallization from dichloromethane over a long period of time and in the presence of light 
resulted in oxidation to ruthenium(III) and replacement of the carbonyl against a chloride 
ligand (Scheme 43, Figure 27). 
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Scheme 43. Chlorination of the carbonyl complex 34a. 
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Figure 27. Molecular structure of complex 35 in solid state, characteristic bond lengths [Å], 
angles [deg], the co-crystallized dichloromethane molecule is omitted for clarity: Ru1-Cl1 
2.4159(18), Ru1-Cl2 2.405(5), Ru1-Cl3 2.358(2), Ru1-N1 2.039(5), Ru1-N2 2.089(5), Ru1-N4 
2.043(5), Cl1-Ru1-Cl2 93.88(11), Cl1-Ru1-Cl3 177.59(6), Cl1-Ru1-N1 87.82(15), Cl1-Ru1-
N2 89.66(15), Cl1-Ru1-N4 89.56(16), Cl2-Ru1-Cl3 87.79(12), Cl2-Ru1-N1 177.92(18), Cl2-
Ru1-N2 101.86(18), Cl2-Ru1-N4 104.24(18), Cl3-Ru1-N1 90.55(16), Cl3-Ru1-N2 91.70(15), 
Cl3-Ru1-N4 88.34(16), N1-Ru1-N2 76.9(2), N1-Ru1-N4 77.0(2), N2-Ru1-N4 153.9(2). 
 
 As in 33a, the ruthenium centre in 35 is again coordinated in a distorted octahedral 
geometry with the tridentate N,N,N-donor adopting a mer-arrangement. The Ru-N on one side 
and the Ru-Cl distances on the other side are almost identical, slight differences are related to 
packing effects in the solid state structure. The bond angles Cl3-Ru-N are approaching 90°, 
corroborating the discussion of the steric influence of the triphenylphosphine ligand on the 
structure of 33a. 
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3.2.1.2 Ruthenium Complexes with Bidendate Ligands 
 Reacting the ligands 17a-q with the ruthenium(II) precursor [(η6-cymene)Ru(Cl)(µ2-
Cl)]2 at room temperature in dichloromethane solution gave red to brown coloured cationic 
ruthenium(II) complexes of the type [(η6-cymene)Ru(Cl)(pdpm)]Cl (36a-q(Cl); pdpm = 
chelating 2-amino-4-(2-pyridinyl)pyrimidine ligand) in almost quantitative yields (Scheme 44). 
For catalyst optimization, the chloride anion was exchanged against three larger and thus 
weaker coordinating anions (BF4-, PF6-, BPh4-) for a part of the ruthenium complexes, which 
additionally enforced the crystallization of the compounds. Stirring the freshly prepared 
complexes 36a-q(Cl) with either NaBPh4, NaBF4 or KPF6 directly led to the ruthenium(II) 
complexes 36a-q(X). 
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Scheme 44. Synthesis of the ruthenium(II) complexes 36a-q(X). 
 
 Due to the two different N-donor moieties, the metal site becomes a centre of chirality 
leading to two diasterotopic methyl groups and four magnetically inequivalent aromatic C-H 
sites at the cymene ligand. This is clearly demonstrated by the 1H and 13C NMR spectra of the 
ruthenium complexes. The methyl groups of cymene ring appear as two doublets at about 0.8 
and 0.9 ppm and four peaks between 82 and 86 ppm can be assigned to the four magnetically 
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inequivalent aromatic carbon atoms of cymene ring. Coordination of the 2-amino-4-(2-
pyridinyl)pyrimidines to the Lewis-acidic ruthenium(II) centre causes a shift of the H1 
resonance to lower field (for the numbering see Scheme 44): ca. 9.50 ppm for ligands with R = 
NH2, ca. 9.48 ppm for ligands with R = NH(alkyl), ca. 9.32 ppm for R = NMe2 and ca. 9.24 
ppm for R = N(CH2)4. Obviously, by functionalizing the amino group with more electron 
donating groups, the resonance of H1 in the complex shifts to higher field. This is a quite 
pronounced influence of a substituent located far at the other side of the ligand and an indirect 
hint for the electronic situation at the ruthenium(II) centre, which should become more electron 
rich in the series R = NH2 < NHAlkyl < NMe2 < N(CH2)4. The resonances of protons H2 (ca. 
7.83 ppm) and H3 (ca. 8.24 ppm) are almost independent from the substituent at the pyrimidine 
ring, while H4 shows a similar but less pronounced behavior as H1. Protons H7 at the 
pyimidine moiety are sensitive to the presence (ca. 8.21-8.39 ppm) or absence (ca. 7.69-7.86 
ppm) of aromatic substituents in the 8-positition and the shift of protons H8 is almost 
independent from the amine substituent. 
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Figure 28. 1H NMR spectra of (a) 
 
 In the 13C NMR spectra, nine carbon resonances for the nine carbon atoms of the 
cymene ligand can be assigned, proving the presence of a centre of chirality in the molecule. 
Generally the 13C NMR shifts are less sensitive towards the substitution pattern of the 2
4-(2-pyridinyl)pyrimidine system than the 
shifted about 10 ppm towards lower field with respect to the other compounds. This is 
probably due to a deshielding effect of the naphthyl substituent.
 For complexes 36a(PF6), 36b(BPh
and 36l(BPh4) single crystals suitable for X
molecular structures in the solid state are presented in 
complexes show a typical piano
 
36i, (b) 36j, (c) 36n and (d) 36a. 
1H NMR shifts. Solely C7 of complex 
 
4), 36f(BPh4), 36h(BPh4), 36j(BPh
-ray diffraction studies were obtained, and their 
Figures 29-36. All the cati
-stool geometry with Ru(II) centers adopting a distorted 
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octahedral arrangement and being coordinated by a chelating 2-amino-4-(2-
pyridinyl)pyrimidine type ligand, an η6-cymene ring and a terminal chloride, Table 8. Although 
the Ru(II) centers are stereogenic, all complexes are obtained as a racemic mixture and 
crystallized in centrosymmetric space groups (Table 9). 
 
Figure 29. Molecular structure of complex 36a(PF6) in solid state at 50 % probability level; 
top: the cation 36a+, bottom: hydrogen bonds between thr NH2 moity, the co-crystallized 
ethanol and the PF6- anion. 
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Figure 30. Molecular structure of complex 36f(BPh4) in solid state at 50 % probability level; 
top: the cation 36f+, bottom: hydrogen bonds between thr NH2 moity, the co-crystallized 
ethanol. 
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Figure 31. Molecular structure of complex 36b(BPh4) in solid state at 50 % probability level 
with the counter anion and co-crystallized solvents being omitted for clarity. 
 
 
 
Figure 32. Molecular structure of complex 36h(BPh4) in solid state at 50 % probability level 
with the counter anion and co-crystallized solvents being omitted for clarity. 
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Figure 33. Molecular structure of complex 36j(BPh4) in solid state at 50 % probability level 
with the counter anions and co-crystallized solvents being omitted for clarity. 
 
Figure 34. Molecular structure of complex 36g(BPh4) in solid state at 50 % probability level 
with the counter anion and co-crystallized solvents being omitted for clarity. 
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Figure 35. Molecular structure of complex 36k(BPh4) in solid state at 50 % probability level 
with the counter anion and co-crystallized solvents being omitted for clarity.  
 
 
Figure 36. Molecular structure of complex 36l(BPh4) in solid state at 50 % probability level 
with the counter anion and co-crystallized solvents being omitted for clarity. 
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Table 8. Selected geometric parameters of the cymene ruthenium complexes. The numbering is according to Scheme 44. 
 36a(PF6) 36b(BPh4) 36f(BPh4) 36j(BPh4) 36h(BPh4) 36k(BPh4) 36l(BPh4) 
R H Ph t-butyl H t-butyl H H 
R‘ NH2 NH2 NH2 NMe2 NMe2 N(CH2)4 NH(CH2)2CH3 
distances (Å)        
Ru1-N1 2.0819(19) 2.0845(13) 2.0875(15) 2.0745(15) 2.084(2) 2.0800(17) 2.080(2) 
Ru1-N2 2.1200(17) 2.1080(13) 2.0992(15) 2.1446(15) 2.1509(19) 2.1379(16) 2.108(2) 
Ru1-cymenea 1.6886(9) -1.6892(7) -1.6815(7) 1.6747(8) -1.6913(11) 1.6774(9) 1.6883(11) 
Ru1-Cl1 2.3953(5) 2.3992(4) 2.4028(5) 2.4034(5) 2.4189(7) 2.3891(5) 2.3839(7) 
angles (°)        
N1-Ru1-N2 76.55(7) 76.21(5) 76.12(6) 77.84(5) 77.16(8) 77.78(6) 76.57(8) 
N1-Ru1-Cl1 87.61(5) 87.49(4) 89.48(4) 82.56(4) 81.97(6) 81.75(5) 85.88(6) 
N2-Ru1-Cl1 85.49(5) 87.09(4) 84.12(4) 90.30(4) 91.02(5) 87.84(5) 84.50(6) 
torsion angle (°)        
N1-C5-C6-N2 0.7(3) 2.72(19) 7.2(2) -11.0(2) 14.3(3) 14.7(3) 3.4(3) 
a. The distance between Ru1 and the mean plane of cymene.  
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Table 9. Summary of the crystallographic data and details of data collection and refinement for compounds 36a(PF6), 36b(BPh4), 36f(BPh4), 
36h(BPh4), 36j(BPh4), 36k(BPh4) and 36l(BPh4). 
 36a(PF6) 36b(BPh4) 36f(BPh4) 36j(BPh4) 36h(BPh4) 36k(BPh4) 36l(BPh4) 
empirical 
formula C21H28ClF6N4OPRu C49H46BClN4Ru C53H65BClN4O1.5Ru C45H46BClN4Ru C49H54BClN4Ru C48H50BClN4Ru C47H50BCl3N4Ru 
formula weight 633.96 838.23 929.42 790.19 846.29 830.25 889.14 
crystal size [mm] 0.28x0.21x0.18 0.20x0.13x0.08 0.40x0.17x0.13 0.18x0.12x0.11 0.25x0.09x0.05 0.18 x 0.07 x 0.03 
0.16 x 0.08 x 
0.06 
T [K] 150(2) 150(2) 150(2) 150(2) 150(2) 150(2) 150(2) 
λ [Å] 1.54184 1.54184 1.54184 1.54184 1.54184 1.54184 1.54184 
crystal system monoclinic monoclinic monoclinic monoclinic monoclinic monoclinic monoclinic 
space group P21/c P21/c P21/c P21/n P21/c P21/c P21/c 
a [Å] 10.3751(1) 13.5219(1) 15.2326(1) 13.0910(2) 14.6567(3) 12.2710(1) 12.89110(10) 
b [Å] 15.0288(2) 21.5269(2) 13.8012(1) 11.8941(1) 9.6078(2) 14.9669(1) 14.90500(10) 
c [Å] 16.0810(2) 14.0468(1) 24.5075(2) 25.6986(3) 33.5405(6) 22.3485(2) 22.7354(2) 
α [°] 90 90 90 90 90 90 90 
β [°] 102.954(1) 90.424(1) 107.188(1) 95.960(1) 100.226(2) 95.163(1) 98.3670(10) 
γ [°] 90 90 90 90 90 90 90 
V [Å3] 2442.77(5) 4088.70(6) 4922.07(6) 3979.79(8) 4648.10(16) 4087.85(6) 4321.93(6) 
Z 4 4 4 4 4 4 4 
ρcalcd. [g cm-3] 1.724 1.362 1.254 1.319 1.209 1.349 1.366 
µ [mm-1] 7.452 4.002 3.392 4.076 3.521 3.994 4.925 
θ-range [o] 4.08-62.64 3.76-62.64 3.04-62.65 3.46-62.74 3.06-62.63 3.56-62.65 3.47-62.67 
refl. coll. 17462 31505 40936 31463 24700 32737 33782 
indep. refl. 3903 [Rint = 0.0274] 
6538 
[Rint = 0.0241] 
7866 
[Rint = 0.0225] 
6363 
[Rint = 0.0237] 
7402 
[Rint = 0.0367] 
6515 
[Rint = 0.0336] 
6916 
[Rint = 0.0299] 
data/restr./param. 3903/2/327 6538/2/514 7866/40/580 6363/0/474 7402/0/513 6515/0/499 6916/1/512 
final R indices 
[I>2σ(I)] a 0.0230, 0.0589 0.0200, 0.0529 0.0244, 0.0647 0.0218, 0.0562 0.0310, 0.0771 0.0245, 0.0652 0.0292, 0.0796 
R indices (all 0.0245, 0.0596 0.0225, 0.0535 0.0264, 0.0655 0.0240, 0.0570 0.0390, 0.0797 0.0293, 0.0665 0.0346, 0.0815 
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data) b 
GooF c 1.079 1.034 1.042 1.041 0.946 1.045 1.045 
∆ρmax/min (e·Å-3) 0.319/-0.618 0.227/-0.360 0.414/-0.335 0.292/-0.597 0.402/-0.581 0.536/-0.388 0.679/-0.944 
a R1 = Σ||Fo| - |Fc||/ Σ |Fo|. b ωR2 = [Σω(Fo2 - Fc2)2/ Σω Fo2]1/2. c GooF = [Σω (Fo2 - Fc2)2/(n-p)]1/2 
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 The observed distances of Ru-N1 (2.07-2.09 Å), Ru-cymene (1.67-1.69 Å) and Ru-Cl 
(2.40-2.42 Å) are comparable to related structures. For published structures of [(η6-
arene)Ru(N,N')Cl]+ type compounds, wherein N,N' are bidentate N-aromatic heterocycles, the 
reported Ru-N(pyridine) distances are observed at 2.06-2.12 Å, whereas Ru-(η6-arene) 
distances and Ru-Cl bonds found at 1.67-1.70 Å and 2.38-2.43 Å, respectively130 . 
 Further examination of the metric parameters in Table 8 reveals that in all complexes 
36a(PF6), 36b(BPh4), 36f(BPh4), 36h(BPh4), 36j(BPh4), 36k(BPh4) and 36l(BPh4) the Ru1-
N1 distance is always significantly shorter than the Ru1-N2 distance, proofing a stronger 
binding of pyridine compared to pyrimidines. The introduction of an electron-donating 
substituent such as phenyl or tbutyl in the pyrimidine ring (36b(BPh4) and 36f(BPh4) vs. 
36a(PF6)) increases the electron density of the coordinating N-atom, which eventually forces 
the distance of Ru1-N2 shorter (2.1080(13) Å and 2.0992(15) Å vs. 2.1200(17) Å, 
respectively). At the same time the corresponding Ru1-Cl1 bonds are slightly stretched. The 
N,N-dimethylation of the NH2 group is supposed to enhance this trend due to the higher 
electron-donating ability of the NMe2 group compared to NH2. Contrarily a Ru1-N2 bond 
elongation was observed, 2.1446(15) Å vs. 2.1200(17) Å for complex 36j(BPh4) vs. 36a(PF6) 
and 2.1509(19) Å vs. 2.0992 (15) Å for complex 36h(BPh4) vs. 36f(BPh4). Simultaneously a 
dramatic increase of the torsion angle of N1-C5-C6-N2 was also observed, -11.0(2) ° vs. 0.7(3) 
° for complex 36j(BPh4) vs. 36a(PF6) and 14.3(3) ° vs. 7.2(2) ° for complex 36h(BPh4) vs. 
36f(BPh4). That suggests that the introduction of the bulkier NMe2 group in the close 
proximity to Ru(II) centre distorts the desired co-planarity of the pyridine and pyrimidine rings 
(last entry in Table 8), which may play an important role in the metal-ligand orbital 
overlapping. But interestingly, despite the quite large variation in steric and electronic aspects 
of the applied N,N-chelating ligands, the bite angle at the metal stays almost un-influenced 
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(N1-Ru1-N2, 76.12-77.84 °) for 36a(PF6), 36b(BPh4), 36f(BPh4), 36h(BPh4), 63j(BPh4), 
36k(BPh4) and 36l(BPh4). 
3.2.1.3 Ruthenium Complex with Symmetrical 4,4'-Bipyrimidine-2,2'-diamine 
 The ruthenium complex 37(BPh4) was synthesized like the others by reacting the 
ligand 19 with the ruthenium(II) precursor [(η6-cymene)Ru(Cl)(µ2-Cl)]2 at room temperature in 
dichloromethane solution in almost quantitative yield (Scheme 45). By stirring the freshly 
prepared complex 37(Cl) with NaBPh4, the chloride anion was exchanged against the larger 
and thus weaker coordinating BPh4- and directly led to the ruthenium(II) complex 37(BPh4). 
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Scheme 45. Synthesis of the ruthenium(II) complex with the symmetric 4,4'-bipyrimidine-2.2'-
diamine.  
 
 Due to the two similar N-donor moieties, the metal site is no longer a centre of chirality 
leading to a symmetrical complex therefore the methyl groups as well as the four aromatic C-H 
sites at the cymene ligand become magnetically equivalent. This is clearly demonstrated by the 
1H and 13C NMR spectra of the 37(BPh4) (Figures 37 and 38). The methyl groups of the 
cymene ring appear as one doublet at about 0.87 ppm and two doublets at about 6.15 and 6.02 
ppm can be assigned to the aromatic hydrogen atoms of the cymene ring. In the 13C NMR 
spectrum two peaks at 85.9 and 81.9 ppm can be assigned to the four magnetically different 
aromatic carbon atoms of the cymene ring and the methyl groups at cymene ring appear as one 
peak at about 21.6 ppm. Coordination of the 4,4'-bipyrimidine-2,2'-diamine to the Lewis-acidic 
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ruthenium(II) centre causes a shift of the H2 and H3 resonances to lower field
ppm. 
Figure 37. 1H NMR spectrum of ruthenium complex 
 
 
37(BPh4). 
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 of about 0.3 
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Figure 38. 13C NMR spectrum of ruthenium complex 
 
 Attempts to obtain single crystals of 
determination by crystallization from dimethylsulfoxide over a long period of time and in the 
presence of oxygen, water and light resulted in ruthenium complex 
cymene ligand against two DMSO ligands and 
occurred (Scheme 46, Figure 39
DMSO is oxidized to sulfate which coordinates to the ruthenium. In a study on organic 
pollutants in water and wastewater DMSO was shown to be oxidized leading to sulfate as the 
thermodynamically most stable product 
methansulfonate.131 Formation of methanesulfonic acid by the reaction of methanesulfinic acid 
with OH radicals has been reported by Holezman
37(BPh4). 
37(BPh4) suitable for X
38. Replacement of the 
the chlorido ligand against one sulfate ligand 
). It seems that in the presence of oxygen, water and light 
via the formation of methanesulfinate and 
132
 and Scaduto.133 The oxidation mechanism 
 
-ray structure 
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of dimethyl sulfoxide (DMSO) by OH radicals in the liquid phase was investigated by Arbilla 
et. all.134  
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Scheme 46. Formation of complex 38 in DMSO in presence of light and oxygen. 
 
 Most notably hydroxyl radicals are produced from the decomposition of 
hydroperoxides (ROOH) or, in atmospheric chemistry, by the reaction of excited atomic 
oxygen with water. In organic synthesis hydroxyl radicals are most commonly generated by 
photolysis of 1-hydroxy-2(1H)-pyridinethione which is structurally similar to 2-
iminopyrimidin-1(2H)-ol (Scheme 47). 
1-hydroxy-2(1H)-pyridinethione
N
S
OH
N
N
NH
OH
2-iminopyrimidin-1(2H)-ol
 
Scheme 47. Structure of 1-hydroxy-2(1H)-pyridinethione and 2-iminopyrimidin-1(2H)-ol. 
 
 Although aerobic oxidation of sulfur atoms in disulfides in the presence of copper(II) is 
well documented,135 according to my knowledge there is no report for ruthenium assisted 
oxidation of DMSO. There are few ruthenium complexes known with a bidentate coordinating 
sulfate as ligand.136 To synthesize them, silver sulfate salt has been used directly. 
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Figure 39. Molecular structure of complex 38 in solid state. 
 
 This complex shows a distorted octahedral arrangement with Ru(II) in center being 
coordinated by the chelating 4,4'-bipyrimidine-2,2'-diamine ligand, two DMSO ligands, 
coordinating by the sulfur atom which are oriented trans to each other and cis to the chelating 
bidentate ligands. The most important aspect of the structure is the bidentate mode of the 
coordinating sulfate group which is in the trans position to the N,N ligand. The Ru(1)-O(2) 
distance is 2.1383(14) Å (even longer than the Ru-O bond in RuCl(SO4)(NO)(PPh3)2, 2.079(7) 
Å)137 and the O(2)#1-Ru(1)-O(2) angle is 67.23(8)°. According to these parameters, and 
because of the strain involved in the four-membered ring RuOSO ring, the sulfate ligand is not 
chelated as strong as other bidentate ligands. The O-S-O bond angles are 101.18(11), 
109.88(9), 110.69(8) and 113.81(14) which show, that the tetrahedral sulfate is slightly 
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distorted. As expected, the S-O bond lengths of the terminal oxygen atoms are shorter than the 
corresponding bond lengths of the coordinated oxygen atoms (1.4453(16) vs. 1.5321(15) Å). 
The angular distortions in the tetrahedron can be explained according to the Gillespie-Nyholm 
model in which it is assumed that the bonds with greater bond order will achieve a maximum 
angular separation. 
 The N(1)-Ru(1) bond length is shorter than the N(2)-Ru(1) length of complex 38 
(2.0599(16) vs. 2.1200(17) Å). Ru(1)-S(1) bond length is 2.3076(5) Å which is in the normal 
range of Ru-S bond lengths of coordinating DMSO.138 As the different bond angles in Table 10 
shows, DMSO is coordinated as a distorted tetrahedron. S(1)-O(1) bond length is 1.4839(15) Å 
which is close to the averaged value of 1.475(10) Å for ionic sulfate.137 
 
Table 10. Bond angles of coordinated DMSO. 
Bond angles (°) 
O(1)-S(1)-C(6) 107.49(10) 
O(1)-S(1)-C(5) 107.27(11) 
C(6)-S(1)-C(5) 101.13(13) 
O(1)-S(1)-Ru(1) 116.19(6) 
C(6)-S(1)-Ru(1) 113.00(8) 
C(5)-S(1)-Ru(1) 110.55(8) 
 
3.2.2 Palladium Complexes 
 Palladium complexes are widely used as catalysts for carbon-carbon, carbon-nitrogen, 
carbon-oxygen and even carbon-fluorine bond formations in agrochemicals, pharmaceuticals, 
and materials.139  
3.2.2.1 Palladium Complexes with Bidendate Ligands 
 Di(chloro)(4-(pyridin-2-yl)pyrimidin-2-amine)palladium(II) complexes 39a-f were 
obtained by the reaction of the corresponding ligands with PdCl2(CH3CN)2 in dichloromethane 
at room temperature (Scheme 48). All complexes tended to precipitate from the reaction 
96 
 
solutions, and optimized yields were obtained by adding excessive amounts of ether to the 
reaction mixtures. The complexes 39a-f are pale yellow to orange solids. 
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Scheme 48. Preparation of palladium complexes 39a-f. 
 
 After coordination to palladium, the resonance of all hydrogen atoms in the 1H NMR 
spectrum shifted to lower field in comparison to the free ligands (Figure 40). The resonance of 
the hydrogen atoms of the amino group not only shifted to lower field by about 2 ppm but also 
show two broad resonances. Therefore, these atoms are no longer magnetically equivalent after 
coordination to palladium. There may be electronic or steric reasons for this behavior: 1) one of 
the NH2 protons is in an ideal position to perform a H…Cl hydrogen bond (Scheme 48) and 2) 
due to coordination to the Lewis acidic metal site, the π-delocalization from the amino group 
into the pyrimidine ring will increase. Both effects result in a hindered rotation around the C-
NH2 bond. Generally the 13C NMR shifts are less sensitive towards the substitution pattern than 
the 1H NMR shifts. C3 is the most influenced carbon atom and is shifted about 4 ppm towards 
lower field with respect to the free ligands.  
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Figure 40. 1H NMR spectrum of ligand 
 
 With ligands 17g-k no palladium complex was obtained, probably due to steric effects. 
3.2.2.2 Palladium Complexes with Tridendate Ligands
 Pd(N,N,C)Cl type complexes 
ligands (N-(4-aryl)-4-(pyridin
dichloromethane at room temperature (Scheme 
the reaction solution and optimized yields 
in the reaction mixture. Since the complexes are not very soluble in CH
dissolved in DMSO for further purification, some drops of ethanol were added and then the 
pure products were precipitat
deep orange colored solids.  
 
17f and complex 39f. 
 
40a-e were obtained by the reaction of the corresponding 
-2-yl)pyrimidin-2-amine) with PdCl
49). All complexes tended to precipitate from 
were obtained by adding excessive amounts of ether 
ed by adding diethylether. The complexes 
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Scheme 49. Synthesis of Pd(N,N,C)Cl complexes 40a-e. 
 
 As expected the resonances of the hydrogen atoms in the 1H NMR spectrum all shifted 
to lower field after coordination to palladium in comparison to the free ligand. The resonance 
of the hydrogen atom of the amino group shifted about 1.5 ppm to lower field. In the 
heterocyclic part of the ligand, H1 was influenced most. Its resonance is shifted by about 0.6 
ppm to lower field. Since one of the carbon atoms of the phenyl ring now coordinates to 
palladium via a CH bond activation, the hydrogen atoms of the phenyl ring become all 
magnetically inequivalent and the pattern of these resonances in the 1H NMR spectrum 
changes dramatically. The resonance of H11 has disappeared completely and a distinguished 
resonance can be assigned for the other hydrogen atoms (Figure 41). The new substitution 
pattern has affected the resonances of H12, H13 and H15, so that they appear at higher field for 
40d (8.00, 6.69 and 7.14 ppm , respectively) with the electron donating methoxy group and 
they shifted to lower field for 40e (8.71, 7.29 and 7.47 ppm, respectively) with the electron 
withdrawing cyanido group. Generally the 13C NMR shifts are less sensitive towards the 
substitution pattern than the 1H NMR shifts belongs to the heterocyclic part of the ligand. The 
pattern of the 13C NMR spectrum in the phenyl part has become very complex. For each carbon 
atom of the ring, one signal can be assigned (Figure 42).  
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Figure 41. 1H NMR spectrum of ligand 
 
 
20d and complex 40d. 
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Figure 42. 13C NMR spectrum of ligand 
 
 For complexes 40a and 40
obtained from DMSO. Their molecular structures in the solid state are presented in Figure
and 44. Both complexes show a typical square
distorted arrangement and being coordinated by a chelating 
(Table 11).  
  
20d and complex 40d. 
d single crystals suitable for X-ray diffraction studies were 
-planar geometry with Pd(II) centers adopting a 
N,N,C type and a chloride ligand 
 
s 43 
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Table 11 . Selected bond length and angles.  
 40a 40d 
R H OMe 
Distances (Å)   
C(15)-Pd(1) 1.990(3) 1.993(2) 
N(1)-Pd(1) 2.111(2) 2.1161(18) 
N(2)-Pd(1) 2.015(2) 2.0068(19) 
Cl(1)-Pd(1) 2.3192(7) 2.3226(5) 
Angles (°)   
C(15)-Pd(1)-N(2) 93.45(10) 93.20(8) 
N(2)-Pd(1)-N(1) 80.27(9) 79.96(7) 
C(15)-Pd(1)-Cl(1) 94.76(8) 94.84(7) 
N(1)-Pd(1)-Cl(1) 92.04(7) 92.71(5) 
C(15)-Pd(1)-N(1) 172.27(10) 171.24(8) 
N(2)-Pd(1)-Cl(1) 169.37(7) 168.75(6) 
  
 
Figure 43. Molecular structure of complex 40a in solid state.  
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Figure 44. Molecular structure of complex 40d in solid state.  
 
 Both complexes crystallize in the monoclinic space group monoclinic with one 
additional molecule of DMSO. The aromatic rings are not completely planar, a slight torsion is 
observed. The distances Pd-N1 (2.111(2) and 2.1161(18) Å for 40a and 40d, respectively), Pd-
C15 (1.990(3) and 1.993(2) Å for 40a and 40d, respectively) and Pd-Cl1 (2.3192(7) and 
2.3226(5) Å for 40a and 40d, respectively) are similar to related structures. In published 
molecular structures of Pd(N,N,C)Cl type compounds, wherein N,N,C are tridentate N-aromatic 
heterocycles, the reported Pd-N(pyridine) bonds lengths fall into the region 1.95-2.15 Å, 
whereas Pd-C(phenyl) distances and Pd-Cl bonds lie in the region 1.97-1.99 Å and 2.29-2.36 
Å, respectively.140 
 Further examination of the metric parameters in Table 11 reveals that in both 
complexes 40a and 40d the Pd1-N2 distance is slightly shorter than the corresponding Pd1-N1 
distance, which may be due to the steric reasons. 
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3.3 Catalytic Experiments 
 The synthesized ruthenium complexes were tested as catalysts for transfer 
hydrogenation and palladium complexes as catalysts for Suzuki coupling reaction.  
3.3.1  Catalytic Activities  
3.3.1.1  Transfer Hydrogenation 
 Ruthenium and rhodium complexes are the commonly most efficient catalysts for the 
transfer hydrogenation of ketones (Scheme 50). It has been shown before in Thiel’s group that 
ruthenium complexes bearing nitrogen containing ligands can catalyze both the direct and the 
transfer hydrogenation of ketones.26h,127  
O
[Ru], iPrOH
OH
 
Scheme 50. Catalytic transfer hydrogenation of acetophenone leading to 1-phenylethanol. 
 
3.3.1.1.1 Catalytic Activities of Ru(NNN)Cl(PPh3) Complexes 
 Although more than two complexes of the type Ru(NNN)Cl(PPh3) were synthesized, 
just complexes 33a and 33b could be obtained in high purity and thus be used as catalyst. 
Acetophenone has been chosen as a model substrate to explore the catalytic performance of 
compounds 33a,b and 34a,b in transfer hydrogenation. The reaction conditions were optimized 
by first using 33a (Table 12). Due to the poor solubility of the catalyst in 2-propanol, 
dichloromethane was added to obtain a homogeneous solution. All reactions were carried out at 
room temperature and the catalyst generally showed high activities even under these very mild 
conditions. It seemed that too much base and a high dilution of the solution reduced the 
reaction rate (entries 8 and 5, Table 12). As expected, the rate of the reaction increased 
dramatically by increasing the temperature (entry 7, Table 12). A blank experiment carried out 
in the absence of the catalyst gave no hydrogenation of acetophenone at all (entry 9, Table 12). 
104 
 
Table 12. Transfer hydrogenation of acetophenon with 33a[a]. 
entry substrate : catalyst : base 
ratios 
solvent 
(mL) 
yields (%) after 
0.5 h 1 h 1.5 h 
1 200 1 - 25 0 0 0 
2 200 1 1 25 92 93 94 
3 200 1 2.5 25 88 92 92 
4 200 1 5 25 73 87 99[b] 
5 200 1 5 50 69 92 92 
6 500 1 5 25 48 62 71 
7[c] 200 1 5 25 100[d] 0 0 
8 200 1 10 25 22 37 49 
9 200 - 5 25 0 0 0[e] 
 [a] Reaction conditions: 2.5⋅10-2 mmol of 33a, 20 mL of isopropanol, 5 mL of CH2Cl2, room 
temperature, N2, monitored by GC. [b] Reaction completed after 80 min. [c] Reaction carried 
out at 82 °C. [d] Reaction completed after 5 min. [e] Even after about 3 h no product was 
detected without catalyst. 
 
 According to these results, the catalyses were carried out using a 0.5 M solution of the 
substrate, 0.5 mol-% of the catalyst, and 0.025 mol of KOH. For this purpose, a solution of the 
substrate in 2-propanol was added at room temperature to a 2-propanol/CH2Cl2 solution 
containing the catalyst and the base. With the addition of the base, the color of the solution 
turned to a more intense red color, but during the reaction the color of the solution remained 
unchanged. 
 Complex 33a was found to catalyze the reduction of acetophenone to 1-phenylethanol 
quantitatively in 80 min at room temperature. Substitution of the protons in the 5-position of 
the pyrazole ring against n-butyl groups dramatically increases the performance: in the 
presence of catalyst 33b, the transformation is completed in less than 15 min at room 
temperature (Table 13), giving a minimum TOF of 800 h–1. We assign this finding to an 
increase in steric hindrance by the n-butyl groups, which will force the allyl chains to be 
oriented away from the rear side of the catalyst. This will probably enable the dissociation of 
the triphenylphosphane ligand and activate the catalyst for the transfer hydrogenation process. 
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This mechanistic idea is corroborated by replacing the triphenylphosphane ligand with a carbon 
monoxide ligand (compounds 34a,b), which makes the catalyst almost inactive even at 82 °C. 
 
Table 13. Transfer hydrogenation of acetophenone with different ruthenium catalysts[a]. 
entry catalyst time (min) yields (%) 
1 33a 80 99 
2 33b 15 100 
3 34a 1080 0 
4 34b 1080 traces 
5[b] 34a 60 0 180 traces 
6[b] 34b 60 13 180 16 
[a] Reaction conditions: 5⋅10-3 mmol of catalyst, 1 mmol of substrate, 2.5⋅10-2 mmol of KOH, 4 
mL of isopropanol, 1 mL of CH2Cl2, room temperature, N2, monitored by GC. [b] Reaction 
carried out at 82 °C. 
 
 Finally the activity of 33b was tested with a few different ketones to show its general 
applicability in transfer hydrogenation (Table 14). The results prove that increasing the 
electron density at the aromatic ring reduces the reaction rate. Complete conversion for the first 
two substrates was observed after 10 min at room temperature resulting in a minimum TOF of 
1200 h –1. 
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Table 14. Transfer hydrogenation of different ketones with 33b[a]. 
entry substrate yields (%) 
1 
O
 
100 
2 
O
Cl
 
100 
3 
O
H3C
 
96 
4 
O
O
 
51 
[a] Reaction conditions: 1 mmol of substrate, 5⋅10-3 mmol of 33b, 2.5⋅10-2 mmol of KOH, 4 
mL of isopropanol, 1 mL of CH2Cl2, room temperature, N2, reactions monitored by GC, 
samples were taken after 10 min. 
 
 Concerning the mechanism of the transfer hydrogenation catalyzed by 33a,b, a reaction 
sequence following an inner coordination of the substrate can be suggested. There is no 
evidence for a ligand-assisted process, which could be initiated by splitting one or both of the 
allylic chains through an SN2 or SN2' reaction with the base leading to an anionic pyrazolate 
donor (Scheme 51) and a vacant coordination site at the ruthenium(II) center. This reaction 
would generate an intermediate suitable for a ligand-assisted, outer-coordination mechanism. 
N
N N
N N
R
R
Ru
Cl
PPh3
Cl 33a,b
-OH
N
N N
N N
R
R
Ru
PPh3
Cl
OH
-
- Cl-
 
Scheme 51. Cleavage of the allyl–N bond by the base. 
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 Treatment of 33a,b with KOH did not result in cleavage of the N–allyl bond. Cleaving 
the Ru–P bond, further promoted by the steric demand of the butyl chain in complex 33b, 
should therefore be the initial step to generate a reactive 16-VE ruthenium(II) species, which 
then leads to the formation of the catalytically active ruthenium hydrido species. This is 
supported by the fact that addition of an excess of PPh3 to the catalyst strongly decreases the 
reaction rates of 33a,b, which is similar to findings reported in the literature.46 Comparing the 
activity of 33b (TOF ≥ 1200 h –1) at room temperature makes it clear that we have obtained a 
highly active structural motif. It already had been shown in the literature that ruthenium(II) 
complexes with trans-coordinated chloro ligands are less active in the transfer hydrogenation 
of ketones than ruthenium(II) complexes with cis-coordinated chloro ligands (such as 
33a,b).10b  
3.3.1.1.2 Catalytic Activities of Ru(NN)(Cymene)Cl Complexes   
 Compound 36a(Cl) was taken to optimize the reaction conditions for the transfer 
hydrogenation of acetophenone in isopropanol solution. A first series of experiments proved, 
that the catalyst becomes active at about 82 °C in the presence of KOH as the base. Evaluation 
of the optimum amount of base showed that with a base to catalyst ratio of 2.5:1 about 64 % of 
conversion can be observed after 3 h (Table 15, entry 3). However, under these conditions the 
catalyst becomes inactive and will not reach 100% of conversion, which is possible by 
increasing the base to catalyst ratio to 10:1 (Table 15, entry 1). The catalyst shows no activity 
in the absence of the base.   
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Table 15. Optimization of the base to catalyst ratio.[a] 
entry base : catalyst conversion [%] after 3h 24h 
1 10 : 1 37 100 
2 5 : 1 32 94 
3 2.5 : 1 64 81 
4 0 : 1 0 0 
[a] reaction conditions: acetophenone (2.5 mmol), 36a(Cl) (1.25⋅10-2 mmol), isopropanol (25 
mL), 82 °C; the reactions were monitored by GC. 
 
 After having fixed the reaction conditions, the catalyst structure was optimized by 
changing A) the counter ion, B) the substitution in the 5-position of the pyrimidine ring (R), 
and C) the nature of the amine group (R’) (see Scheme 44). Table 16 summarizes the influence 
of the counter ion in the series 36c(X) (X = Cl-, BF4-, PF6-, BPh4-). Although the differences are 
not pronounced, the weakly coordinating tetraphenylborate anion (Table 16, entry 4) clearly 
gives the best results at both, short and long reaction times. 
 
Table 16. Effect of the counter ion.[a] 
entry anion conversion [%] after 
 X 2 h 6 h 24 h 
1 Cl- 28 60 100 
2 BF4- 26 53 70 
3 PF6- 45 69 78 
4 BPh4- 49 63 100 
[a] reaction conditions: acetophenone (2.5 mmol), 36c(X) (1.25⋅10-2 mmol), KOH (1.25⋅10-1 
mmol), isopropanol (25 mL), 82 °C; the reactions were monitored by GC. 
 
 In the following, the substitution pattern on the pyrimidine ring was changed. As 
summarized in Table 17, there are pronounced effects of the substituents in the 5-position of 
the pyrimidine ring, reflecting that increased electron donation of the substituent results in an 
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increase of catalytic activity. It is also clear, that substituents with a π-system, which will 
overlap with the pyrimidine π-system, are beneficial.  
 
 Table 17. Influence of the substituent in the 5-position of the pyrimidine ring.[a] 
entry catalyst conversion [%] after 
2h 6h 
1 36a(BPh4) 19 35 
2 36b(BPh4) 69 89 
3 36c(BPh4) 49 63 
4 36d(BPh4) 73 87 
5 36f(BPh4) 79 98 
[a] Reaction conditions: acetophenone (2.5 mmol), catalyst (1.25⋅10-2 mmol), KOH (1.25⋅10-1 
mmol), isopropanol (25 mL), 82 °C; the reactions were monitored by GC. 
 
 For the 6-para-methoxyphenyl functionalized system 36d(BPh4), the delocalization 
even includes the oxygen atom as outlined in Scheme 52, which will donate additional charge 
density to the nitrogen donor atom of the pyrimidine ring. This will reduce the strength of the 
Ru-Cl bond and therefore will allow this ligand easier to be replaced by an isopropanolato 
ligand and subsequently undergo the transfer of a hydrido ligand to the ruthenium site. 
Comparing these catalytic data with the structural data of compounds 36a(PF6), 36k(BPh4), 
and 36p(BPh4) (for crystal structures see Figure 29-36) reveals that as the Ru1-N2 distance 
decreases, the catalytic activity will increase.  
110 
 
Ru Cl
N
N
N
NH2
36d+
O
 
Scheme 52. Electron delocalization including the oxygen atom. 
 
 It should be mentioned at this point that [(η6-cymene)Ru(Cl)(bipy]+Cl- (bipy = 2,2’-
bipyridyl) was included into this study. This catalyst shows - with chloride as the counter ion - 
higher activities than all members of the series 36a-f(BPh4) suggesting that the presence of a 
NH2 group has a detrimental rather than positive effect on the catalytic performance. Therefore 
the NH2 functionalized ligands should not take part in the catalytic process in terms of a 
bifunctional mechanism. Therefore, it was proposed that like with Baratta’s catalysts, this 
system performs an inner-sphere mechanism in which the alcohol and the ketone coordinate to 
the metallic center during the catalytic process.10,11 Similar results have been reported by 
Schlaf et al.141 who showed that a NH2 substituted catalyst failed to show higher activity. They 
explained their finding with either the low pKa value of the NH2 group or with a mismatch of 
the proton-hydride distance in the active species. The active hydride species could not be 
traped but according to the similarity of this catalysts with the Schlaf’s system, steric reasons 
seem to be important. 
 To overcome the drawbacks of the 2-amino group, a series of catalysts were 
synthesized, containing either secondary or tertiary amino groups in the 2-position of the 
pyrimidine ring. The data of these compounds in the catalytic transfer hydrogenation are 
summarized in Table 18. Generally, the introduction of a tertiary amine improves the 
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conversions dramatically. Contrary to the findings discussed above, electron donating groups 
in the 4-position of the pyrimidine ring are decreasing the catalytic performance, the best result 
was found for the pyrolidinyl functionalized system 36g(BPh4) (Table 18, entry 4). Moreover, 
this compound was also checked for its activity in the absence of the base and it achieved 51% 
and 85% of conversion after 6h and 24h, respectively, while the NH2 functionalized catalyst 
36a(Cl) gave no conversion at all under these conditions. Still the reactivity of 36g(BPh4) is 
lower in the absence than in the presence of KOH. However, since the base is required to 
activate the catalyst by generation of a hydride species, an alternative mechanism has to be 
found to explain these findings. This will be discussed in the next section. 
 
Table 18. Effects of the amino group.[a] 
entry catalyst conversion [%] (time [min]) 
1 36i(BPh4) 45 (120) 
2 36h(BPh4) 48 (120) 
3 36j(BPh4) 100 (90) 
4 36g(BPh4) 97 (20) 
5 36q(BPh4) 100 (600) 
6 36m(BPh4) 100 (600) 
7 36p(BPh4) 100 (600) 
[a] reaction conditions: acetophenone (2.5 mmol), catalyst (1.25⋅10-2 mmol), KOH (1.25⋅10-1 
mmol), isopropanol (25 mL), 82 °C; the reactions were monitored by GC. 
 
3.3.1.1.3  Investigation of the Mechanism 
 Chanati et al. had reported the activation of sp3 C-H bonds adjacent to the nitrogen 
atom of an alkylamine group in ruthenium catalyzed coupling reactions142 and Whittlesey et al. 
had reported a facile C-H bond activation at room temperature occuring on the N-heterocyclic 
carbene ligand 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (IMes) in 
Ru(IMes)(PPh3)2CO(H)2 in the presence of a sacrificial alkene.143 Here the C-H cleavage 
product readily reforms the starting dihydride upon reaction with H2.143 The same group had 
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also exploited this ruthenium complex for an indirect Wittig reaction using alcohols as the 
substrate, in which the catalyst removes hydrogen from the alcohol.143 Crucial to the success of 
this complex for both direct and transfer hydrogenation reactions143 is a reversible C-H bond 
activation process.  
 These findings led me to the idea, that an intramolecular C-H bond activation occurring 
in the ligand environment of the catalyst could be the key step in the base-free transfer 
hydrogenation with catalysts 36g(BPh4), 36j(BPh4) and 36k(BPh4). To elucidate the 
mechanism, the activity of 36g(BPh4) was investigated in more details. First its activity was 
checked for the catalytic dehydrogenation of 1-phenylethanol and it was found that after 48 h 
at 82 °C in toluene solution just traces of acetophenone could be detected, even in the presence 
of KOH, which means that there is likely the formation of a rutheniumhydrido species, but this 
compound cannot lose dihydrogen. So, there is no C-H activation on the ligand, neither by 
oxidative addition which is discussed in the literature for zero valent ruthenium 
complexes,142,144,145 nor by direct H2 evolution, otherwise ongoing dehydrogenation of 1-
phenylethanol under evolution of dihydrogen would be feasible.146 
 Next, it was checked if 36g(BPh4) reacted in a 1:2.5 ratio with 1-phenylethanol 
(approximately quantitative) can dehydrogenize the substrate in the absence of KOH and an 
hydrogen acceptor (such as acetophenone). After 24 h we found 31% conversion of 1-
phenyethanol to acetophenone, which is about 80% corresponding to the amount of 36g(BPh4) 
added in this experiment, which might either be explained by an incomplete conversion or by 
reaching the equilibrium as shown in Scheme 53. This proves that the formation of a 
hydridoruthenium species is possible, although this compound could not be isolated up to now. 
The hydridoruthenium formation can be explained just by a C-H bond activation occurring on 
the ligand.  
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Scheme 53. Stoichiometric reaction between 36g(BPh4) and 1-phenylethanol. 
 
 Furthermore, there is no stoichiometric hydrogenation of acetophenone in the absence 
of isopropanol. To investigate this, a 1.35:1 mixture of acetophenone and 36g(BPh4) was 
stirred for 24 h at 82 °C in toluene solution. No trace of 1-phenylethanol could be detected. 
This excludes a double C-H activation on the ligand, a pathway that is discussed in the 
literature, too.147 
 To support that there is an intramolecular C-H bond activation occurring in the ligand 
environment of the catalyst and experimentally elucidate the process of C-H activation, 
electrospray mass spectrometry investigations were carried out in collaboration with Fabian 
Menges from the group of Prof. Nieder-Schatteburg, using collision-induced dissociation 
(CID) mass spectrometry with compounds 36a(BPh4), 36g(BPh4), and 36j(BPh4) under 
variation of the fragmentation amplitude (see below). Under mild conditions (no CID), the 
corresponding cations 36a+, 36g+, and 36j+ were detected without any fragmentation. Inducing 
fragmentation by increasing the fragmentation amplitude gave directly rise to HCl elimination 
for all three ruthenium complexes (Figures 45-47). However, the energy required for this 
process is considerably higher for the cation 36a+ than for its N-alkylated congeners 36g+ and 
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36j+ (Figure 48). Relative abundances of the CID fragments (fragment yield curves) were fitted 
using a sigmoidal function. The corresponding E50% values (50% of the fragment ion intensity 
with respect to the total ion intensity) are thought to represent the relative appearance energies 
of the related fragmentation processes. 
 
Figure 45. ESI-MS spectra of 36a+. Experimental spectrum of 36a+ (a) and of the 
fragmentation of 36a+ (loss of HCl) (b), simulated spectrum of 36a+ (c) and of the fragments of 
36a+ (loss of HCl (green) and HCl and H2 (red)) (d). 
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Figure 46. ESI-MS spectra of 36g+. Experimental spectrum of 36g+ (a) and of the 
fragmentation of 36g+ (loss of HCl) (b), simulated spectrum of 36g+ (c) and of the fragment of 
36g+ (loss of HCl) (d). 
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Figure 47. ESI-MS spectra of 36j+. Experimental spectrum of 36j+ (a) and of the fragmentation 
of 36j+ (loss of HCl) (b), simulated spectrum of 36j+ (c) and of the fragment of 36j+ (loss of 
HCl) (d). 
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Figure 48. Collision-induced fragmentation of the cations 36a+ (■), 36a+-d1 (●), 36j+ (▾), 36j+-
d1 (♦) and 36g+ (▴). 
 
 To gain a deeper insight into the transfer hydrogenation mechanism, identification of 
the location of the C-H activation was started. Since the η6-coordinated cymene ligand and the 
pyridine moiety are common features of 36a(BPh4), 36g(BPh4), and 36j(BPh4), C-H 
activation at one of these sites should not result in pronounced differences between 36a+ on 
one side and 36g+, 36j+ on the other. Therefore the efforts were concentrated on the pyrimidine 
moiety. The proton H7 was replaced against deuterium using 2,3,4,6,7,8-hexahydro-1H-
pyrimido[1,2-a]pyrimidine (TBD) as an efficient isotope exchanger catalyst in CDCl3 at room 
temperature (Scheme 54).148 
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Scheme 54. Synthesis of the deutrated ligand 17a+-d1, 17j+-d1. 
 
 Repeating the ESI-MS experiment with 36a+-d1 and 36j+-d1 revealed exclusively the 
elimination of DCl (Figure 49), proving that the C-H activation occurs selectively at the 5-
position of the pyrimidine ring. Furthermore 36j+-d1 was dissolved in dry isopropanol and the 
2H NMR has been measured overnight before and after heating. The deuterium peak vanished 
after heating which is another evidence for an intramolecular C-H bond activation occurring on 
the 5-position of the pyrimidine ring (Figure 50).  
 
Figure 49. Comparison of the ESI-MS data of 36j+ and 36j+-d1. Experimental spectrum of 36j+ 
(a) and of the fragmentation of 36j+ (loss of HCl) (b), experimental spectrum of 36j+-d1 (c) and 
of the fragment of 36j+-d1 (loss of DCl) (d). 
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Figure 50. 2H NMR spectra of 
 
  To further evaluate this process, DFT calculations on the cations 
were carried out by Prof. Thiel. The elimination of HCl from the 18e systems 
36j+ is obviously an endothermic, dissociative process in all cases, and is generally induced by 
breaking the Ru-N(pyrimidine) bond. Subsequently the pyrimidine moiety re
C5 and H5 is transferred to the chloride ligand resulting in an HCl
(η6-cymene)Ru complex, which then loses HCl with a very small barrier of activation. Results 
of the calculations on the C-
(∆Hf) for the HCl elimination show that all energies are about 10
than for 36j+ and about 9-11 kcal/mol higher for 
Table 19). Since these differences in energy are already found for TS1, the 
 
36j+-d1 before (top) and after (bottom) heatin
3
-adduc
H activation process are  shown in Figure 51
-12 kcal/mol higher for 
36a+ than for 36g+ (
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g. 
6a+, 36g+, and 36j+149 
36a+, 36g+, and 
-coordinates with 
t of a C,N-coordinated 
. The calculated data 
36a+ 
36a+ >> 36g+ > 36j+; 
breaking of the Ru-
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N(pyrimidine) bond is crucial for the C-H activation. This can be assigned to an increase of 
steric hindrance with the cymene ligand when the NH2 group (36a+) is substituted against a 
NR2 group (36g+ and 36j+). The catalytic activities follow an ordering of 36a(BPh4) << 
36j(BPh4) < 36g(BPh4), the inversed ordering of 36j(BPh4) and 36g(BPh4), with respect to 
their catalytic activities, may be due to solvent and/or counterion effects. 
 
Table 19. Calculated heats of formation (∆∆Hf), enthalpies (∆∆H, italics) and Gibbs energies 
(∆∆G, underlined) of the C-H activation steps in kcal/mol. 
step 36a+ 36j+ 36g+ 
A 0.00 / 0.00 / 0.00 0.00 / 0.00 / 0.00 0.00 / 0.00 / 0.00 
TS1 34.81 / 33.66 / 32.11 24.64 / 23.60 / 20.92 25.29 / 24.28 / 22.56 
B 24.32 / 23.86 / 23.21 12.89 / 12.47 / 10.13 12.99 / 12.68 / 11.55 
TS2 48.11 / 43.56 / 42.76 38.20 / 33.93 / 31.81 38.52 / 34.35 / 32.97 
C 45.94 / 43.17 / 40.92 36.66 / 34.00 / 30.46 37.11 / 34.56 / 32.39 
TS3 50.03 / 46.54 / 40.98 39.43 / 36.09 / 31.20 39.81 / 36.53 / 32.01 
D 49.22 / 45.36 / 32.78 38.17 / 34.47 / 20.98 38.49 / 34.75 / 21.27 
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Figure 51. Calculated heats of formation (∆∆Hf, solid lines), enthalpies (∆∆H, dashed lines) 
and Gibbs energies (∆∆G, dotted lines) leading to the elimination of HCl from the cations 36a+ 
(black curves), 36j+ (red curves), and 36g+ (green curves). The calculated structures of all 
intermediates and final products derived from 36a+ and 36j+ are depicted. 
 
 Recently, it was shown that with so-called “thermometer ions” (substituted 
benzylpyridinium ions), it is possible to calibrate the internal voltage scales of the mass 
spectrometers fragmentation amplitudes towards appearance energies (E50%) of the fragment 
ions.150 The precision of such an approach is compromised if additional fragmentation channels 
are taken into account. For 36j+ and 36g+ only one reaction channel, the elimination of HCl 
(resp. DCl) was found, 36a+ showed the additional loss of H2. The underlying mechanism of 
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the C-H activation of 36a+, 36g+ and 36j+ implies a tight transition state (see DFT 
calculations), which might lead to a kinetic shift in the appearance energies obtained by CID.  
 Fabian Menges calibrated the CID breakdown curves of 36a+, 36g+ and 36j+ with seven 
“thermometer ions” (C5H5N+-CH2-C6H4-R; R=H, o-CH3, p-CH3, p-F, p-Cl, p-CN, p-OCH3) 
against the calculated enthalpies (∆Hcalc; B3LYP, G6-31*, ZPE-correction, 298.15 K, BSSE 
corrected) for a bond cleavage regarding the loss of neutral pyridine (with cationic substituted 
benzylium ions as ionic products (in case of R=H, p-Cl, p-CN, p-OCH3)). Zins et al. 
investigated the competing formation of tropylium ions (in case of o-CH3, p-CH3, p-F), which 
also was calculated and used for calibration.149c 
 Data from CID experiments of benzylpyridinium ions and 36a+, 36g+ and 36j+ were 
center-of-mass transformed and compared according to their E50% values. A linear fit function 
(∆Hcalc versus CID E50% value of substituted benzylpyridinium ions) was used to estimate the 
enthalpies of the HCl (DCl) loss for 36a+, 36g+ and 36j+. This analysis results in a qualitative 
trend of activation energies (loss of HCl or DCl) of the Ru-catalysts 36a+, 36g+ and 36j+ with 
respect to the “thermometer ions” (Table 20). 
 
Table 20. Estimated enthalpies of Ru-catalysts 36a+, 36g+ and 36j+ (∆Hfit) from a linear fit 
function of benzylpyridinium ions (∆Hcalc versus CID E50% value) and calculated ZPE 
corrected enthalpies (∆H) of the transition state TS3 of the HCl loss. 
 
∆H
 fit (kcal/mol) ∆H (kcal/mol) 
36a+ 49 46.5 
36a+-d1 49 - 
36j+ 34 36.1 
36j+-d1 35 - 
36g+ 36 36.5 
  
 Since the presence of the base is solely accelerating the reaction but is, as mentioned 
above, not a condition precedent for the transfer hydrogenation with 36g(BPh4), the following 
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mechanism is proposed according to the experiments and calculation which have been done 
(Scheme 55).  
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Scheme 55. Reaction mechanism for the transfer hydrogenation in the absence of the base. 
 
 Using experimental and theoretical results unusual activities of different catalysts can 
be explained as follow:  
• If there is a substituent at the 5-position of pyrimidine ring, no C-H bond activation will 
take place because of steric reasons and the mechanism of the reaction is the classical one, 
meaning that the catalytic cycle requires a base to be completed. Here the catalyst will benefit 
from electron donating substituent at the 5-position of pyrmidine ring. 
• If there is no substituent at the 5-position of the pyrimidine ring so that C-H bond 
activation can occur the catalyst will benefit from more steric hindrance of alkylated amines 
which results in a C,N coordination mode. This facilitates the elimination of HCl and makes a 
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coordination site free for coordination of the alcohol. In this case, the carbon atom can perform 
the role of an internal base so that the catalyst is active also in the absence of external base. 
• Since in the first step of catalytic cycle the chloride ligand should leave the 
coordination sphere and since this can be expedited by the C,N coordination mode, the 
complexes having no substituent at the 5-position of pyrimidine ring seem to be promising 
catalysts for transfer hydrogenation of ketons in the absence and presence of a base. 
 In order to trap and characterize the CH activated intermediate some additional 
experiments were carried out. Heating a NMR probe of 36g(BPh4) with CDCl3 as solvent 
results in de-coordination of ligands. It is noteworthy that two extra peaks which can be 
assigned to CH2Cl2 (δ = 5.30 ppm) and benzene (δ = 7.36 ppm) are also detectable in the 1H 
NMR spectrum. Adding triethylamine as a base to a NMR probe of 36g(BPh4) with CDCl3 as 
solvent (without heating) results in decomposition of the complex after one day. Parallel to 
this, the peaks at 5.30 and 7.36 ppm are detected. If again a similar probe is heated for 1h in 
addition to the peaks at 5.30 and 7.36 ppm a further peak at 11.78 ppm can be detected which 
can be assigned to the triethylammonium cation. In all cases it seems that the probe’s medium 
is getting acidic and that the counterion has released benzene, a process that can occur in an 
acidic medium151 (Scheme 56, Equation 13). Also it seems that the formed triphenylborane has 
reacted with the solvent and produced dichloromethylium (Scheme 56, Equation 14) which 
may take a hydride from cymene ring and be converted to dichloromethane (Scheme 56, 
Equation 15). The cymene can release a proton and become stable results in decomposition of 
the catalyst. This will result in a more acidic medium which autocatalyzes the reaction 13.  
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BPh4- + H+ BPh3 + C6H6 (13)
BPh3 + CHCl3 BPh3Cl- + CHCl2+ (14)
H
+ CHCl2+ + CH2Cl2
-H+ (15)
 
Scheme 56. Benzene formation from tetraphenyborate in an acidic medium (eq. 13), reaction 
between triphenylborane and solvent (eq. 14), reaction between dichloromethylium and 
cymene ligand (eq. 15).  
 
 Obviously these conditions are too harsh and result in complex decomposition. So 
without adding a base, a NMR probe of 36g(BPh4) with CDCl3 as solvent was heated just to 60 
°C for 15 h. In this case no peak at 5.30 ppm is detected but still the complex decomposed and 
a peak appears at 7.36 ppm which means that the medium gets acidic by heating. This can by 
itself be a hint for C-H bond activation which results in release of a proton and makes the 
medium acidic. Using a milder condition AgOAc was added to NMR probe of 36g(BPh4) with 
CDCl3 as solvent. Here silver can catch the chloride and the acetate, which is a weak base, will 
capture the proton. But even after 3 days without any heating no changes has been observed in 
the 1H NMR spectrum.  
 It was expected to trap a hydrido ruthenuim complex by refluxing 36j(BPh4) and 
NaBH4 in dry methanol for 15 h. But in the 1H NMR spectrum no peaks below 0 ppm to be 
assigned to a hydrido species. However there are some changes in the spectrum. The most 
important one is that the doublet peak at about 6.70 ppm which was assigned to H7 on the 
pyrimidine ring vanished and another doublet peak appeared at about 8.7 ppm. Also all the 
peaks of the N,N ligand and counter ion are shifted to lower field. Moreover the peaks of the 
cymene ring show a more symmetric pattern. This can be explained as follows: 
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 NaBH4 and methanol form an adduct which will take a proton from the complex and 
release H2.152 This makes the reaction to occur in one direction and will produce BH3, NaCl 
and the 16e intermediate simultaneously. Methanol can be activated by liberated BH3 and 
donate its proton to the nitrogen atom of the N,N ligand (Scheme 57). This proton might appear 
at low field at about 8.7 ppm in the 1H NMR spectrum.  
Ru Cl
N
N
N
N + MeOH + NaBH4
Ru
N
N NH+
N
+ MeOBH3- + NaCl + H2
H
OH
 
Scheme 57. Formation of a 18e intermediate in the presence of NaBH4 in methanol. 
 
 Furthermore no formation of the CH2Cl2 and benzene has occurred which is a result of 
replacing chloroform with methanol. It seems that the formed intermediate is too active and 
will react with chloroform to produce dichloromethane and this makes the medium acidic 
which causes the splitting of a benzene ring from counter ion as discussed above. Although the 
active intermediate in the transfer hydrogenation could not be detected by these experiments, 
all of them confirm the CH bond activation indirectly.  
 As it was mentioned in section 1.5.1, there are five classes for CH bond activation 
according to the Bercaw classification65:  
1) Oxidative addition, which is typical for electron-rich, low-valent complexes of the late 
transition metals. This will occur for Ru0, our complexes cannot undergo this type of 
reaction. 
2) Sigma-bond metathesis, which is typical for complexes of the early transition metals in 
which ruthenium is not included. 
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3) Metalloradical activation, which is typical for dimeric complexes. 
4) 1,2-Addition, which is common for an addition across a metal-nonmetal double bond. 
5) Electrophilic activation, which occurs in polar or acidic media and is typical for late- or 
post-transition metal. 
In our case the complex should lose HX in the first step. This is not reported for ruthenium 
complexes until now but all evidences mentioned above confirm that this can be the right class 
for this type of CH bond activation.  
3.3.1.2 Suzuki Coupling 
 After the first report in 1981, the Suzuki–Miyaura reaction has been used in the 
construction of varied biaryls,74,153 which have many applications in pharmaceutical, material 
and agricultural chemistry.154 In the past decades phosphine ligand based palladium catalysts 
were extensively used due to their extreme donor ability. Despite their toxicity, Pd(II) catalysts 
with phosphine ligands have shown very high turnover numbers (TONs).155 Recently, Pd(II) 
catalysts with different N-donor ligands became attractive for catalytic applications as they 
possess lower toxicity and are easy to handle.156,157 As examples, N-coordinated palladium-
imidazole, imidazoline complexes158 and palladiumbenzimidazole complexes159 were found to 
be catalytically active in the Suzuki–Miyaura reaction. Furthermore, Boykin and co-workers 
have developed a simple amine–Pd(OAc)2 catalyst system for the Suzuki–Miyaura reaction.160 
Moreover, bidentate nitrogen donors, which are more air-stable, have also been used as ligands 
for this reaction.157f,161 Here, I focus on the catalytic activity of complexes 39a-f for the 
Suzuki–Miyaura reaction. 
 Complex 39d was first tested as a catalyst in the model Suzuki–Miyaura reaction of 
bromobenzene with benzeneboronic acid to ascertain the optimum conditions (Table 21). As 
obvious from the results, this complex is even active at low temperatures near to room 
temperature and although lowering the loading will decrease the activity but the system is still 
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active. Since the proper combination of base and solvent was extremely important, several 
different bases and solvents were examined. Obviously an increase in the polarity of the 
solvent will increase the activity of the catalyst. Although ethanol is a very good solvent, a 
mixture of the DMF and water seems to be the best solvent. From the entries 9-13 one can 
conclude, that the activity benefits from a larger cation in base and carbonate as its counterion 
which makes Cs2CO3 a good base for this system. Furthermore the ratio of DMF and water was 
tested and therefore the optimized conditions were found using the complex 39d as follows: 
the reaction proceeded with 89% in DMF/H2O with Cs2CO3 at 70 °C for 1 h.  
 
Table 21. Optimization of the reaction conditions using 39d.[a] 
Entry Solvent Solvents 
ratio 
Cat. 
Loading 
[mol-%] 
base base [mol-%] T[°C] 
Yield [%] 
1h 2h 24h 
1 1,4-dioxane - 1 Cs2CO3 120 RT 0 0 0 
2 1,4-dioxane - 1 Cs2CO3 120 40 trace trace Trace 
3 1,4-dioxane - 1 Cs2CO3 120 60 24 30 44 
4 1,4-dioxane - 1 Cs2CO3 120 75 27 36 71 
5 1,4-dioxane - 1 Cs2CO3 120 70 27 - - 
6 DMF - 1 Cs2CO3 120 70 0 - - 
7 Toluene - 1 Cs2CO3 120 70 23 - - 
8 EtOH - 1 Cs2CO3 120 70 81 - - 
9 DMF/H2O 50:50 1 Cs2CO3 120 70 89 - - 
10 DMF/H2O 50:50 1 NaOAc 120 70 9 - - 
11 DMF/H2O 50:50 1 Na2CO3 120 70 71 - - 
12 DMF/H2O 50:50 1 K3PO4 120 70 73 - - 
13 DMF/H2O 50:50 1 K2CO3 120 70 81 - - 
14 DMF/H2O 75:25 1 Cs2CO3 120 70 46 - - 
15 DMF/H2O 25:75 1 Cs2CO3 120 70 65 - - 
16 DMF/H2O 50:50 1 Cs2CO3 60 70 60 - - 
17 DMF/H2O 50:50 1 Cs2CO3 240 70 92 - - 
18 DMF/H2O 50:50 0.1 Cs2CO3 120 70 67 - - 
19 DMF/H2O 50:50 0.01 Cs2CO3 120 70 42 - - 
[a] Reaction conditions: phenyl bromide (1 mmol), benzeneboronic acid (1.5 mmol), solvent (5 
mL,) under N2. The reactions are monitored by GC. 
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 At the end, complexes 39a-f (Scheme 58) with different substituents on the pyrimidyl 
ring were tested for this reaction (Table 22). As it is shown, substituents on the pyrimidyl ring 
decrease the activity of the catalyst.  
N
N N
NH2
R
Pd
Cl
Cl
 
Scheme 58. (N,N)PdCl2 complexes with different substituents on pyrimidyl ring.  
 
Table 22. Effect of the substituent on the Suzuki-Miyaura reaction of bromobenzene with 
benzenebronic acid and different palladium catalysts 39a-f.[a] 
Catalyst R Yield 
39a H 100 
39b phenyl 77 
39c naphtyl 96 
39d 4-methoxyphenyl 89 
39e 4-nbuthoxyphenyl 66 
39f tbutyl 85 
[a] Reaction conditions: catalyst (0.01 mmol), aryl halide (1 mmol), benzeneboronic acid (1.5 
mmol), DMF/H2O (5 ml, 1:1) at 70 °C under N2. The reactions were monitored by GC. 
 
 To elucidate the further potential of complex 39a in Suzuki–Miyaura transformation, 
substituted aryl halides were chosen to react with benzeneboronic acid, Table 23. Both 
activated and deactivated aryl bromides and iodides are efficiently converted into biaryls. Aryl 
chlorides were also examined: unfortunately, the differences in yields determined by GC and 
1H NMR are large for aryl chlorides and the yield could not be determined exactly since 
different products are formed during the reaction which could not be identified with GC and 1H 
NMR. 
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Table 23. Suzuki-Miyaura reaction of the aryl halides with benzenebronic acid and 39a.[a] 
entry aryl halide product yield(%)
[b]
 TOF NMR GC 
1 4-bromoacetophenone 
O
 
100 100 133 
2 4-iodoacetophenone 
O
 
90 96 120 
3 4-chloroacetophenone 
O
 
22 13 29 
4 4-bromotoluene 
 
98 100 131 
5 4-iodotoluene 
 
99 100 132 
6 4-chlorotoluene 
 
27 4 36 
7 2-bromoacetophenone 
O
 
67 77 89 
8 2-bromotoluene 
 
89 90 119 
9 1-bromo-4-methoxybenzene 
O
 
63 74 84 
10 4-bromo-xylene 
 
--- 2 --- 
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[a] Reaction conditions: 39a (0.01 mmol), aryl halide (1 mmol), benzeneboronic acid (1.5 
mmol), DMF/H2O (5 mL, 1:1) at 70 °C under N2. [b] after 1h. The reactions are monitored by 
GC and 1H NMR. 
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4 Conclusion and Outlook 
 The scientific intention of this work was to synthesize and characterize new bidentate, 
tridentate and multidentate ligands and to apply them in heterogenous catalysis. For each type 
of the ligands, new methods of synthesis were developed. Starting from 1,1'-(pyridine-2,6-
diyl)diethanone and dimethylpyridine-2,6-dicarboxylate different bispyrazolpyridines were 
synthesized and novel ruthenium complexes of the type (L)(NNN)RuCl2 could be obtained 
(Scheme 59). The complexes with L = triphenylphosphine turned out to be highly efficient 
catalyst precursors for the transfer hydrogenation of aromatic ketones. Introduction of a butyl 
group in the 5-positions of the pyrazoles leads to a pronounced increase of catalytic activity. 
Since these catalysts are active at room temperature, the chiral analogues of the 
dipyrazolylpyridine ligands for evaluation of enantioselective transfer hydrogenation shall be 
synthesized in future (Scheme 60).  
N O
O
O
O
N
N NN N
R R
N
OO
N
N NN N
N
N N
N N
R
R
Ru
Cl
L
Cl
L = PPh3 or CO
 
Scheme 59. Synthesis of NNN ligands and their ruthenium complexes. 
N
N NN N
 
Scheme 60. An example for a chiral ligand. 
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 To find a method for the synthesis of bispyrimidinepyridines, different reactants 
(Scheme 61) and condition were applied and it was found that these tridentate ligands can be 
obtained by mixing and grinding the tetraketone with guanidinium carbonate and silica, which 
plays the role of a catalyst in this ring closing reaction. In the future, these ligands shall also be 
investigated for application in catalysis. 
N
O O
RR
N
O
R
O
R
N
O O
RR
OO
N
N N
RR
NN
NH2 NH2
 
Scheme 61. Different reactants examined for synthesizing bispyrimidinepyridines. 
 
 The bidentate 2-amino-4-(2-pyridinyl)pyrimidines were synthesized from different 
substrates according to the desired substituent on the pyrimidine ring (Sheme 62). 
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Scheme 62. Different reactants used for synthesizing 2-amino-4-(2-pyridinyl)pyrimidines. 
 
 Reacting these bidentate ligands with the ruthenium(II) precursor [(η6-
cymene)Ru(Cl)(µ2-Cl)]2 gave cationic ruthenium(II) complexes of the type [(η6-
cymene)Ru(Cl)(adpm)]Cl (adpm = chelating 2-amino-4-(2-pyridinyl)pyrimidine ligand). 
Stirring the freshly prepared complexes with either NaBPh4, NaBF4 or KPF6, the chloride 
anion was exchanged against other coordinating anions (BF4-, PF6-, BPh4-) (Scheme 63). 
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Scheme 63. Synthesis of the ruthenium(II) complexes with bidentate ligands. 
 
 Some of these ruthenium complexes have shown very special activities in the transfer 
hydrogenation of ketones by reacting them in the absence of the base. This led to detailed 
investigations on the mechanism of this reaction. According to the activities and with the help 
of ESI-MS experiments and DFT calculations, the following mechanism was proposed for the 
transfer hydrogenation of acetophenone in the absence of the base (Scheme 64). It shows that 
in the absence of the base, a C-H bond activation at the pyrimidine ring should occur to 
activate the catalyst. In the future, this concept might be transferred to the other catalytic 
systems. Additionally, the structure of the ligands can be modified in more details including 
the synthesis of chiral ligands for enantioselective catalysis.  
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Scheme 64. Reaction mechanism for the transfer hydrogenation in the absence of the base. 
 
 The palladium complexes of bidentate N,N ligands were examined in coupling 
reactions. As expected, they did not show very special activities. However, in future, they 
should be linked to some phosphine moieties and be investigated for catalytic applications in 
coupling reactions. 
 Multidentate ligands, having pyrimidine groups as relatively soft donors for late 
transition metals and simultaneously possessing a binding position for a hard Lewis-acid, could 
be obtained using the new synthesized bidentate and tridentate ligands (Scheme 65 and 66). 
Such systems are matter of interest in the SFB/TRR-88 (3MET) at the TU Kaiserslautern and 
their complexes should be investigated in future. Hereafter, based on the synthesized bidentate 
and tridentate ligands more multidentate ligands can be synthesized (Scheme 67). 
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Scheme 65. Synthesis of multidentate ligands starting from bidentate ligand. 
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Scheme 66. Synthesis of multidentate ligands starting from tridentate ligand. 
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Scheme 67. Two examples of mutidentate ligands which might be synthesized in future.
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5 Experimental 
5.1 General Performance 
All bought reactants were used without further purification. The silicagel Merck (60, 
0.063–0.200 mm) was used for chromatography. 
5.2 Used Devices 
NMR spectroscopy: 
• Bruker DPX 200 (1H: 200.1 MHz, 13C: 50.3 MHz, 31P: 81.0 MHz) 
• Bruker DPX 400 (1H: 400.1 MHz, 13C: 100.6 MHz, 31P: 162.0 MHz) 
• Bruker AVANCE 600 (1H: 600.1 MHz, 13C: 150.9 MHz) 
The chemical shifts are given in δ-values [ppm]. As internal standard for 1H NMR and 13C 
NMR spectra the resonance signal of the solvent was concerned according to Gottlieb and 
Nudelmann; abbreviation: s = singlet, d = doublet, t = triplet, m = multiplet.162 
Elemental analysis: 
The determination of the percentage of carbon, hydrogen, nitrogen and sulfur was done at the 
analytical laboratory of the TU Kaiserslautern. For this, the following devices were used. 
• Perkin Elmer Elemental Analyzer 2400 CHN 
• Firma Elementar Analysentechnik: vario Micro cube (CHNS) 
Solid state structure analysis: 
The measurement of the crystal structures were carried out by Dr. Yu Sun (see index) on a  
• Stoe-IPDS X-ray diffractometer and an 
• Oxford Diffraction Gemini S Ultra 
Gaschromatography/massspectrometry: 
GC/MS measurements were done on a Varian 3900 gaschromatograph in combination with a 
Varian GC/MS Saturn 2100T massspectrometer. 
MS spectra were obtained from a  
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• ESI: Bruker Esquire 3000plus: a 10-3-10-4 molar solution of the sample in acetonitrile was 
used. The measurements were done by Dipl.-Chem. Fabian Menges from Niedner-
Schatteburg’s group. 
IR-Spectroscopy data were measured as KBr pellets with a 
• Jasco FT-IR 6100 spectrometer 
Drying of the solvents: 
For THF, toluene, diethylether, pentane and dichloromethane a Mbraun MB-SPS solventdrier 
was used. All the other solvents were dried according to general methods.163 
5.3 Ligand Synthesis 
5.3.1. Synthesis of the NNN Ligands 
5.3.1.1. Synthesis of Ligands with a Bispyrazolylpyridine Backbone 
N
N NN N
1
2
3
4
5
6
7
8
9
 
2,6-Di(1-allyl-1H-pyrazol-3-yl)pyridine (5). 0.16 g of LiH (20 mmol) were added to a 
solution of 2.1 g of 2,6-di(1H-pyrazol-3-yl)pyridine (10 mmol) in 75 mL of dry THF. After the 
evolution of dihydrogen ceased, 1.2 g of allylicbromide (20 mmol) were added and the reaction 
mixture and was stirred for 12 h. After evaporating the solvent under vacuum, the product was 
extracted with chloroform and the organic phase was filtered over sodium sulfate. Removing 
the solvent under reduced pressure gave the desired product. Yield: 1.9 g (65%, pale yellow 
solid). Anal. calcd for C17H17N5: C, 70.08; H, 5.88; N, 24.04. Found: C, 70.82; H, 5.74; N, 
23.44. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.22 (s, 2H, H2), 7.86 (s br., 1H, H1), 7.75 (d, 
JHH = 2.35 Hz, 2H, H5), 7.55 (d, JHH = 2.35 Hz, 2H, H6), 6.08-5.98 (m, 2H, H8), 5.31-5.24 (m, 
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4H, H9), 4.85 (d, JHH = 5.87 Hz, 4H, H7). 13C{1H} NMR (100.6 MHz, CDCl3, 20 °C): δ 147.9 
(s, C3), 144. 8 (s, C4), 143.3 (s, C1), 132.0 (s, C8), 131.7 (s, C6), 121.4 (s, C2), 119.7 (s, C9), 
108. 9 (s, C5), 55.4 (s, C7). 
N
N NN N
1
2
3
4
5
6
7
8
9
 
2,6-Di(1-allyl-5-butyl-1H-pyrazol-3-yl)pyridine (6a). The same procedure as for 2,6-di(1-
allyl-1H-pyrazol-3-yl)pyridine was applied, just 2,6-bis(5-butyl-1H-pyrazol-3-yl)pyridine was 
used instead of 2,6-di(1H-pyrazol-3-yl)pyridine. Yield: 2.8 g (70%, pale yellow solid). Anal. 
calcd for C25H33N5: C, 74.40; H, 8.24; N, 17.35. Found: C, 74.29; H, 8.25; N, 17.40. 1H NMR 
(400.1 MHz, CDCl3, 20 °C): δ 7.79 (d, JHH = 7.83 Hz, 2H, H2), 7.59 (t, JHH = 7.82 Hz, 1H, 
H1), 6.76 (s, 2H, H5), 5.95-5.82 (m, 2H, H8), 5.05 (d, JHH = 10.17 Hz, 2H, H9a), 4.88 (d, JHH 
= 17.22 Hz, 2H, H9b), 4.62 (s br., 4H, H7), 2.46 (t, JHH = 7.83 Hz, 4H, Hbu), 1.61-1.54 (m, 4H, 
Hbu), 1.35-1.26 (m, 4H, Hbu), 0.84 (t, JHH = 7.43 Hz, 6H, Hbu). 13C{1H} NMR (100.6 MHz, 
CDCl3, 20 °C): δ 151.8 (s, C3), 150.7 (s, C4), 144.4 (s, C1), 136.5 (s, C6), 133.1 (s, C8), 117.9 
(s, C2), 116.5 (s, C9), 103.1 (s, C5), 51.6 (s, C7), 30.2 (s, Cbu), 24.9 (s, Cbu), 22.1 (s, Cbu), 13.6 
(s, Cbu). 
N
N NN N
1
2
3
4
5
6
7
8
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2,6-Di(1-allyl-5-octyl-1H-pyrazol-3-yl)pyridine (6b). The same procedure as for 2,6-di(5-
butyl-1H-pyrazol-3-yl)pyridine was applied. Yield: 2.0 g (39%, pale brown solid). Anal. calcd 
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for C33H49N5 + 0.5CH2Cl2: C, 72.08; H, 9.03; N, 12.55. Found: C, 72.11; H, 8.92; N, 11.93. 1H 
NMR (400.1 MHz, CDCl3, 20 °C): δ 7.83 (d, JHH = 7.83 Hz, 2H, H2), 7.65 (t, JHH = 7.63 Hz, 
1H, H1), 6.81 (s, 2H, H5), 5.99-5.92 (m, 2H, H8), 5.15 (d, JHH = 10.18 Hz, 2H, H9a), 4.98 (d, 
JHH = 17.16 Hz, 2H, H9b), 4.72 (d, JHH = 5.09, 4H, H7), 2.57 (t, JHH = 7.63 Hz, 4H, Hoctyl), 
1.71-1.61 (m, 4H, Hoctyl), 1.36-1.25 (m, 20H, Hoctyl), 0.86 (t, JHH = 6.04 Hz, 6H, Hoctyl). 
13C{1H} NMR (100.6 MHz, CDCl3, 20 °C): δ 152.2 (s, C3), 151.1 (s, C4), 144.6 (s, C1), 136.6 
(s, C6), 133.5 (s, C8), 118.2 (s, C2), 116.8 (s, C9), 103.5 (s, C5), 51.9 (s, C7), 31.8 (s, Coctyl), 
29.3 (s, Coctyl), 29.1 (s, Coctyl), 28.6 (s, Coctyl), 25.6 (s, Coctyl), 22.6 (s, Coctyl) , 14.0 (s, Coctyl). 
N
N NN N
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2,6-Di(1-allyl-5-tbutyl-1H-pyrazol-3-yl)pyridine (6c). The same procedure as for 2,6-di(1-
allyl-1H-pyrazol-3-yl)pyridine was applied, just 2,6-bis(5-tbutyl-1H-pyrazol-3-yl)pyridine was 
used instead of 2,6-di(1H-pyrazol-3-yl)pyridine. Yield: 3.2 g (81%, pale yellow solid). Anal. 
calcd for C25H33N5 + 0.33CH2Cl2: C, 70.45; H, 7.86; N, 16.22. Found: C, 69.36; H, 8.02; N, 
16.42. 1H NMR (200.1 MHz, CDCl3, 20 °C): δ 7.85 (d, JHH = 7.7 Hz, 2H, H2), 7.71-7.62 (m, 
1H, H1), 6.81 (s, 2H, H5), 6.00-5.90 (m, 2H, H8), 5.19 (d, JHH = 10.8 Hz, 2H, H9a), 5.01 (d, 
JHH = 17.6 Hz, 2H, H9b), 4.91 (d, JHH = 4.8 Hz, 4H, H7), 1.40 (s, 18H, Htbu). 13C{1H} NMR 
(50.3 MHz, CDCl3, 20 °C): δ 152.8 (s, C3), 152.2 (s, C4), 150.5 (s, C1), 136.9 (s, C6), 134.7 
(s, C8), 118.5 (s, C2), 116.9 (s, C9), 102.6 (s, C5), 53.7 (s, C7), 31.5 (s, Ctbu), 30.3 (s, Ctbu). 
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2,6-Bis(1-allyl-5,6,7,8-tetrahydro-4H-cycloheptapyrazol-3-yl)pyridine (6d). The same 
procedure as for 2,6-di(5-butyl-1H-pyrazol-3-yl)pyridine was applied. Yield: 3.7 g (88%, pale 
brown solid). Anal. calcd for C27H33N5 + 0.25CH2Cl2: C, 72.92; H, 7.52; N, 15.60. Found: C, 
73.01; H, 7.76; N, 15.14. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 7.74 (d, JHH = 7.62 Hz, 2H, 
H2), 7.68-7.64 (m, 1H, H1), 5.99-5.90 (m, 2H, H8), 5.15 (d, JHH = 10.49 Hz, 2H, H9a), 5.00 
(d, JHH = 17.16 Hz, 2H, H9b), 4.72 (d, JHH = 5.09, 4H, H7), 3.17 (t, JHH = 5.4 Hz, 4H, 
Hcycloheptyl), 2.68 (t, JHH = 5.4 Hz, 4H, Hcycloheptyl) 1.83-1.80 (m, 4H, Hcycloheptyl), 1.68-1.67 (m, 
8H, Hcycloheptyl). 13C{1H} NMR (100.6MHz, CDCl3, 20 °C): δ 153.5 (s, C3), 147.5 (s, C4), 
143.6 (s, C1), 136.4 (s, C6), 133.8 (s, C8), 120.7 (s, C5), 119.8 (s, C2), 116.6 (s, C9), 52.2 (s, 
C7), 32.0 (s, Ccycloheptyl), 28.6 (s, Ccycloheptyl), 26.8 (s, Ccycloheptyl), 26.4 (s, Ccycloheptyl), 24.7 (s, 
Ccycloheptyl). 
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2,6-Di(1-allyl-5-propyl-1H-pyrazol-3-yl)pyridine (6e). The same procedure as for 2,6-di(5-
butyl-1H-pyrazol-3-yl)pyridine was applied. Yield: 3.3 g (89%, pale yellow solid). Anal. calcd 
for C23H29N5: C, 73.57; H, 7.78; N, 18.65. Found: C, 73.29; H, 8.10; N, 18.40. 1H NMR (400.1 
MHz, CDCl3, 20 °C): δ 7.83 (d, JHH = 7.71 Hz, 2H, H2), 7.68 (t, JHH = 7.7 Hz, 1H, H1), 6.81 
(s, 2H, H5), 6.01-5.91 (m, 2H, H8), 5.16 (d, JHH = 10.27 Hz, 2H, H9a), 4.98 (d, JHH = 16.88 
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Hz, 2H, H9b), 4.73 (s, 4H, H7), 2.56 (t, JHH = 7.33 Hz, 4H, Hpropyl), 1.74-1.69 (m, 4H, Hpropyl), 
0.99 (t, JHH = 7.34 Hz, 6H, Hpropyl). 13C{1H} NMR (100.6 MHz, CDCl3, 20 °C): δ 152.2 (s, 
C3), 151.2 (s, C4), 143.4 (s, C1), 136.7 (s, C6), 133.5 (s, C8), 118.2 (s, C2), 116.8 (s, C9), 
103.6 (s, C5), 52.0 (s, C7), 27.6 (s, Cpropyl), 21.9 (s, Cpropyl), 13.9 (s, Cpropyl). 
5.3.1.2 Synthesis of Ligands with a Bispyrimidylpyridine Backbone 
General methode for the synthesis of 2,6-bis(2-amino-4-alkyl-6-
pyrimidyl)pyridines. 10 mmol of precusor 3, 10 mmol of guanidinium carbonate and X g of 
silica (X= [mass of the precourser 3 in grams + mass of the guanidinium carbonate in grams] * 
2) were ground together and the mixture was put in an oven at 200° C for 4 h. After cooling to 
room teperature, the product was washed from the silica with ethanol using a soxhlet extractor.  
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2,6-Bis(2-amino-4-nbutyl-6-pyrimidyl)pyridine (8a). Since the product was not pure no 
yield and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.36 (d, JHH = 
7.83 Hz, 2H, H2), 7.92 (t, JHH = 7.82 Hz, 1H, H1), 7.60 (s, 2H, H5), 5.63 (s br., 4H, NH2), 2.70 
(t, JHH = 7.82 Hz, 4H, Hbutyl), 1.79-1.71 (m, 4H, Hbutyl), 1.48-1.39 (m, 4H, Cbutyl), 0.96 (t, JHH = 
7.44 Hz, 6H, Hbutyl). 13C NMR (100.6 MHz, CDCl3, 20 °C): δ 173.6 (s, C6), 163.8 (s, C4), 
163.4 (s, C7), 154.5 (s, C3), 137.9 (s, C1), 122.8 (s, C2), 107.1 (s, C5), 38.0 (s, Cbutyl), 31.1 (s, 
Cbutyl), 22.7 (s, Cbutyl), 14.0 (s, Cbutyl). 
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2,6-Bis(2-amino-4-noctyl-6-pyrimidyl)pyridine (8b). Since the product was not pure no yield 
and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.42 (d, JHH = 7.83 
Hz, 2H, H2), 7.94 (t, JHH = 7.43 Hz, 1H, H1), 7.67 (s, 2H, H5), 5.12 (s br, 4H, NH2), 2.74 (t, 
JHH = 7.83 Hz, 4H, Hoctyl), 1.79-1.74 (m, 4H, Hoctyl), 1.42-1.27 (m, 26H, Coctyl). The sample was 
very impure and 13C NMR could not be interpreted.  
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2,6-bis(2-amino-4-tbutyl-6-pyrimidyl)pyridine (8c). Since the product was not pure no yield 
and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.40 (d, JHH = 7.83 
Hz, 2H, H2), 7.96-7.91 (m, 3H, H1 & H5), 5.12 (s br., 4H, NH2), 1.39 (s, 18H, Ht-butyl). 13C 
NMR (100.6 MHz, CDCl3, 20 °C): δ 180.5 (s, C6), 163.9 (s, C4), 163.2 (s, C7), 154.5 (s, C3), 
138.0 (s, C1), 122.5 (s, C2), 103.8 (s, C5), 37.6 (s, Ct-butyl), 29.5 (s, C t-butyl).  
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2,6-Bis(2-amino-4-isopropyl-6-pyrimidyl)pyridine (8d). Since the product was not pure no 
yield and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.41 (d, JHH = 
7.83 Hz, 2H, H2), 7.94 (t, JHH = 7.82 Hz, 1H, H1), 7.71 (s br., 2H, H5), 5.15 (s br., 4H, NH2), 
3.00-2.93 (m, 2H, Hpropyl), 1.36 (d, JHH = 7.04 Hz, 12H, Hpropyl). 13C NMR (100.6 MHz, CDCl3, 
20 °C): δ 178.4 (s, C6), 164.0 (s, C4), 163.4 (s, C7), 154.5 (s, C3), 138.0 (s, C1), 122.8 (s, C2), 
105.1 (s, C5), 36.3 (s, Cpropyl), 21.8 (s, Cpropyl). 
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2,6-Bis(2-amino-4-npropyl-6-pyrimidyl)pyridine (8e). Since the product was not pure no 
yield and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.42 (d, JHH = 
7.83 Hz, 2H, H2), 7.94 (t, JHH = 7.82 Hz, 1H, H1), 7.66 (s br., 2H, H5), 5.14 (s br., 4H, NH2), 
2.71 (t, JHH = 7.44 Hz, 4H, Hpropyl), 1.83-1.79 (m, 4H, Hpropyl), 1.04 (t, JHH = 7.04 Hz, 6H, 
Hpropyl). 13C NMR (100.6 MHz, CDCl3, 20 °C): δ 173.4 (s, C6), 163.8 (s, C4), 163.4 (s, C7), 
154.5 (s, C3), 138.0 (s, C1), 122.9 (s, C2), 107.3 (s, C5), 40.3 (s, Cpropyl), 22.3 (s, Cpropyl), 14.1 
(s, Cpropyl). 
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2,6-Bis(2-amino-4-ethyl-6-pyrimidyl)pyridine (8f). Since the product was not pure no yield 
and elemental analysis is reported. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 8.43 (d, JHH = 7.83 
Hz, 2H, H2), 7.95 (t, JHH = 7.83 Hz, 1H, H1), 7.70 (s br., 2H, H5), 5.12 (s br., 4H, NH2), 2.79 
(q, 4H, Hethyl), 1.36 (t, JHH = 7.43 Hz, 6H, Hethyl). 13C NMR (100.6 MHz, CDCl3, 20 °C): δ 
174.6 (s, C6), 163.9 (s, C4), 163.3 (s, C7), 154.5 (s, C3), 138.0 (s, C1), 122.9 (s, C2), 106.6 (s, 
C5), 31.4 (s, Cethyl), 13.1 (s, Cethyl). 
5.3.2 Synthesis of NN Ligands 
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Synthesis of precursors 12-14. Precursor 12,164 13102b and 1491c, 165 were synthesized 
according to procedures published in the literature. 
N
N N
NH2
1
2
3
4
5
6 7 8
9
 
4-(Pyridin-2-yl)pyrimidin-2-amine (17a). Method 1. Under an atmosphere of nitrogen 
atmosphere 1.0 g of Na (43.5 mmol) was added to a solution of 1.8 g of guanidinium carbonate 
(18.3 mmol) in dry EtOH (20 ml). When the reaction of Na and EtOH was completed, 3.0 g of 
precursor 12 (17 mmol) were added and the solution was refluxed for 24 h. After evaporating 
the solvent, the residue was washed several times with ice-cooled water and the product was 
recrystalized from CH2Cl2/Et2O. Yield: 2.3 g (80%, pale brown solid). Anal. Calcd for 
C9H8N4: C, 62.78; H, 4.68; N, 32.54. Found: C, 62.48; H, 4.68; N, 31.87. 1H NMR (400.1 
MHz, DMSO-d6, 20 °C): δ 8.68 (d, JHH = 4.3 Hz, 1H, H1), 8.41 (d, JHH = 4.7 Hz, 1H, H8), 8.32 
(d, JHH = 8.22 Hz, 1H, H4), 7.95-7.91 (m, 1H, H3), 7.49-7.45 (m, 2H, H2 & H7), 6.79 (s br., 
2H, NH2). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 163.8 (s, C9), 162.9 (s, C6), 159.5 (s, 
C8), 154.0 (s, C5), 149.4 (s, C1), 137.2 (s, C3), 125.3 (s, C2), 120.7 (s, C4), 106.0 (s, C7). 
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4-Phenyl-6-(pyridin-2-yl)pyrimidin-2-amine (17b). Method 2. 1.67 g of precursor 13b (8 
mmol) were added to a solution of 2.35 g of guanidinium carbonate (24 mmol) in EtOH (25 
ml). The solution was refluxed for 24 h. The solvent was evaporated and the residue was 
dissolved in CH2Cl2. The organic phase was washed three times with water and dried over 
MgSO4. Yellow crystals were obtained after one day from CH2Cl2/Hexane in the refrigerator. 
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Yield: 1.8 g (92%, pale yellow solid). Anal. calcd for C15H12N4: C, 72.56; H, 4.87; N, 22.57. 
Found: C, 71.48; H, 4.91; N, 22.54. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 8.75 (d, JHH = 
4.3 Hz, 1H, H1), 8.39 (d, JHH = 7.83 Hz, 1H, H4), 8.16-8.13 (m, 2H; H11), 8.06 (s, 1H, H7), 
7.98-7.93 (m, 1H, H3), 7.6-7.4 (m, 3H, H2, H12 & H13), 6.92 (s br., 2H, NH2). 13C NMR 
(100.6 MHz, DMSO-d6, 20 °C): δ 165.2 (s, C6), 164.1 (s, C8), 164.1 (s, C9), 154.2 (s, C5), 
149.4 (s, C1), 137.3 (s, C10), 137.2 (s, C3), 130.5 (s, C13), 128.7 (s, C12), 126.8 (s, C11), 
125.4 (s, C2), 121.0 (s, C4), 101.8 (s, C7).  
N
N N
NH2
1
2
3
4
5
6 7 8
9
 
4-(Naphthalen-1-yl)-6-(pyridin-2-yl)pyrimidin-2-amine (17c). The synthesis of 17c was 
carried out as described for 17b, but using 2.07 g of precursor 13c (8 mmol) and it was 
crystalized from hexane. Yield: 2.1 g (88%, pale pink solid). Anal. calcd for C19H14N4 + 0.5 
Et2O: C, 75.15; H, 5.67; N, 16.7. Found: C, 75.65; H, 5.19; N, 17.83. 1H NMR (400.1 MHz, 
DMSO-d6, 20 °C): δ 8.70 (d, JHH = 3.92 Hz, 1H, H1), 8.42 (d, JHH = 7.83 Hz, 1H, H4), 8.26-
8.23 (m, 2H, H11), 8.05-7.99 (m, 3H, H3
 
& Hnaphthyl), 7.74 (s, 1H, H7), 7.73-7.51 (m, 5H, H2 
& Hnaphthyl), 6.97 (s br., 2H, NH2). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 168.0 (s, C8), 
163.9 (s, C6), 163.5 (s, C9), 154.1 (s, C5), 149.5 (s, C1), 137.3 (s, C3), 136.9 (s, Cnaphthyl), 
133.4 (s, Cnaphthyl), 130.1 (s, Cnaphthyl), 129.5 (s, Cnaphthyl), 128.7 (s, C2), 128.4 (s, Cnaphthyl), 127.0 
(s, Cnaphthyl), 126.6 (s, Cnaphthyl), 126.1 (s, C4), 125.4 (s, Cnaphthyl), 125.4 (s, Cnaphthyl), 125.3 (s, 
Cnaphthyl).  
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4-(4-Methoxyphenyl)-6-(pyridin-2-yl)pyrimidin-2-amine (17d). The synthesis of 17d was 
carried out as described for 17b, but using 1.91 g of precursor 13d (8 mmol) and the product 
was crystalized in EtOH. Yield: 1.5 g (66%, yellow solid). Anal. calcd for C16H14N4O: C, 
69.05; H, 5.07; N, 20.13. Found: C, 68.72; H, 5.18; N, 19.91. 1H NMR (400.1 MHz, DMSO-
d6, 20 °C): δ 8.74 (d, JHH = 4.7 Hz, 1H, H1), 8.36 (d, JHH = 7.82 Hz, 1H, H4), 8.13 (d, JHH = 
8.6 Hz, 2H, H11), 8.01-7.95 (m, 2H, H7 & H3), 7.54-7.51 (m, 1H, H2), 7.08 (d, JHH = 8.6 Hz, 
2H, H12), 6.77 (s br., 2H, NH2), 3.82 (s, 3H, H14). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): 
δ 165.2 (s, C6), 164.4 (s, C9), 164.2 (s, C8), 161.8 (s, C13), 154.7 (s, C5), 149.8 (s, C1), 137.8 
(s, C3), 130.0 (s, C10), 128.8 (s, C12), 125.8 (s, C2), 121.3 (s, C4), 114.6 (s, C11), 101.3 (s, 
C7), 55.8 (s, C14).  
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Synthesis of 4-(4-Butoxyphenyl)-6-(pyridin-2-yl)pyrimidin-2-amine (17e). The synthesis of 
17e was carried out as described for 17d, but 2.25 g of precursor 13e (8.0 mmol) were applied. 
Yield: 1.8 g (70%, yellow solid). Anal. calcd for C19H20N4O: C, 71.23; H, 6.29; N, 17.49. 
Found: C, 69.69; H, 6.33; N, 17.11. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 8.74 (d, JHH = 
4.3 Hz, 1H, H1), 8.36 (d, JHH = 7.82 Hz, 1H, H4), 8.10 (d, JHH = 8.6 Hz, 2H, H11), 8.01-7.95 
(m, 2H, H7 & H3), 7.54-7.51 (m, 1H, H2), 7.05 (d, JHH = 9 Hz, 2H, H12), 6.76 (s br., 2H, 
NH2), 4.01 (t, JHH = 6.65 Hz, 2H, H14), 1.71-1.68 (m, 2H, H15), 1.45-1.40 (m, 2H, H16), 0.91 
(t, JHH = 7.43, 3H, H17). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 164.7 (s, C6), 164.0 (s, 
C9), 163.7 (s, C8), 160.8 (s, C13), 154.3 (s, C5), 149.4 (s, C1), 137.3 (s, C3), 129.3 (s, C10), 
128.3 (s, C12), 125.3 (s, C2), 120.9 (s, C4), 114.5 (s, C11), 100.8 (s, C7), 67.3 (s, C14), 30.7 
(s, C15), 18.7 (s, C16), 13.7 (s, C17). 
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4-tert-Butyl-6-(pyridin-2-yl)pyrimidin-2-amine (17f). Method 3. A solution of 0.8 g of 
guanidinium carbonate (8.0 mmol) and 0.2 g of Na (8.0 mmol) in dry EtOH (25 ml) was 
refluxed for 1 h under an atmosphere of nitrogen. 1.64 g of precusor 14 (8 mmol) were added 
to the solution and it was refluxed for another 24 h. After evaporating the solvent, the residue 
was washed with cold water and the product was crystalized from EtOH. Yield: 0.5 g (30%, 
pale yellow crystal). Anal. calcd for C13H16N4: C, 68.39; H, 7.06; N, 24.54. Found: C, 68.18; 
H, 6.97; N, 24.13. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 8.70 (d, JHH = 3.92 Hz, 1H, H1), 
8.30 (d, JHH = 8.22 Hz, 1H, H4), 7.96-7.92 (m, 1H, H3), 7.56 (s, 1H, H7), 7.50-7.47 (m, 1H, 
H2), 6.60 (s br., 2H, NH2), 1.27 (s, 9H, H11). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 
179.2 (s, C8), 163.5 (s, C6), 163.2 (s, C9), 154.4 (s, C5), 149.3 (s, C1), 137.2 (s, C3), 125.1 (s, 
C2), 120.8 (s, C4), 101.0 (s, C7), 37.1 (s, C10), 29.2 (s, C11). 
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4-(Pyridin-2-yl)-2-(pyrrolidin-1-yl)pyrimidine (17g). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 3.2 g (84%, pale yellow solid). Anal. calcd for 
C13H14N4: C, 69.00; H, 6.24; N, 24.76. Found: C, 69.35; H, 6.25; N, 24.30. 1H NMR (400.1 
MHz, DMSO-d6, 20 °C): δ 8.67 (d, JHH = 4.31 Hz, 1H, H1), 8.44 (d, JHH = 5.09 Hz,1H, H8), 
8.36 (d, JHH = 7.83 Hz, 1H, H4), 7.94-7.90 (m, 1H, H3), 7.49-7.45 (m, 2H, H2 & H7), 3.51 (s 
br., 4H, H10 & H13), 1.91-1.87 (m, 4H, H11 & H12). 13C NMR (100.6 MHz, DMSO-d6, 20 
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°C): δ 162.3 (s, C6), 160.0 (s, C9), 159.0 (s, C8), 154.2 (s, C5), 149.3 (s, C1), 137.1 (s, C3), 
125.3 (s, C2), 120.8 (s, C4), 104.6 (s, C7), 44.2 (s, C10 & C13), 25.0 (s, C11 & C12).  
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4-tert-Butyl-N,N-dimethyl-6-(pyridin-2-yl)pyrimidi-2-amine (17h). Method 3 was applied, 
using the corresponding guanidinium derivative. Yield: 0.7 g (35%, pale yellow solid). Anal. 
calcd for C15H20N4: C, 70.28; H, 7.86; N, 21.86. Found: C, 69.94; H, 7.69; N, 21.94. 1H NMR 
(400.1 MHz, DMSO-d6, 20 °C): δ 8.70 (d, JHH = 3.91 Hz, 1H, H1), 8.40 (d, JHH = 7.82 Hz 1H, 
H4), 7.97-7.93 (m, 1H, H3), 7.55 (s, 1H, H7), 7.55-7.49 (m, 1H, H2), 3.21 (s, 6H, H12), 1.30 
(s, 9H, H11). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 178.7 (s, C8), 162.7 (s, C6), 161.7 
(s, C9), 154.5 (s, C1), 149.2 (s, C5), 137.3 (s, C3), 125.2 (s, C2), 121.0 (s, C4), 99.8 (s, C7), 
37.4 (s, C10), 36.5 (s, C12), 29.2 (s, C11). 
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4-(4-Methoxyphenyl)-6-(pyridin-2-yl)-2-(pyrrolidin-1-yl)pyrimidine (17i). Method 2 was 
applied, using the corresponding guanidinium derivative. Yield: 2.3 g (88%, pale yellow solid). 
Anal. calcd for C20H20N4O: C, 72.27; H, 6.06; N, 16.86. Found: C, 71.81; H, 6.03; N, 16.67. 1H 
NMR (400.1 MHz, DMSO-d6, 20 °C): δ 8.74 (d, JHH = 4.69 Hz, 1H, H1), 8.45 (d, JHH = 7.82 
Hz, 1H, H4), 8.18 (d, JHH = 8.61 Hz, 2H, H11), 8.01-7.97 (m, 1H, H3 & H7), 7.55-7.52 (m, 
1H, H2), 7.09 (d, JHH = 8.61 Hz, 2H, H12), 3.84 (s, 3H, H14), 3.67 (s br., 4H, H15 & H18), 
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1.99 (s br., 4H, H16 & H17). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 164.1 (s, C6), 163.2 
(s, C8), 161.4 (s, C13), 160.4 (s, C9), 154.4 (s, C5), 149.3 (s, C1), 137.3 (s, C3), 129.7 (s, 
C10), 128.4 (s, C12), 125.4 (s, C2), 121.0 (s, C4), 114.1 (s, C11), 99.5 (s, C7), 55.3 (s, C14), 
46.4 (s, H15 & H18), 25.1 (s, C16
 
& C17). 
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N,N-Dimethyl-4-(pyridine-2-yl)pyrimidine (17j). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 2.9 g (85%, pale yellow solid). Anal. calcd for 
C11H12N4: C, 65.98; H, 6.04; N, 27.98. Found: C, 66.19; H, 6.10; N, 26.68. 1H NMR (400.1 
MHz, DMSO-d6, 20 °C): δ 8.67 (d, JHH = 4.7 Hz, 1H, H1), 8.47 (d, JHH = 5.09 Hz, 1H, H8), 
8.38 (d, JHH = 8.22 Hz, 1H, H4), 7.95-7.92 (m, 1H, H3), 7.5-7.45 (m, 2H, H2 & H7), 3.17 (s 
br., 6H, H10). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 162.3 (s, C6), 161.9 (s, C9), 159.0 
(s, C8), 154.1 (s, C5), 149.3 (s, C1), 137.2 (s, C3), 125.4 (s, C2), 120.8 (s, C4), 104.7 (s, C7), 
36.5 (s, C10).  
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4-(2-Pyridinyl)-2-(1-piperidinyl)-pyrimidin (17k). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 1.3 g (55%, brown oil). Anal. calcd for 
C14H16N4: C, 69.97; H, 6.71; N, 23.32. Found: C, 69.32; H, 7.18; N, 23.24. 1H NMR (400.1 
MHz, DMSO d6, 20 °C): δ 8.65 (d, JHH = 3.92 Hz, 1H, H1), 8.44 (d, JHH = 5.08 Hz, 1H, H8), 
8.31 (d, JHH = 7.84 Hz, 1H, H4), 7.87 (t, JHH = 7.72 Hz, 1H, H3), 7.46 (d, JHH = 5.08 Hz, 1H, 
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H7), 7.42 (t, JHH = 5.88 Hz, 1H, H2), 3.37 (t, JHH = 5.10 Hz, 4H, Hpiperdinyl), 1.51-1.53 (m, 2H, 
Hpiperdinyl), 1.46-1.47 (m, 4H, Hpiperdinyl). 13C NMR (100.6 MHz, DMSO d6, 20 °C): δ 162.5 (s, 
C9), 161.2 (s, C8), 158.9 (s, C6), 154.1 (s, C5), 149.2 (s, C1), 136.9 (s, C3), 125.1 (s, C2), 
120.7 (s, C4), 104.9 (s, C7), 54.8 (s, Cpiperdinyl), 44.1 (s, Cpiperdinyl), 25.2 (s, Cpiperdinyl). 
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N-1-Propyl-4-(2-pyridinyl)pyrimidin-2-amin (17l). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 1.2 g (58%, light pink solid). Anal. calcd for 
C12H14N4: C, 67.27; H, 6.59; N, 26.15. Found: C, 67.75; H, 6.83; N, 25.41. 1H NMR (400.1 
MHz, DMSO d6, 20 °C): δ 8.67 (d, JHH = 3.88 Hz, 1H, H1), 8.40 (d, JHH = 3.92 Hz, 1H, H8), 
8.33 (d, JHH = 5.88 Hz, 1H, H4), 7.95 (t, JHH = 7.62 Hz, 1H, H3), 7.49 (t, JHH = 6.06 Hz, 1H, 
H2), 7.43 (d, JHH = 4.68 Hz, 1H, H7), 7.24 (s, 1H, NH), 3.31 (s, 2H, Hpropyl), 1.54-1.59 (m, JHH 
= 6.67 Hz, 2H, Hpropyl), 0.89 (t, JHH = 7.44 Hz, 3H, Hpropyl). 13C NMR (100.6 MHz, DMSO d6, 
20 °C): δ 162.6 (s, C9), 159.4 (s, C6, C8), 154.2 (s, C5), 149.5 (s, C1), 137.4 (s, C3), 125.5 (s, 
C2), 120.9 (s, C4), 105.5 (s, C7), 42.7 (s, CPropyl), 22.3 (s, CPropyl), 11.6 (s, CPropyl). 
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N-1-Butyl-4-(2-pyridinyl)pyrimidin-2-amin (17m). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 1.0 g (45%, light brown solid). Anal. calcd for 
C13H16N4: C, 68.39; H, 7.06; N, 24.54. Found: C, 68.92; H, 6.53; N, 24.54. 1H NMR (400.1 
MHz, DMSO d6, 20 °C): δ 8.69 (d, JHH = 4.5 Hz 1H, H1), 8.41 (d, JHH = 3.92 Hz, 1H, H8), 8.34 
(s br., 1H, H4), 7.97 (t, JHH = 7.82 Hz, 1H, H3), 7.50 (t, JHH = 5.86 Hz, 1H, H2), 7.44 (d, JHH = 
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4.88 Hz, 1H, H7), 7.25 (s, 1H, NH), 3.35-3.30 (m, 2H, Hbutyl), 1.54-1.57 (m, 2H, Hbutyl), 1.33-
1.38 (m, 2H, Hbutyl), 0.90 (t, JHH = 7.24 Hz, 3H, Hbutyl). 13C NMR (100.6 MHz, DMSO d6, 20 
°C): δ 162.5 (s, C9), 159.3 (s, C6, C8), 154.1 (s, C5), 149.4 (s, C1), 137.3 (s, C3), 125.3 (s, 
C2), 120.7 (s, C4), 105.3 (s, C7), 40.4 (s, Cbutyl), 31.1 (s, Cbutyl), 19.7 (s, Cbutyl), 13.8 (s, Cbutyl).  
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N-1-Octyl-4-(2-pyridinyl)pyrimidin-2-amin (17n). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 1.5 g (54%, light brown soild). Anal. calcd for 
C17H24N4: C, 71.79; H, 8.51; N, 19.70. Found: C, 71.14; H, 8.36; N, 19.20. 1H NMR (400.1 
MHz, DMSO d6, 20 °C): δ 8.66 (d, JHH = 3.92 Hz, 1H, H1), 8.40 (d, JHH = 4.72 Hz, 1H, H8), 
8.34 (d, JHH = 4.00 Hz, 1H, H4), 7.90 (t, JHH = 7.82 Hz, 1H, H3), 7.46 (t, JHH = 4.90 Hz, 1H, 
H2), 7.44 (d, JHH = 4.68 Hz, 1H, H7), 7.23 (s, 1H, NH), 1.54 (t, JHH = 6.00 Hz, 2H, Hoctyl), 
1.14-1.27 (m, 12H, Hoctyl), 0.75 (t, JHH = 6.06 Hz, 3H, Hoctyl). 13C NMR (100.6 MHz, DMSO 
d6, 20 °C): δ 162.5 (s, C9), 159.1 (s, C6, C8), 154.2 (s, C5), 149.3 (s, C1), 137.0 (s, C3), 125.2 
(s, C2), 120.6 (s, C4), 105.3 (s, C7), 40.7 (s, Coctyl), 31.3 (s, Coctyl), 29.0 (s, Coctyl), 28.9 (s, 
Coctyl), 28.8 (s, Coctyl), 26.6 (s, Coctyl), 22.1 (s, Coctyl), 13.8 (s, Coctyl). 
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N-(S)-(+)-1-Phenylethyl-4-(2-pyridinyl)pyrimidin-2-amin (17o). Method 1 was applied, 
using the corresponding guanidinium derivative. Yield: 1.3 g (55%, brown oil). Anal. calcd for 
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C17H16N4 + 0.5 EtOH: C, 72.52; H, 6.58; N, 18.29. Found: C, 73.93; H, 6.52; N, 18.93. 1H 
NMR (400.1 MHz, DMSO d6, 20 °C): δ 8.66 (d, JHH = 3.68 Hz, 1H, H1), 8.42 (d, JHH = 4.92 
Hz, 1H, H8), 8.33 (s, 1H, H4), 7.89-7.92 (m, 2H, H3 & NH), 7.48-7.51 (m, 3H, H7, H13), 7.43 
(t, JHH = 5.76 Hz, 1H, H2), 7.28 (t, JHH = 7.54 Hz, 2H, H14), 7.15 (t, JHH =7.34 Hz, 1H, H15), 
5.21-5.27 (m, 1H, H10), 1.51 (d, JHH = 7.04 Hz, 3H, H11). 13C NMR (100.6 MHz, DMSO d6, 
20 °C): δ 161.7 (s, C9) 159.3 (s, C6 & C8), 154.1 (s, C5), 149.3 (s, C1), 146.0 (s, C12), 137.1 
(s, C3), 128.1 (s, C14), 126.1 (s, C13), 126.3 (s, C15), 125.3 (s, C2), 120.8 (s, C4), 105.8 (s, 
C7), 50.2 (s, C10), 23.0 (s, C11). 
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N-(R)-(+)-1-Phenylethyl-4-(2-pyridinyl)pyrimidin-2-amin (17p). Method 1 was applied, 
using the corresponding guanidinium derivative. Yield: 0.6 (45% brown oil). Anal. calcd for 
C17H16N4 + 0.33 EtOH + 0.33 CH2Cl2): C, 67.82; H, 6.00; N, 17.26. Found: C, 67.54; H, 5.84; 
N, 17.11. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 8.76 (d, JHH = 3.68 Hz, 1H, H1), 8.48 (d, 
JHH = 4.00 Hz, 1H, H8), 8.36 (d, JHH =4.00 Hz, 1H, H4), 7.89-7.87 (m, 2H, H3 & NH), 7.66 (d, 
JHH = 4.00 Hz, 1H, H7), 7.55 (t, JHH = 8.00 Hz, 2H, H13), 7.43 (t, JHH = 6.00 Hz, 1H, H2), 7.33 
(t, JHH = 8.00 Hz, 1H, H15), 7.28 (s br., 2H, H14), 5.37-5.40 (m, 1H, H10), 1.70 (d, JHH = 8.00 
Hz, 3H, H11). 13C NMR (100.6 MHz, DMSO d6, 20 °C): δ 160.7 (s, C9) 158.1 (s, C6 & C8), 
153.7 (s, C5), 148.2 (s, C1), 143.8 (s, C12), 135.8 (s, C3), 127.4 (s, C14), 125.9 (s, C15), 125.0 
(s, C13), 123.8 (s, C2), 120.4 (s, C4), 106.0 (s, C7), 49.9 (s, C10), 22.0 (s, C11). 
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N-Isopropyl-4-(2-pyridinyl)pyrimidin-2-amin (17q). Method 1 was applied, using the 
corresponding guanidinium derivative. Yield: 1.0 g (48%, colorless crystal). Anal. calcd for 
C12H14N4: C, 67.27; H, 6.59; N, 26.15. Found: C, 67.30; H, 6.66; N, 25.94. 1H NMR (600.1 
MHz, DMSO d6, 20 °C): δ 8.68 (d, JHH = 4.5 Hz, 1H, H1), 8.41 (d, JHH = 4.7 Hz, 1H, H8), 8.34 
(d, JHH = 7.0 Hz, 1H, H4), 7.95 (td, JHH = 7.7, 1.5 Hz, 1H, H3), 7.48 (dd, JHH = 7.0, 5.0 Hz, 1H, 
H2), 7.44 (d, JHH = 5.0 Hz, 1H, H7), 7.08 (d, JHH = 6.8 Hz 1H, NH), 4.15 (s br., 1H, Hisopropyl), 
1.19 (d, JHH = 6.65 Hz, 6H, Hisopropyl. 13C NMR (151 MHz, DMSO d6, 20 °C) δ 162.6 (s, C9), 
161.8 (s, C8), 159.3 (s, C6), 154.2 (s, C5), 149.4 (s, C1), 137.2 (s, C3), 125.3 (s, C2), 120.7 (s, 
C4), 105.3 (s, C7), 42.1 (s, CisoPropyl), 22.3 (s, CisoPropyl). 
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4,4'-Bipyrimidine-2,2'-diamine (19). The synthesis of 19 was carried out as described for 
17a, but using precursor 18 and two equivalents of guanidinium carbonate. Yield: 2.0 g (64%). 
Anal. calcd for C8H8N6 + 0.2 CH2Cl2: C, 48.00; H, 4.13; N, 40.96. Found: C, 48.02; H, 4.14; N, 
39.53. 1H NMR (400.1 MHz, DMSO-d6, 70 °C): δ 8.42 (d, JHH = 5.0 Hz, 1H, H3), 7.37 (d, JHH 
= 5.0 Hz, 1H, H2), 6.46 (s, 2H, NH2). 13C NMR (151 MHz, DMSO-d6, 70 °C) δ 163.4 (s, C1), 
161.8 (s, C4), 159.1 (s, C3), 106.0 (s, C2). 
5.3.3 Synthesis of NNC Ligands 
General method for the synthesis of CNN 20a-e. Under an atmosphere of nitrogen 
0.5 g of Na (22 mmol) were added to a solution of the proper guanidinium salt (11 mmol) in 
dry EtOH (50 ml). When the reaction of Na and EtOH was completed, 1.80 g of precursor 12 
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(10 mmol) were added and the solution was refluxed for 24 h. After cooling the solution to 0 
°C the precipitated solid was filtered. The unreacted salt and the excesses of the base were 
washed out with water. The product was recrystallized from ethanol. 
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N-Phenyl-4-(pyridine-2-yl)pyrimidin-2-amine (20a). Yield: 1.2 g (50%, pale yellow solid). 
Anal. calcd for C15H12N4: C, 72.56; H, 4.87; N, 22.57. Found: C, 72.35; H, 5.21; N, 22.47. 1H 
NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.76 (s br., 1H, NH), 8.75 (d, JHH = 4.3 Hz, 1H, H1), 
8.65 (d, JHH = 5.09 Hz, 1H, H8), 8.41 (d, JHH = 7.83 Hz, 1H, H4), 8.07-8.02 (m, 1H, H3), 7.85 
(d, JHH = 7.82 Hz, 2H, H11), 7.73 (d, JHH = 5.09 Hz, 1H, H7), 7.58-7.55 (m, 1H, H2), 7.33 (t, 
JHH = 7.82 Hz, 2H, H12), 6.98 (t, JHH = 7.04 Hz, 1H, H13). 13C NMR (100.6 MHz, DMSO-d6, 
20 °C): δ 162.8 (s, C9), 160.1 (s, C6), 159.5 (s, C8), 153.7 (s, C5), 149.6 (s, C1), 140.5 (s, 
C10), 137.6 (s, C3), 128.6 (s, C12), 125.7 (s, C2), 121.5 (s, C4), 121.0 (s, C13), 119.0 (s, C11) 
108.0 (s, C7). 
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N-(4-Fluorophenyl)-4-(pyridine-2-yl)pyrimidin-2-amine (20b). Yield: 1.4 g (53%, pale 
yellow solid). Anal. calcd for C15H11FN4: C, 67.66; H, 4.16; N, 21.04. Found: C, 67.49; H, 
4.28; N, 20.90. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.79 (s br., 1H, NH), 8.74 (d, JHH = 
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4.3 Hz, 1H, H1), 8.63 (d, JHH = 4.7 Hz, 1H, H8), 8.39 (d, JHH = 7.83 Hz, 1H, H4), 8.05-8.00 
(m, 1H, H3), 7.85-7.81 (m, 2H, H12), 7.81 (d, JHH = 5.08 Hz, 1H, H7), 7.58-7.55 (m, 1H, H2), 
7.17 (t, JHF = 9 Hz, 2H, H11). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 162.8 (s, C9), 160.0 
(s, C6), 159.5 (s, C8), 158.4 (d, JCF = 237.67 Hz, C13), 153.6 (s, C5), 149.6 (s, C1), 137.6 (s, 
C3), 136.9 (d, JCF = 2.77 Hz, C10), 125.7 (s, C2), 121.1 (s, C4), 120.7 (d, JCF = 7.4 Hz, C11), 
115.2 (d, JCF = 22.19 Hz, C12), 108.0 (s, C7). 
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N-(4-Chlorophenyl)-4-(pyridine-2-yl)pyrimidin-2-amine (20c). Yield: 1.3 g (45%, pale 
yellow solid). Anal. calcd for C15H11ClN4: C, 63.72; H, 3.92; N, 19.82. Found: C, 63.46; H, 
4.10; N, 19.75. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.92 (s br., 1H, NH), 8.75 (d, JHH = 
3.91 Hz, 1H, H1), 8.66 (d, JHH = 4.7 Hz, 1H, H8), 8.40 (d, JHH = 7.83 Hz, 1H, H4), 8.04 (t, JHH 
= 7.43 Hz, 1H, H3), 7.89 (d, JHH = 9 Hz, 2H, H12), 7.75 (d, JHH = 5.08 Hz, 1H, H7), 7.58-7.55 
(m, 1H, H2), 7.39 (d, JHH = 8.61 Hz, 2H, H11). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 
162.9 (s, C9), 159.8 (s, C6), 159.6 (s, C8), 153.5 (s, C5), 149.6 (s, C1), 139.5 (s, C10), 137.6 
(s, C3), 128.4 (s, C11), 125.8 (s, C2), 124.9 (s, C13), 121.1 (s, C4), 120.3 (s, C12) 108.3 (s, 
C7). 
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N-(4-Methoxyphenyl)-4-(pyridine-2-yl)pyrimidin-2-amine (20d). Yield: 1.9 g (70%, pale 
yellow solid). Anal. calcd for C16H14N4O: C, 69.05; H, 5.07; N, 20.13. Found: C, 66.36; H, 
4.81; N, 19.70. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.56 (s br., 1H, NH), 8.74 (d, JHH = 
4.31 Hz, 1H, H1), 8.59 (d, JHH = 4.7 Hz, 1H, H8), 8.38 (d, JHH = 7.82 Hz, 1H, H4), 8.02 (t, JHH 
= 7.43 Hz, 1H, H3), 7.73 (d, JHH = 9 Hz, 2H, H12), 7.66 (d, JHH = 5.09 Hz, 1H, H7), 7.57-7.54 
(m, 1H, H2), 6.94 (d, JHH = 9 Hz, 2H, H11), 3.74 (s, 3H, H14). 13C NMR (100.6 MHz, DMSO-
d6, 20 °C): δ 162.7 (s, C9), 160.2 (s, C6), 159.5 (s, C8), 154.3 (s, C5), 153.8 (s, C13), 149.6 (s, 
C1), 137.5 (s, C3), 133.6 (s, C10), 125.6 (s, C2), 121.0 (s, C4), 120.7 (s, C11), 113.8 (s, C12) 
107.4 (s, C7), 55.2 (s, C14). 
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4-(4-(Pyridin-2-yl)pyrimidin-2-ylamino)benzonitrile (20e). Yield: 1.3 g (47%, pale yellow 
solid). Anal. calcd for C16H11N5: C, 70.32; H, 4.06; N, 25.63. Found: C, 69.70; H, 4.14; N, 
25.01. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 10.34 (s br., 1H, NH), 8.77 (d, JHH = 4.7 Hz, 
1H, H1), 8.74 (d, JHH = 5.09 Hz, 1H, H8), 8.42 (d, JHH = 7.83 Hz, 1H, H4), 8.06-8.04 (m, 3H, 
H3 & H12), 7.85 (d, JHH = 4.7 Hz, 1H, H7), 7.79 (d, JHH = 8.6 Hz, 2H, H11), 7.61-7.58 (m, 1H, 
H2). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 163.1 (s, C9), 159.9 (s, C6), 159.5 (s, C8), 
153.3 (s, C5), 149.7 (s, C1), 144.9 (s, C10), 137.7 (s, C3), 133.1 (s, C11), 126.0 (s, C2), 121.2 
(s, C4), 119.6 (s, C13), 118.4 (s, C12), 109.4 (s, C7
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5.3.4 Synthesis of Multidendate Ligands 
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26. Under an atmosphere of nitrogen 331 mg of 2-methoxybenzoic acid (2.18 mmol) were 
dissolved in 20 ml of thionylchloride. The solution was refluxed for 2.5 h and then the excess 
of the thionylchloride was distilled off. The residue was dissolved in 20 ml of pyridine and 400 
mg of the diamine 7 (1.06 mmol) were added to the solution which was stirred over night. 
After distillation of the solvent a 10% solution of NaHCO3 was added to the residue and the 
product was extracted with dichloromethane. The organic phases were dried over MgSO4. 
After evaporation of the solvent, the product was crystallized in ethanol. Yield: 428.0 mg 
(63%, colorless solid). Anal. calcd for C37H39N7O4: C, 68.82; H, 6.09; N, 15.18. Found: C, 
68.74; H, 6.05; N, 15.30. 1H NMR (400.1 MHz, DMSO-d6): δ 10.83 (s, 2H, NH), 8.23-8.20 
(m, 4H, H2 & H5), 8.13 (t, JHH = 7.6 Hz, 1H, H1), 7.66 (d, JHH = 7.4 Hz, 2H, H13), 7.49 (t, JHH 
= 7.8 Hz, 2H, H11), 7.12-7.09 (m, 4H, H10 & H12), 3.71 (s, 6H, H14), 1.28 (s, 18H, H16). 13C 
NMR (100.6 MHz, DMSO-d6): δ 179.9 (s, C6), 165.7 (s, CO), 162.7 (s, C4), 157.6 (s, C7), 
156.2 (s, C9), 152.9 (s, C3), 139.0 (s, C1), 132.0 (s, C11), 129.7 (s, C13), 125.2 (s, C8), 123.0 
(s, C2), 120.7 (s, C12), 111.9 (s, C10), 107.0 (s, C5), 55.8 (s, C14), 37.4 (s, C15), 28.8 (s, 
C16). IR (KBr): ῡ = 3340 cm-1 (s), 3078 (br.), 2959 (s), 2900 (m), 2870 (m), 2838 (br.), 1697 
(s), 1600 (s), 1577 (s), 1536 (m), 756 (m).  
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27. Under an atmosphere of nitrogen to the solution of 502 mg of the diamine 7 (1.33 mmol) in 
20 ml of pyridine 362 mg of ethyl(chlorocarbonyl)formate (2.65 mmol) were added and the 
solution was stirred over night at room temperature. After distillation of the solvent, a 10% 
solution of NaHCO3 was added to the residue and the product was extracted with 
dichloromethane. The organic phases were washed three times with diluted HCl and then dried 
over MgSO4. Evaporating the solvent resulted in desired product. Yield: 630.0 mg (63%, 
colorless solid). Anal. calcd for C29H35N7O6: C, 60.03; H, 6.11; N, 16.97. Found: C, 60.00; H, 
6.04; N, 16.36. 1H NMR (400.1 MHz, DMSO-d6): δ 11.70 (s, 2H, NH), 8.42 (d, JHH = 7.8 Hz, 
2H, H2), 8.35-8.31 (m, 3H, H1 & H5), 4.31 (q, JHH = 7.0 Hz, 4H, H8), 1.37 (s, 18H, H11), 1.20 
(t, JHH = 7.0 Hz, 6H, H9). 13C NMR (100.6 MHz, DMSO-d6): δ 180.6 (s, C6), 163.0 (s, C4), 
160.3 (s, CO), 158.3 (s, CO), 156.3 (s, C7), 152.8 (s, C3), 139.5 (s, C1), 123.3 (s, C2), 108.2 (s, 
C5), 61.7 (s, C8), 37.7 (s, C10), 28.7 (s, C11), 13.7 (s, C9). IR (KBr): ῡ = 3427 cm-1 (w), 3388 
(w), 2959 (m), 2926 (m), 2870 (w), 1769 (s), 1744 (s), 1727 (s), 1692 (w), 1604 (s), 1577 (s), 
1541 (s), 1523 (s), 1393 (m), 1351 (m), 743 (w).  
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2-Methoxy-N-(4-(pyridin-2-yl)pyrimidin-2-yl)benzamide, 28. Under atmosphere of nitrogen 
903 mg of 2-methoxybenzoic acid (5.93 mmol) were dissolved in 20 ml of thionylchloride. 
The solution was refluxed for 2.5 h and then the excess of the thionylchloride was distilled off. 
The residue was dissolved in 20 ml pyridine and 1.01 g of the monoamine 17a (5.87 mmol) 
were added to the solution which was stirred over night. After distillation of the solvent the 
residue was washed twice with a 10% solution of NaHCO3, four times with water and then 
with hot ethanol. Yield: 1.30 g (72%, colorless solid). Anal. calcd for C17H14N4O2. 0.25H2O: 
C, 66.13; H, 4.92; N, 17.63; Found: C, 66.04; H, 4.80; N, 17.69. 1H NMR (400.1 MHz, 
DMSO-d6): δ 10.85 (s, 1H, NH), 8.81 (d, JHH = 5.0 Hz, 1H, H8), 8.73 (d, JHH = 3.7 Hz, 1H, 
H1), 8.02-8.01 (m, 2H, H7 & H15), 7.92 (t, JHH = 7.48 Hz, 1H, H3), 7.73 (d, JHH = 7.2 Hz, 1H, 
H4), 7.56-7.51 (m, 2H, H2 & H13), 7.15-7.10 (m, 2H, H12 & H14), 3.80 (s, 3H, H16). 13C 
NMR (100.6 MHz, DMSO-d6): δ 164.8 (s, CO), 162.9 (s, C9), 159.9 (s, C8), 157.7 (s, C6), 
156.5 (s, C11), 152.9 (s, C5), 149.7 (s, C1), 137.5 (s, C3), 132.4 (s, C13), 130.0 (s, C15), 126.0 
(s, C2), 124.5 (s, C10), 121.4 (s, C4), 120.8 (s, C14), 112.1 (s, C7), 112.0 (s, C12), 56.0 (s; 
C16), IR (KBr): ῡ = 3318 cm-1 (br.), 3191 (br.), 3107 (m), 2965 (m), 2906 (m), 1658 (s), 1586 
(s), 1556 (s), 815 (m), 756 (s).  
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3-Methoxy-N-(4-(pyridin-2-yl)pyrimidin-2-yl)benzamide, 29. Under an atmosphere of 
nitrogen 900 mg of 3-methoxybenzoic acid (5.92 mmol) were dissolved in 20 ml of 
thionylchloride. The solution was refluxed for 1.5 h and then the excess of the thionylchloride 
was distilled off. The residue was dissolved in 20 ml of pyridine and 1.02 g of the monoamine 
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17a (5.92 mmol) were added to the solution which was stirred over night. After distillation of 
the solvent the residue was dissolved in dichloromethane and the organic phase was washed 
with a saturated solution of NaHCO3 and dried over MgSO4. Evaporating the dichloromethane 
resulted in 29. Yield: 1.1 g (63%, colorless). Anal. calcd for C17H14N4O2: C, 66.66; H, 4.61; N, 
18.29; Found: C, 66.18; H, 4.86; N, 18.09. 1H NMR (400.1 MHz, DMSO-d6): δ 11.12 (s br., 
1H, NH), 8.89 (d, JHH = 5.1 Hz, 1H, H8), 8.77 (d, JHH = 3.9 Hz, 1H, H1), 8.44 (d, JHH = 7.8 Hz, 
1H, H4), 8.09 (d, JHH = 5.1 Hz, 1H, H7), 8.06-8.01 (m, 1H, H3), 7.60-7.57 (m, 3H, H2, H11 & 
H15), 7.46 (t, JHH = 7.8 Hz, 1H, H12), 7.19 (dd, J = 2.2 , 8.0 Hz, 1H, H13), 3.85 (s, 3H, H16). 
13C NMR (100.6 MHz, DMSO-d6): δ 165.4 (s, CO), 163.2 (s, C9), 159.8 (s, C8), 159.1 (s, 
C14), 158.3 (s, C6), 153.1 (s, C5), 149.8 (s, C1), 137.6 (s, C3), 135.7 (s, C10), 129.5 (s, C12), 
126.1 (s, C2), 121.5 (s, C4), 120.5 (s, C11), 118.2 (s, C13), 113.0 (s, C15), 112.5 (s, C7), 55.3 
(s, C16). IR (KBr): ῡ = 3244 cm-1 (m), 3208 (m), 3179 (m), 3028 (m), 3005 (m), 2958 (m), 
2932 (m), 2834 (m), 1699 (s), 1587 (s), 742 (s).  
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N-(4-(Pyridin-2-yl)pyrimidin-2-yl)benzamide, 30. Under an atmosphere of nitrogen 510 mg 
of 17a (2.96 mmol) were dissolved in 15 ml of pyridine and 408 mg of benzoyl chloride (2.96 
mmol) were added to the solution which was stirred over night. After destillation of the 
solvent, the residue was washed with a 10% solution of NaHCO3 and crystalized from ethanol. 
Yield: 279.0 mg (34%, colorless solid). Anal. calcd for C16H12N4O: C, 69.55; H, 4.38; N, 
20.28; Found: C, 68.99; H, 4.34; N, 19.88. 1H NMR (400.1 MHz, DMSO-d6): δ 11.12 (s, NH), 
8.89 (d, JHH = 5.0 Hz, 1H, H8), 8.77 (d, JHH = 3.8 Hz, 1H, H1), 8.41 (d, JHH = 7.8 Hz, 1H, H4), 
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8.15-7.94 (m, 4H, H3, H7, H11 & H15), 7.72-7.45 (m, 4H, H2, H12, H13 & H14). 13C NMR 
(100.6 MHz, DMSO-d6): δ 165.9 (s, CO), 163.2 (s, C9), 159.8 (s, C8), 158.4 (s, C6), 153.1 (s, 
C5), 149.8 (s, C1), 137.6 (s, C3), 134.4 (s, C10), 132.0 (s, C13), 128.4 (s, C12 & C14), 128.2 
(s, C11 & C15), 126.1 (s, C2), 121.5 (s, C4), 112.4 (s, C7). IR (KBr): ῡ = 3218 cm-1 (br.), 3170 
(m), 3125 (br.), 3082 (br.), 3056 (br.) 2993 (m), 1690 (s), 1601 (s), 1546 (s), 1546 (s), 1516 (s), 
803 (s) 731 (s), 701 (s). 
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31. Under an atmosphere of nitrogen 1.80 g of 2-methoxybenzoic acid (11.8 mmol) were 
dissolved in 25 ml of thionylchloride. The solution was refluxed for 2 h and then the excess of 
the thionylchloride was distilled off. The residue was dissolved in 20 ml of pyridine and 1.00 g 
of the monoamine 17a (5.81 mmol) were added to the solution which was stirred over night. 
After distillation of the solvent the residue was washed twice with a 10% solution of NaHCO3, 
four times with water and then with hot ethanol. Yield: 1.0 g (40%, colorless solid), calcd for 
C25H20N4O4: C, 68.17; H, 4.58; N, 12.72; Found: C, 67.87; H, 4.76; N, 12.57. 1H NMR (400.1 
MHz, CDCl3): δ 8.80 (d, JHH = 5.1 Hz, 1H, H8), 8.65 (d, JHH = 4.4 Hz, 1H, H1), 8.13 (d, JHH = 
5.1 Hz, 1H, H7), 8.09 (d, JHH = 8.2 Hz, 1H, H4), 7.75-7.70 (m, 3H, H3 & H15), 7.36-7.29 (m, 
3H, H2 & H13), 6.92 (t, JHH = 7.5 Hz, 2H, H14), 6.76 (d, JHH = 8.2 Hz, 2H, H12), 3.72 (s, 6H, 
H16). 13C NMR (100.6 MHz, CDCl3): δ 170.0 (s, CO), 164.2 (s, C9), 160.0 (s, C6), 159.5 (s, 
C8), 157.4 (s, C11), 153.3 (s, C5), 149.5 (s, C1), 137.1 (s, C3), 133.1 (s, C13), 131.2 (s, C15), 
125.7 (s, C2), 124.8 (s, C10), 122.1 (s, C4), 120.5 (s, C14), 114.6 (s, C7), 111.1 (s, C12), 55.6 
(s, C16). IR (KBr): ῡ = 3426 cm-1 (br.), 3318 (br.), 3088 (br.), 3065 (br.), 3006 (m), 2967 (m), 
2942 (m), 2839 (m), 1725 (s), 1668 (s), 1577 (s), 1541 (s), 1489 (s), 815 (s), 757 (s).  
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N2,N6-Bis(4-pyridin-2-yl)pyrimidin-2-yl)pyridine-2,6-dicarboxamide 32. Under an 
atmosphere of nitrogen 504 mg of pyridine-2,6-dicarboxylic acid (3.02 mmol) were dissolved 
in 20 ml of thionylchloride. The solution was refluxed for 2 h and then the excess of the 
thionylchloride was distilled off. The residue was dissolved in 20 ml of pyridine and 1.00 g of 
the monoamine 17a (5.81 mmol) were added to the solution which was stirred over night. After 
distillation of the solvent the residue was washed twice with a 10% solution of NaHCO3, four 
times with water and then with hot ethanol. Yield: 892.0 mg (62%, colorless solid). Anal. calcd 
for C25H17N9O2 + 2.5 H2O: C, 57.69; H, 4.26; N, 24.22; Found: C, 57.54; H, 4.06; N, 23.74. 1H 
NMR (400.1 MHz, DMSO-d6): δ 12.06 (s, 2H, NH), 8.99 (d, JHH = 5.1 Hz, 2H, H5), 8.79 (d, 
JHH = 4.0 Hz, 2H, H12), 8.57 (d, JHH = 7.8 Hz, 2H, H9), 8.48 (d, JHH = 7.8 Hz, 2H, H2), 8.38-
8.33 (m, 1H, H1), 8.18 (d, JHH = 5.1 Hz, 2H, H6), 8.08 (t, JHH = 7.8 Hz, 2H, H10), 7.63 (q, JHH 
= 4.0 Hz, 2H, H11). 13C NMR (100.6 MHz, DMSO-d6): δ 163.5 (s, CO), 162.1 (s, C4), 160.0 
(s, C5), 157.8 (s, C7), 153.0 (s, C8), 149.8 (s, C 12), 148.9 (s, C3), 140.0 (s, C1), 137.7 (s, 
C10), 126.2 (s, C2), 126.2 (s, C11), 121.7 (s, C9), 113.1 (s, C6). IR (KBr): ῡ = 3324 cm-1 (m), 
3052 (br.), 2922 (br.), 2854 (br.), 1723 (s), 1586 (s), 1541 (s), 782 (s).  
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5.4 Synthesis of Transitional Metal Complexes 
5.4.1 Ruthenum Complexes 
5.4.1.1 Ruthenium Complexes with Tridendate Ligands 
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Dichloro(2,6-di(1-allyl-1H-pyrazol-3-yl)pyridine)triphenylphosphineruthenium(II) (33a). 
0.15 g of 5 (0.37 mmol) were added to a solution of 0.355 g of (PPh3)3RuCl2 (0.37 mmol) in 10 
ml of dry CH2Cl2. The reaction mixture was stirred at room temperature for about 2 h. After 
concentrating the solution to about 5 mL, 25 mL of dry diethylether were added to precipitate 
the product, which was filtered off and washed with diethylether to remove liberated 
triphenylphosphine. Yield: 268.0 mg (100%, red solid). Anal. calcd for C35H32Cl2N5PRu: C, 
57.93; H, 4.45; N, 9.65. Found: C, 57.64; H, 4.45; N, 9.65. 1H NMR (400.1 MHz, CDCl3, 20 
°C): δ 7.35 (d, JHH = 2.72 Hz, 2H, H6), 7.29 (t, JHH = 7.49 Hz, 1H, H1), 7.25-7.18 (m, 5H, 
H2,HPh), 7.09-7.06 (m, 12H, HPh), 6.75 (d, JHH = 2.72 Hz, 2H, H5), 6.15-6.04 (m, 2H, H8), 
5.80 (dd, 4H, H7), 5.32 (m, 4H, H9), 4.76 (dd, 2H, H7). 13C{1H} NMR (100.6 MHz, CDCl3, 
20 °C): δ 155.8 (s, C1), 152.6 (s, C4), 134.1 (d, JCP = 41.62 Hz, CPh), 133.4 (d, JCP = 9.24 Hz, 
CPh), 133.0 (s, C8), 132.5 (s, C6), 132.0 (s, C3), 129.0 (s br., CPh), 127.8 (d, JCP = 8.33 Hz, 
CPh), 120.2 (s, C2), 116.9 (s, C9), 105.5 (s, C5), 56.2 (s, C7). 31P{1H} NMR (162 MHz, 
CDCl3, 20 °C): δ 44.2. 
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Dichloro(2,6-di(1-allyl-5-butyl-1H-pyrazol-3-yl)pyridine)triphenyl-
phosphineruthenium(II) 33b. The same procedure as for 33a was applied. Yield: 310.0 mg 
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(100%, red solid). Anal. calcd for C43H48Cl2N5PRu: C, 61.67; H, 5.73; N, 8.36. Found: C, 
61.95; H, 5.68; N, 7.68. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 7.34 (t, JHH = 8.22 Hz, 1H, 
H1), 7.21 (m, 3H, Hph), 7.15 (d, JHH = 7.44 Hz, 2H, H2), 7.11-7.07 (m, 12H, HPh), 6.47 (s, 2H, 
H5), 6.22-6.19 (m, 4H, H7 & H8), 5.14-5.10 (m, 4H, H9), 4.24-4.18 (m, 2H, H7), 2.59-2.54 
(m, 4H, Hbutyl), 1.60-1.56 (m, 4H, Hbutyl), 1.39-1.34 (m, 4H, Hbutyl), 0.94 (t, JHH = 7.05 Hz, 6H, 
Hbutyl). 13C{1H} NMR (100.6 MHz, CDCl3, 20 °C): δ 156.2 (s, C1), 151.6 (s, C4), 148.0 (s, 
C3), 134.5 (d, JCP = 40.69 Hz, Cph), 134.4 (s, C8), 133.4 (d, JCP = 9.24 Hz, CPh), 131.8 (s, C6), 
128.8 (s br., CPh), 127.6 (d, JCP = 9.25 Hz, CPh), 117.6 (s, C2), 116.5 (s, C9), 104.0 (s, C5), 53.8 
(s, C7), 30.1 (s, Cbutyl), 25.8 (s, Cbutyl), 22.4 (s, Cbutyl), 14.00 (s, Cbutyl). 31P{1H} NMR (162 
MHz, CDCl3, 20 °C): δ 42.7. 
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Dichloro(2,6-di(1-allyl-5-octyl-1H-pyrazol-3-yl)pyridine)triphenyl-
phosphineruthenium(II) 33d. The same procedure as for 33a was applied. Since the product 
was too much soluble and air sensitive, the high content of free triphenylphosphine oxide and 
impurites could not be washed out. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 7.33 (t, JHH = 7.92 
Hz, 1H, H1), 7.23 (m, 3H, HPh), 7.15 (d, JHH = 7.64 Hz, 2H, H2), 7.10-7.06 (m, 12H, HPh), 6.47 
(s, 2H, H5), 6.22-6.15 (m, 4H, H7 & H8), 5.14-5.10 (m, 4H, H9), 4.24-4.18 (m, 2H, H7), 2.59-
2.51 (m, 4H, Hoctyl), 1.60-1.57 (m, 4H, Hoctyl), 1.28-1.19 (m, 20H, Hoctyl), 0.89 (t, JHH = 6.36 
Hz, 6H, Hoctyl). 31P{1H} NMR (162 MHz, CDCl3, 20 °C): δ 44.00. 
N N N
N N
1
2
345
6
7 8
9
Ru
Cl
Cl
PPh3
 
168 
 
Dichloro(2,6-bis(1-allyl-5,6,7,8-tetrahydro-4H-cycloheptapyrazol-3-yl)pyridine triphenyl-
phosphineruthenium(II) 33e. The same procedure as for 33a was applied. Because of the 
high solubility and air sensitivity of the product the high content of free triphenylphosphine 
oxide and impurites could not be washed out. 1H NMR (400.1 MHz, CDCl3, 20 °C): δ 7.32-
7.19 (m, H1, H2 and free OPPh3), 7.11-7.04 (m, 12H, HPh), 6.98 (t, JHH = 7.5 Hz, 3H, HPh), 
6.45 (m, 2H, H7), 6.18-6.08 (m, 2H, H8), 5.11-5.06 (m, 4H, H9), 4.31-4.25 (m, 2H, H7), 2.92-
2.77 (m, 4H, Hcycloheptyl), 2.65 (t, JHH = 5.11 Hz, 4H, Hcycloheptyl), 1.89-1.80 (m, 4H, Hcycloheptyl), 
1.77-1.75 (m, 4H, Hcycloheptyl), 1.70-1.61 (m, 4H, Hcycloheptyl). 31P{1H} NMR (162 MHz, CDCl3, 
20 °C): δ 44.67. 
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Carbonyldichloro(2,6-di(1-allyl-1H-pyrazol-3-yl)pyridine)ruthenium(II), 34a. 0.145 g of 
33a (0.2 mmol) were dissolved in dry toluene/CH2Cl2 (10:1) and CO gas was bubbled into the 
refluxing solution. The colour of the solution changed from red to yellow. When the reaction 
mixture cooled down to room temperature, a yellow powder precipitated which was filtered off 
washed with dry diethylether. Yield: 98.0 mg (100%, yellow solid). Anal. calcd for 
C18H17Cl2N5ORu + CH2Cl2: C, 39.60; H, 3.32; N, 12.15. Found: C, 40.05; H, 3.56; N, 12.33. 
1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 8.21-8.10 (m, 5H, H1, H2 & H6), 7.36 (d, JHH = 
2.19 Hz, 2H, H5), 6.16-6.09 (m, 2H, H8), 5.51-5.47 (dd, 2H, H7), 5.23-5.19 (m, 6H, H7 & 
H9). 13C{1H} NMR (100.6 MHz, DMSO-d6, 20 °C): δ 191.0 (s, CO), 152.8 (s, C3), 152.3 (s, 
C4), 138.8 (s, C8), 135. (s, C6), 133.7 (s, C1), 119.2 (s, C2), 118.3 (s, C9), 106.7 (s, C5), 53.9 
(s, C7). IR (KBr, cm-1): 1936 (C=O). 
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Carbonyldichloro(2,6-di(1-allyl-1H-pyrazol-3-yl)pyridine)ruthenium(II) 34b. The same 
procedure as for 34a was applied. Yield: 121.0 mg (100%, yellow solid). Anal. calcd for 
C26H33Cl2N5ORu: C, 51.74; H, 5.51; N, 11.60. Found: C, 50.73; H, 5.54; N, 11.60. 1H NMR 
(400.1 MHz, DMSO-d6, 20 °C): δ 8.15 (t, JHH = 7.49 Hz, 1H, H1), 8.05 (d, JHH = 7.83 Hz, 2H, 
H2), 7.21 (s, 2H, H5), 6.05-5.96 (m, 2H, H8), 5.58 (dd, 2H, H7), 5.19 (dd, 4H, H9), 5.07 (d, 
JHH = 17.37 Hz, 2H, H7), 2.76-2.66 (m, 4H, Hbutyl), 1.70-1.62 (m, 4H, Hbutyl), 1.43-1.36 (m, 4H, 
Hbutyl), 0.96-0.91 (m, 6H, Hbutyl). 13C{1H} NMR (100.6 MHz DMSO-d6, 20 °C): δ 191.2 (s, 
CO), 153.0 (s, C3), 151.4 (s, C4), 148.3 (d, C6), 138.8 (s, C8), 133.3 (s, C1), 119.0 (s, C2), 
117.1 (s, C9), 105.0 (s, C5), 51.3 (s, C7), 29.3 (s, Cbutyl), 24.7 (s, Cbutyl), 21.8 (s, Cbutyl), 13.7 (s, 
Cbutyl). IR (KBr, cm-1): 1948 (C=O). 
5.4.1.2 Ruthenium Complexes with Bidendate Ligands 
General synthesis of [RuCl (p-cymene)L]Cl. A solution of the ligand (0.32 mmol) in 
CH2Cl2 (5 ml) was added dropwise to a solution of 92.0 mg of [RuCl2(p-cymene)]2 (0.15 
mmol) in CH2Cl2 (20 ml). After stirring for 20 h at room temperature the solution was 
concentrated and the product was precipitated by adding Et2O (10 ml). The product was 
filtered, washed twice with Et2O and dried under vacuum. 
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[2-Amino-4-(pyridin-2-yl)pyrimidine(chlorido)(η6-p-cymene)ruthenium(II)]chloride 36a-
Cl. Yield: 122.4 mg (81%, yellow solid). Anal. calcd for C19H22Cl2N4Ru: C, 47.70; H, 4.64; N, 
11.71. Found: C, 47.54; H, 4.75; N, 11.79. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.50 (d, 
JHH = 4.99 Hz, 1H, H1), 8.71 (d, JHH = 4.7 Hz, 1H, H8), 8.63 (d, JHH = 7.92 Hz, 1H, H4), 8.30-
8.27 (m, 1H, H3), 7.87-7.82 (m, 2H, H2 & H7), 6.23 (d, JHH = 6.16 Hz, 1H, Hcymene), 6.07-6.02 
(m, 3H, Hcymene), 2.50-2.43 (m, 1H, Hcymene), 2.22 (s, 3H, Hcymene), 0.94 (d, JHH = 6.75 Hz, 3H, 
Hcymene), 0.85 (d, JHH = 6.75 Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 
164.5 (s, C9), 161.5 (s, C8), 161.2 (s, C6), 156.2 (s, C1), 153.8 (s, C5), 140.1 (s, C3), 129.0 (s, 
C2), 125.1 (s, C4), 108.2 (s, C7), 105.9 (s, Ccymene), 103.6 (s, Ccymene), 87.3 (s, Ccymene), 86.4 (s, 
Ccymene), 82.8 (s, Ccymene), 82.3 (s, Ccymene), 30.4 (s, Ccymene), 21.6 (s, Ccymene), 18.5 (s, Ccymene).  
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[2-Amino-4-(pyridin-2-yl)pyrimidine(chlorido)(η6-p-cymene)ruthenium(II)]hexafluoro-
phosphate 36a-PF6. The synthesis of 36a-PF6 was carried out as described in general 
synthesis but 83.0 mg of KPF6 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 164.0 mg (93%, yellow 
solid). Anal. calcd for C19H22ClF6N4PRu: C, 38.82; H, 3.77; N, 9.53. Found: C, 38.60; H, 4.11; 
N, 9.42. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.48 (d, JHH = 4.99 Hz, 1H, H1), 8.72 (d, 
JHH = 4.69 Hz, 1H, H8), 8.60 (d, JHH = 7.63 Hz, 1H, H4), 8.29-8.27 (m, 1H, H3), 7.85-7.83 (m, 
1H, H2), 7.80 (d, JHH = 4.4 Hz, 1H, H7), 6.23 (d, JHH = 5.87 Hz, 1H, Hcymene), 6.05-6.02 (m, 
3H, Hcymene), 2.47-2.45 (m, 1H, Hcymene), 2.22 (s, 3H, Hcymene), 0.95 (d, JHH = 6.75 Hz, 3H, 
Hcymene), 0.85 (d, JHH = 6.75 Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 
164.5 (s, C9), 161.4 (s, C8), 161.1 (s, C6), 156.1 (s, C1), 153.8 (s, C5), 140.1 (s, C3), 128.9 (s, 
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C2), 125.0 (s, C4), 108.1 (s, C7), 105.8 (s, Ccymene), 103.6 (s, Ccymene), 87.2 (s, Ccymene), 86.3 (s, 
Ccymene), 82.8 (s, Ccymene), 82.3 (s, Ccymene), 30.4 (s, Ccymene), 21.6 (s, Ccymene), 18.4 (s, Ccymene). 
31P NMR (242.9 MHz, DMSO-d6, 20 °C): δ -144.16 (h; JPF = 714.1 Hz, PF6-).  
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[2-Amino-4-(pyridin-2-yl)pyrimidine(chlorido)(η6-p-cymene)ruthenium(II)]tetraphenyl-
borate 36a(BPh4). The synthesis of 36a-BPh4 was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 217.2 mg (95%, yellow 
solid). Anal. calcd for C43H42BClN4Ru + 1.5CH2Cl2: C, 60.02; H, 5.06; N, 6.29. Found: C, 
59.00; H, 5.20; N, 6.20. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.48 (d, JHH = 5.28 Hz, 
1H, H1), 8.70 (d, JHH = 4.99 Hz, 1H, H8), 8.58 (d, JHH = 7.92 Hz, 1H, H4), 8.27-8.24 (m, 1H, 
H3), 7.84-7.81 (m, 1H, H2), 7.78 (d, JHH = 4.99 Hz, H7), 7.19 (m, 8H, HPh), 6.92 (m, 8H, HPh), 
6.81-6.78 (m, 4H, HPh), 6.22 (d, JHH = 6.16 Hz, 1H, Hcymene), 6.04-6.02 (m, 3H, Hcymene), 2.47 
(m, 1H, Hcymene), 2.22 (s, 3H, Hcymene), 0.94 (d, JHH = 7.04 Hz, 3H, Hcymene), 0.85 (d, JHH = 7.05 
Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 164.5 (s, C9), 163.9-162.9 (q, 
CPh), 161.4 (s, C8), 161.1 (s, C6), 156.1 (s, C1), 153.8 (s, C5), 140.0 (s, C3), 135.5 (s, CPh), 
128.9 (s, C2), 125.3 (s, CPh), 125.0 (s, C4), 121.5 (s, CPh), 108.1 (s, C7), 105.8 (s, Ccymene), 
103.5 (s, Ccymene), 87.2 (s, Ccymene), 86.3 (s, Ccymene), 82.8 (s, Ccymene), 82.2 (s, Ccymene), 30.4 (s, 
Ccymene), 21.6 (s, Ccymene), 21.6 (s, Ccymene), 18.4 (s, Ccymene). 
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[2-Amino-6-(1-phenyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthenium(II)] 
tetraphenylborate 36b-BPh4. The synthesis of 36b-BPh4 was carried out as described in 
general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and 
before concentrating the excess and formed salts were filtered off. Yield: 211.2 mg (84%, 
fulvous solid). Anal. calcd for C49H46BClN4Ru: C, 70.21; H, 5.53; N, 6.68. Found: C, 69.48; H, 
5.33; N, 6.57. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.50 (d, JHH = 4.4 Hz, 1H, H1), 8.89 
(d, JHH = 7.93 Hz, 1H, H4), 8.39 (s, 1H, H7), 8.37 (d, JHH = 7.04 Hz, 2H, H11), 8.34-8.31 (m, 
1H, H3), 7.86-7.84 (m, 1H, H2), 7.65-7.63 (m, 3H, H12 & H13), 7.17 (s br., 8H, HPh), 6.93-
6.91 (m, 8H, HPh), 6.80-6.78 (m, 4H, HPh), 6.26 (d, JHH = 5.28 Hz, 1H, Hcymene), 6.05-6.03 (m, 
3H, Hcymene), 2.23 (s, 3H, Hcymene), 1.08 (d, JHH = 6.45 Hz, 3H, Hcymene), 0.85 (d, JHH = 6.45 Hz, 
3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 166.5 (s, C9), 164.3 (s, C8), 163.9-
162.9 (q, CPh), 161.9 (s, C6), 156.1 (s, C1), 154.2 (s, C5), 140.0 (s, C3), 135.6 (s, CPh), 134.6 
(s, C10), 132.6 (s, C13), 129.1 (s, C11), 128.8 (s, C2), 127.9 (s, C12), 125.4 (s, CPh), 125.2 (s, 
C4), 121.6 (s, CPh), 105.7 (s, Ccymene), 104.6 (s, C7), 103.6 (s, Ccymene), 87.2 (s, Ccymene), 86.2 (s, 
Ccymene), 83.0 (s, Ccymene), 82.4 (s, Ccymene), 30.4 (s, Ccymene), 21.7 (s, Ccymene), 21.6 (s, Ccymene), 
18.5 (s, Ccymene). 
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[2-Amino-6-(1-naphthyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)] tetrafluoroborate 36c-BF4. The synthesis of 36c-BF4 was carried out as described 
in general synthesis but 49.5 mg of NaBF4 salt (0.45 mmol) were also added to the solution and 
before concentrating the excess and formed salts were filtered off. Yield: 186.9 mg (95%, dark 
tangerine solid). Anal. calcd for C29H28BClF4N4Ru: C, 53.11; H, 4.30; N, 8.54. Found: C, 
52.23; H, 4.57; N, 8.49. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.53 (d, JHH = 4.91 Hz, 
1H, H1), 8.78 (d, JHH = 7.92 Hz, 1H, H8), 8.34-8.28 (m, 2H, H3 & Hnaphthyl), 8.23 (s, 1H, H7), 
8.18 (d, JHH = 8.22 Hz, 1H, Hnaphthyl), 8.10-8.09 (m, 1H, Hnaphthyl), 7.92 (d, JHH = 7.04 Hz, 1H, 
Hnaphthyl), 7.87 (t, JHH = 6.45 Hz, 1H, H2), 7.71 (t, JHH = 7.34 Hz, 1H, Hnaphthyl), 7.65-7.62 (m, 
2H, Hnaphthyl), 6.34 (d, JHH = 6.16 Hz, 1H, Hcymene), 6.10 (m, 3H, Hcymene), 2.58-2.56 (m, 1H, 
Hcymene), 2.28 (s, 3H, Hcymene), 1.03 (d, JHH = 6.75 Hz, 3H, Hcymene), 0.94 (d, JHH = 6.75 Hz, 3H, 
Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 169.6 (s, C8), 164.1 (s, C9), 161.5 (s, 
C6), 156.1 (s, C1), 154.1 (s, C5), 140.0 (s, C3), 134.0(s, Cnaphthyl), 133.4 (s, Cnaphthyl), 131.2 (s, 
Cnaphthyl), 129.8 (s, Cnaphthyl), 128.9 (s, Cnaphthyl), 128.7 (s, C2), 128.6 (s, Cnaphthyl), 127.4 (s, 
Cnaphthyl), 126.5 (s, Cnaphthyl), 125.3 (s, Cnaphthyl), 125.3 (s, Cnaphthyl), 125.0 (s, C4), 109.3 (s, C7), 
105.7 (s, Ccymene), 103.7 87.1 (s, Ccymene), 86.3 (s, Ccymene), 83.0 (s, Ccymene), 82.5 (s, Ccymene), 
30.5 (s, Ccymene), 21.8 (s, Ccymene), 21.5 (s, Ccymene), 18.5 (s, Ccymene).  
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[2-Amino-6-(1-naphthyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)]hexafluorophosphate 36c-PF6. The synthesis of 36c-PF6 was carried out as 
described in general synthesis but 83.0 mg of KPF6 salt (0.45 mmol) were also added to the 
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solution and before concentrating the excess and formed salts were filtered off. Yield: 182.1 
mg (85%, dark tangerine solid). Anal. calcd for C29H28ClF6PN4Ru: C, 48.78; H, 3.95; N, 7.85. 
Found: C, 48.53; H, 4.08; N, 7.79. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.53 (d, JHH = 
4.99 Hz, 1H, H1), 8.77 (d, JHH = 7.92 Hz, 1H, H4), 8.34-8.27 (m, 2H, H3 & Hnaphthyl), 8.22 (s, 
1H, H7), 8.18 (d, JHH = 8.22 Hz, 1H, Hnaphthyl), 8.10-8.08 (m, 1H, Hnaphthyl), 7.92 (d, JHH = 6.45 
Hz, 1H, Hnaphthyl), 7.87 (t, JHH = 7.04 Hz, 1H, H2), 7.71 (t, JHH = 7.34 Hz, 1H, Hnaphthyl), 7.66-
7.63 (m, 2H, Hnaphthyl), 6.34 (d, JHH = 6.16 Hz, 1H, Hcymene), 6.12-6.09 (m, 3H, Hcymene), 2.51-
2.50 (m, 1H, Hcymene), 2.28 (s, 3H, Hcymene), 1.03 (d, JHH = 6.75 Hz, 3H, Hcymene), 0.94 (d, JHH = 
6.74 Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 169.6 (s, C8), 164.1 (s, C9), 
161.5 (s, C6), 156.1 (s, C1), 154.1 (s, C5), 140.0 (s, C3), 134.0 (s, Cnaphthyl), 133.4 (s, Cnaphthyl), 
131.2 (s, Cnaphthyl), 129.8 (s, Cnaphthyl), 128.9 (s, Cnaphthyl), 128.7 (s, C2), 128.5 (s, Cnaphthyl), 127.4 
(s, Cnaphthyl), 126.5 (s, Cnaphthyl), 125.3 (s, Cnaphthyl), 125.3 (s, Cnaphthyl), 125.0 (s, C4), 109.3 (s, 
C7), 105.7 (s, Ccymene), 103.7, (s, Ccymene), 87.2 (s, Ccymene), 86.4 (s, Ccymene), 83.0 (s, Ccymene), 
82.9 (s, Ccymene), 30.4 (s, Ccymene), 21.8 (s, Ccymene), 21.5 (s, Ccymene), 18.5 (s, Ccymene). 31P NMR 
(242.9 MHz, DMSO-d6, 20 °C): δ -144.18 (h; JPF = 711.1 Hz, PF6). 
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[2-Amino-6-(1-naphthyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)]tetrafluoroborate 36c-BPh4. The synthesis of 36c-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 250.5 
mg (94%, dark tangerine solid). Anal. calcd for C53H48BClN4Ru: C, 71.66; H, 5.45; N, 6.31. 
Found: C, 71.61; H, 5.8; N, 6.40. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.52 (d, JHH = 
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5.28 Hz, 1H, H1), 8.74 (d, JHH = 7.92 Hz, 1H, H4), 8.33-8.31 (m, 1H, Hnaphthyl), 8.29-8.26 (m, 
1H, H3), 8.21 (s, 1H, H7), 8.18 (d, JHH = 8.22 Hz, 1H, Hnaphthyl), 8.10-8.08 (m, 1H, Hnaphthyl), 
7.91 (d, JHH = 7.04 Hz, 1H, Hnaphthyl), 7.87-7.85 (m, 1H, H2), 7.71 (t, JHH = 7.33 Hz, 1H, 
Hnaphthyl), 7.65-7.63 (m, 2H, Hnaphthyl), 7.20-7.17 (m, 8H, HPh), 6.94-6.91 (m, 8H, HPh), 6.80-
6.78 (m, 4H, HPh), 6.32 (d, JHH = 6.46 Hz, 1H, Hcymene), 6.09-6.07 (m, 3H, Hcymene), 2.59-2.54 
(m, 1H, Hcymene), 2.28 (s, 3H, Hcymene), 1.03 (d, JHH = 7.04 Hz, 3H, Hcymene), 0.94 (d, JHH = 7.04 
Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 169.6 (s, C8), 164.1 (s, C9), 
163.9-162.9 (q, CPh), 161.5 (s, C6), 156.1 (s, C1), 154.0 (s, C5), 140.0 (s, C3), 135.5 (s, CPh), 
134.0 (s, Cnaphthyl), 133.4 (s, Cnaphthyl), 131.2 (s, Cnaphthyl), 129.8 (s, Cnaphthyl), 128.9 (s, Cnaphthyl), 
128.8 (s, Cnaphthyl), 128.7 (s, C2), 128.5 (s, Cnaphthyl), 127.4 (s, Cnaphthyl), 126.7 (s, Cnaphthyl), 126.5 
(s, Cnaphthyl), 125.3 (s, CPh), 125.0 (s, C4), 115.2 (s, C7), 109.3 (s, Ccymene), 103.7 (s, Ccymene), 
87.1 (s, Ccymene), 86.3 (s, Ccymene), 83.0 (s, Ccymene), 82.5 (s, Ccymene), 30.4 (s, Ccymene), 21.8 (s, 
Ccymene), 21.5 (s, Ccymene), 18.5 (s, Ccymene).  
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[2-Amino-6-(1-naphthyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)]chloride 36c-Cl. The synthesis of 36c-Cl was carried out as described in general 
synthesis. Yield: 170.5 mg (94%, dark tangerine solid). Anal. calcd for C29H28Cl2N4Ru + 0.5 
CH2Cl2: C, 53.83; H, 4.32; N, 8.65. Found: C, 54.61; H, 5.09; N, 8.97. 1H NMR (600.1 MHz, 
DMSO-d6, 20 °C): δ 9.58 (d, JHH = 5.28 Hz, 1H, H1), 8.81 (d, JHH = 7.92 Hz, 1H, H4), 8.34-
8.32 (m, 1H, Hnaphthyl), 8.30 (t, JHH = 7.63 Hz, 1H, H3), 8.24 (s, 1H, H7), 8.18 (d, JHH = 8.21 
Hz, 1H, Hnaphthyl), 8.10-8.08 (m, 1H, Hnaphthyl), 7.93 (d, JHH = 6.45 Hz, 1H, Hnaphthyl), 7.87 (t, JHH 
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= 6.46 Hz, 1H, H2), 7.71 (t, JHH = 7.63 Hz, 1H, Hnaphthyl), 7.65-7.63 (m, 2H, Hnaphthyl), 6.34 (d, 
JHH = 6.17 Hz, 1H, Hcymene), 6.14-6.11 (m, 3H, Hcymene), 2.51-2.49 (m, 1H, Hcymene), 2.28 (s, 
3H, Hcymene), 1.02(d, JHH = 6.75 Hz, 3H, Hcymene), 0.94 (d, JHH = 6.75 Hz, 3H, Hcymene). 13C 
NMR (150.9 MHz, DMSO-d6, 20 °C): δ 169.6 (s, C8), 164.1 (s, C9), 161.5 (s, C6), 156.2 (s, 
C1), 154.0 (s, C5), 140.0 (s, C3), 134.0 (s, Cnaphthyl), 133.4 (s, Cnaphthyl), 131.2 (s, Cnaphthyl), 
129.8 (s, Cnaphthyl), 128.9 (s, Cnaphthyl), 128.7 (s, C2), 128.6 (s, Cnaphthyl), 127.4 (s, Cnaphthyl), 126.5 
(s, Cnaphthyl), 125.3 (s, Cnaphthyl), 125.0 (s, C4), 109.2 (s, C7), 105.7 (s, Ccymene), 103.6 (s, 
Ccymene), 87.2 (s, Ccymene), 86.3 (s, Ccymene), 83.0 (s, Ccymene), 82.5 (s, Ccymene), 30.4 (s, Ccymene), 
21.8 (s, Ccymene), 21.5 (s, Ccymene), 18.5 (s, Ccymene).  
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[2-Amino-6-(3-methoxyphenyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)]tetrafluoroborate 36d-BPh4. The synthesis of 36d-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 242.3 
mg (93%, yellow solid). Anal. calcd for C50H48BClN4Ru: C, 69.16; H, 5.57; N, 6.45. Found: C, 
68.68; H, 6.51; N, 6.58. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.50 (d, JHH = 5.29 Hz, 
1H, H1), 8.88 (d, JHH = 7.92 Hz, 1H, H4), 8.39-8.38 (m, 3H, H7 & H11), 8.33-8.30 (m, 1H, 
H3), 7.85-7.83 (m, 1H, H2), 7.18-7.17 (m, 10H, HPh & H12), 6.93-6.91 (m, 8H, HPh), 6.80-6.78 
(m, 4H, HPh), 6.25 (d, JHH = 6.17 Hz, 1H, Hcymene), 6.06-6.02 (m, 3H, Hcymene), 3.88 (s, 3H, 
H14), 2.48-2.46 (m, 1H, Hcymene), 2.23 (s, 3H, Hcymene), 0.96 (d, JHH = 6.75 Hz, 3H, Hcymene), 
0.86 (d, JHH = 7.04 Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 165.8 (s, C9), 
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164.0 (s, C8), 163.9-162.9 (q, CPh), 163.0 (s, C6), 161.3 (s, C13), 156.0 (s, C1), 154.3 (s, C5), 
139.9 (s, C3), 135.5 (s, CPh), 129.8 (s, C12), 128.6 (s, C10), 126.8 (s, C2), 125.3 (s, CPh), 125.0 
(s, C4), 114.4 (s, C11), 104.0 (s, Ccymene & C7), 103.4 (s, Ccymene), 87.1 (s, Ccymene), 86.2 (s, 
Ccymene), 82.8 (s, Ccymene), 82.2 (s, Ccymene), 30.4 (s, Ccymene), 21.7 (s, Ccymene), 21.5 (s, Ccymene), 
18.4 (s, Ccymene). 
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[2-Amino-6-(3-buthoxyphenyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthe-
nium(II)]tetrafluoroborate 36e-BPh4. The synthesis of 36e-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 224 mg 
(82%, fulvous solid). Anal. calcd for C53H54BClN4Ru: C, 69.93; H, 5.98; N, 6.15. Found: C, 
68.33; H, 6.03; N, 6.03. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.48 (d, JHH = 4.69 Hz, 
1H, H1), 8.86 (d, JHH = 7.63 Hz, 1H, H4), 8.37-8.36 (m, 3H, H7 & H11), 8.31-8.29 (m, 1H, 
H3), 7.84-7.82 (m, 1H, H2), 7.18-7.14 (m, 10H, HPh & H12), 6.93-6.91 (m, 8H, HPh), 6.80-6.78 
(m, 4H, HPh), 6.24 (d, JHH = 5.57 Hz, 1H, Hcymene), 6.02-6.01 (m, 3H, Hcymene), 4.10 (t, JHH = 
5.87 Hz, 2H, H14), 2.48-2.46 (m, 1H, Hcymene), 2.23 (s, 3H, Hcymene), 1.75-1.73 (m, 2H, H15), 
1.48-1.44 (m, 2H, H16), 0.95-094 (m, 6H, Hcymene & H17), 0.85 (d, JHH = 6.46 Hz, 3H, 
Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 165.9 (s, C9), 164.1 (s, C8), 163.9-162.9 
(q, CPh), 162.5 (s, C6), 161.4 (s, C13), 156.0 (s, C1), 154.4 (s, C5), 140.0 (s, C3), 135.6 (s, 
CPh), 129.9 (s, C11), 128.7 (s, C2), 126.6 (s, C4), 125.4 (s, CPh), 125.4 (s, C10), 121.6 (s, CPh), 
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114.9 (s, C12), 105.7 (s, Ccymene), 104.0 (s, C7), 103.5 (s, Ccymene), 87.1 (s, Ccymene), 86.2 (s, 
Ccymene), 82.9 (s, Ccymene), 82.3 (s, Ccymene), 67.7 (s, C14), 30.7 (s, C15), 30.4 (s, Ccymene), 21.7 
(s, Ccymene), 21.6 (s, Ccymene), 18.8 (s, C16), 18.5 (s, Ccymene), 13.8 (s, C17).  
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[2-Amino-6-(tbutyl)-4-(pyridin-2-yl)pyrimidine)(chlorido)(η6-p-cymene)ruthenium(II)]-
tetrafluoroborate 36f-BPh4. The synthesis of 36f-BPh4 was carried out as described in 
general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and 
before concentrating the excess and formed salts were filtered off. Yield: 220.9 mg (90%, 
yellow solid). Anal. calcd for C47H50BClN4Ru: C, 68.99; H, 6.16; N, 6.85. Found: C, 66.58; H, 
6.86; N, 6.33. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.45 (d, JHH = 5.29 Hz, 1H, H1), 
8.75 (d, JHH = 7.92 Hz, 1H, H4), 8.27-8.25 (m, 1H, H3), 7.86 (s, 1H, H7), 7.83-7.80 (m, 1H, 
H2), 7.18-7.17 (m, 10H, HPh & H12), 6.93-6.91 (m, 8H, HPh), 6.80-6.78 (m, 4H, HPh), 6.21 (d, 
JHH = 6.46 Hz, 1H, Hcymene), 6.00-5.98 (m, 3H, Hcymene), 2.45-2.41 (m, 1H, Hcymene), 2.21 (s, 
3H, Hcymene), 1.36 (s, 9H, H11), 0.92 (d, JHH = 6.75 Hz, 3H, Hcymene), 0.85 (d, JHH = 7.04 Hz, 
3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 182.0 (s, C8), 163.9 (s, C9), 163.9-
162.9 (q, CPh), 160.9 (s, C6), 156.0 (s, C1), 154.2 (s, C5), 139.9 (s, C3), 135.6 (s, CPh), 129.0 
(s, C2), 125.2 (s, CPh), 124.9 (s, C4), 121.6 (s, CPh), 105.5 (s, Ccymene), 105.0 (s, C7), 103.4 (s, 
Ccymene), 87.0 (s, Ccymene), 86.1 (s, Ccymene), 82.9 (s, Ccymene), 82.4 (s, Ccymene), 38.0 (s, C10), 30.4 
(s, Ccymene), 28.9 (s, C11), 21.7 (s, Ccymene), 21.4 (s, Ccymene), 18.4 (s, Ccymene). 
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[4-(Pyridin-2-yl)-2-(pyrrolidin-1-yl)pyrimidine(chlorido)(η6-p-cymene)ruthenium(II)]-
tetrafluoroborate 36g-BPh4. The synthesis of 36g-BPh4 was carried out as described in 
general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and 
before concentrating the excess and formed salts were filtered off. Yield: 220.4 mg (90%, 
brown solid). Anal. calcd for C47H48BClN4Ru: C, 69.16; H, 5.93; N, 6.86. Found: C, 68.78; H, 
5.67; N, 6.74. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.24 (d, JHH = 4.99 Hz, 1H, H1), 
8.68 (d, JHH = 4.69 Hz, 1H, H8), 8.41 (d, JHH = 7.92 Hz, 1H, H4), 8.23-8.20 (m, 1H, H3), 7.82-
7.79 (m, 1H, H2), 7.69 (d, JHH = 4.69 Hz, 1H, H7), 7.19-7.17 (m, 8H, HPh ), 6.93-6.91 (m, 8H, 
HPh), 6.80-6.77 (m, 4H, HPh), 5.91 (d, JHH = 6.16 Hz, 1H, Hcymene), 5.77-5.73 (m, 3H, Hcymene), 
4.00-3.63 (4s br., 4H, H10 & H13), 2.37-2.33 (m, 1H, Hcymene), 2.08-1.95 (m br., 6H, Hcymene, 
H11 & H12), 1.71 (s br., 1H, H12), 1.06 (d, JHH = 7.04 Hz, 3H, Hcymene), 0.85 (d, JHH = 6.75 Hz, 
3H, Hcymene). 13C NMR (151 MHz, DMSO d6) δ 165.8 (s, C8), 163.9-162.9 (m, Cph), 163.0 (s, 
C6), 158.5 (s, C9), 156.0 (s, C1), 153.9 (s, C5), 140.1 (s, C3), 135.6 (s, Cph), 128.3 (s, C2), 
125.4 (s, Cph), 124.3 (s, C4), 121.6 (s, Cph), 109.0 (s, C7), 104.5 (s, Ccymene), 100.3 (s, Ccymene), 
85.4 (s, Ccymene), 84.5 (s, Ccymene), 84.4 (s, Ccymene), 83.4 (s, Ccymene), 51.5 (s, C10), 49.6 (s, 
C13), 46.4 (s, C11), 30.4 (s, Ccymene), 24.1 (s, C12), 22.0 (s, Ccymene), 21.1 (s, Ccymene), 17.5 (s, 
Ccymene). 
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[4-tert-Butyl-N,N-dimethyl-6-(pyridin-2-yl)pyrimidi-2-amine(chlorido)(η6-p-cymene)-
ruthenium(II)]tetrafluoroborate 36h-BPh4. The synthesis of 36h-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 233.6 
mg (92%, dark green solid). Anal. calcd for C49H54BClN4Ru + DMSO(d6): C, 65.77; H, 7.09; 
N, 6.02. Found: C, 65.42; H, 6.38; N, 6.04. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.29 (d, 
JHH = 5.28 Hz, 1H, H1), 8.59 (d, JHH = 8.22 Hz, 1H, H4), 8.24-8.21 (m, 1H, H3), 7.83 (s, 1H, 
H7), 7.83-7.79 (m, 1H, H2), 7.18-7.17 (m, 8H, HPh), 6.93-6.91 (m, 8H, HPh), 6.80-6.77 (m, 4H, 
HPh), 5.93 (d, JHH = 6.16 Hz, 1H, Hcymene), 5.83-5.77 (m, 2H, Hcymene), 5.78 (d, JHH = 6.16 Hz, 
1H, H
 cymene), 3.42 (s br., H12 & water), 2.32-2.27 (m, 1H, Hcymene), 2.13 (s, 3H, Hcymene), 1.37 
(s, 9H, H11), 0.96 (d, JHH = 7.04 Hz, 3H, Hcymene), 0.79 (d, JHH = 6.75 Hz, 3H, Hcymene). 13C 
NMR (150.9 MHz, DMSO-d6, 20 °C): δ 178.9 (s, C8), 167.4 (s, C9), 163.9-162.9 (q, CPh), 
163.6 (s, C6), 155.9 (s, C1), 154.3 (s, C5), 140.0 (s, C3), 135.6 (s, CPh), 128.2 (s, C2), 125.4 (s, 
CPh), 124.5 (s, C4), 121.6 (s, CPh), 106.8 (s, C7), 103.5 (s, Ccymene), 101.5 (s, Ccymene), 85.8 (s, 
Ccymene), 85.0 (s, Ccymene), 83.6 (s, Ccymene), 83.3 (s, Ccymene), 38.1 (s, C10), 30.4 (s, Ccymene), 28.7 
(s, C11), 21.8 (s, Ccymene), 21.1 (s, Ccymene), 17.8 (s, Ccymene). 
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[4-(4-Methoxyphenyl)-6-(pyridin-2-yl)-2-(pyrrolidin-1-yl)pyrimidine(chlorido)(η6-p-cym-
ene)ruthenium(II)]tetrafluoroborate 36i-BPh4. The synthesis of 36i-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 243.5 
mg (88%, ginger solid). Anal. calcd for C54H54BClN4ORu: C, 70.32; H, 5.90; N, 6.07. Found: 
C, 69.50; H, 5.88; N, 6.02. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.24 (d, JHH = 5.29 Hz, 
1H, H1), 8.65 (d, JHH = 8.22 Hz, 1H, H4), 8.40(d, JHH = 8.8 Hz, 1H, H11), 8.31 (s, 1H, H7), 
8.27-8.24 (m, 1H, H3), 7.82-7.80 (m, 1H, H2), 7.21-7.18 (m, 8H, HPh), 7.17 (d, JHH = 8.8 Hz, 
1H, H12), 6.94-6.92 (m, 8H, HPh), 6.81-6.78 (m, 4H, HPh), 5.89 (d, JHH = 6.16 Hz, 1H, Hcymene), 
5.78 (d, JHH = 5.87 Hz, 1H, Hcymene), 5.75 (d, JHH = 6.16 Hz, 1H, Hcymene), 5.72 (d, JHH = 6.16 
Hz, 1H, Hcymene), 4.04-3.38 (m br., 7H, H14, H15 & H18), 2.44-2.39 (m, 1H, Hcymene), 2.24-
1.75 (m br., 4H, H16, H17), 2.02 (s, 3H, Hcymene), 1.05 (d, JHH = 6.74 Hz, 3H, Hcymene), 0.85 (d, 
JHH = 6.75 Hz, 3H, Hcymene). 13C NMR (150.9 MHz, DMSO-d6, 20 °C): δ 165.6 (s, C9), 163.9-
162.9 (m, CPh, C6, C8 & C13), 155.9 (s, C1), 154.3 (s, C5), 139.9 (s, C3), 135.6 (s, CPh), 129.9 
(s, C11), 128.0 (s, C10), 126.9 (s, C2), 125.3 (s, CPh), 121.5 (s, CPh), 124.3 (s, C4), 114.5 (s, 
C12), 104.8 (s, Ccymene), 104.5 (s, Ccymene), 99.9 (s, C7), 85.4 (s, Ccymene), 84.7 (s, Ccymene), 84.2 
(s, Ccymene), 83.2 (s, Ccymene), 30.4 (s, Ccymene), 21.9 (s, Ccymene), 21.0 (s, Ccymene), 17.4 (s, 
Ccymene). 
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[N,N-Dimethyl-4-(pyridine-2-yl)pyrimidine(chlorido)(η6-p-cymene)ruthenium(II)]tetra-
fluoroborate 36j-BPh4. The synthesis of 36j-BPh4 was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 222.84 mg (94%, dark green 
solid). Anal. calcd for C45H46BClN4Ru: C, 68.40; H, 5.87; N, 7.09. Found: C, 67.30; H, 5.89; 
N, 7.21. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 9.33 (d, JHH = 5.29 Hz, 1H, H1), 8.74 (d, 
JHH = 4.69 Hz, 1H, H8), 8.47 (d, JHH = 7.93 Hz, 1H, H4), 8.26-8.23 (m, 1H, H3), 7.84-7.82 (m, 
1H, H2), 7.79 (d, JHH = 4.69 Hz, 1H, H7), 7.19-7.17 (m, 10H, HPh), 6.93-6.91 (m, 10H, HPh), 
6.80-6.78 (m, 5H, HPh), 6.00 (d, JHH = 5.87 Hz, 1H, Hcymene), 5.89 (d, JHH = 5.87 Hz, 1H, 
Hcymene), 5.82 (d, JHH = 5.87 Hz, 1H, Hcymene), 5.78 (d, JHH = 5.87 Hz, 1H, Hcymene), 3.52 (s br., 
3H, H10), 3.26 (s br., 3H, H11), 2.35-2.33 (m, 1H, Hcymene), 2.13 (s, 3H, Hcymene), 0.98 (d, JHH 
= 6.75 Hz, 3H, Hcymene), 0.82 (d, JHH = 6.75 Hz, 3H, Hcymene). 13C NMR (151 MHz, DMSO d6) 
δ 168.8 (s, C9), 168.0 (s, C8), 163.2 (s, C6), 163.6-162.6 (q, CPh), 155.5 (s, C1), 153.6 (s, C5), 
139.6 (s, C3), 135.2 (s, Cph), 127.8 (s, C2), 124.7 (s; Cph), 124.1 (s, C4), 120.9 (s, Cph), 109.5 
(s, C7), 104.5 (s, Ccymene), 101.9 (s, Ccymene), 84.7 (s, Ccymene), 84.5 (s, Ccymene), 84.0 (s, Ccymene), 
82.9 (s, Ccymene), 36.2 (s, C10), 29.9 (s, Ccymene), 21.2 (s, Ccymene), 20.7 (s, Ccymene), 17.3 (s, 
Ccymene). 
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[4-(2-Pyridinyl)-2-(1-piperidinyl)-pyrimidin(chlorido)(η6-p-cymene)ruthenium(II)]tetra-
fluoroborate 36k-BPh4. The synthesis of 36k-BPh4 was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 300.0 mg (72%, green 
solid). Anal. calcd forC48H50BClN4Ru: C, 69.44; H, 6.07; N, 6.75. Found: C, 68.83; H, 6.21; N, 
6.65. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.32 (d, JHH = 5.44 Hz, 1H, H1), 8.75 (d, JHH 
= 4.68 Hz, 1H, H8), 8.47 (d, JHH = 8.20 Hz, 1H, H4), 8.24 (t, JHH = 7.82 Hz, 1H, H3), 7.82 (t, 
JHH = 6.46 Hz, 1H, H2), 7.77 (d, JHH = 4.72 Hz, 1H, H7), 7.19 (m, 8H, BPh4-), 6.92 (t, JHH = 
7.24 Hz, 8H, BPh4-), 6.79 (t, JHH = 7.04 Hz, 4H, BPh4-), 5.98 (d, JHH = 5.88 Hz, 1H, Hcymene), 
5.88 (d, JHH = 5.92 Hz, 1H, Hcymene), 5.79-5.75 (m, 2H, Hcymene), 3.78 (t, JHH = 8.22 Hz, 4H, 
Hpiperdinyl), 2.32-2.39 (m, 1H, Hcymene), 2.14 (s, 3H, Hcymene), 1.66 (m, 6H, Hpiperdinyl), 0.97 (d, 
JHH = 7.04 Hz, 3H, Hcymene), 0.82 (d, JHH = 6.68 Hz, 3H, Hcymene). 13C NMR (100.6 MHz, 
DMSO d6, 20 °C): δ 164.1-162.6 (m, BPh4-), 162.5 (s, C9), 161.3 (s, C8), 159.0 (s, C6), 153.9 
(s, C5), 149.4 (s, C1), 140.0 (s, Ccymene), 137.4 (s, C3), 135.5 (s, Ccymene & BPh4-), 128.4 (s, 
Ccymene), 125.3-125.2 (m, BPh4-), 124.7 (s, C2), 121.5 (s, Ccymene & BPh4-), 120.9 (s, C4), 105.0 
(s, C7), 64.9 (s, Cpiperdinyl), 44.2 (s, Cpiperdinyl), 30.4 (s, Ccymene), 25.3 (s, Cpiperdinyl), 21.8 (s, 
Ccymene), 21.1 (s, Ccymene), 17.9 (s, Ccymene). 
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[N-1-Propyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthenium(II)]tetra-
fluoroborate 36l-BPh4. The synthesis of 36l-BPh4 was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 380.0 mg (85%, brown 
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solid). Anal. calcd for C46H48BClN4Ru: C, 68.70; H, 6.02; N, 6.97. Found: C, 68.17; H, 5.89; 
N, 7.04. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.48 (s br., 1H, H1), 8.77 (S br., 1H, H8), 
8.63 (d, JHH = 6.8 Hz 1H, H4), 8.29 (s br., 1H, H3), 7.83 (s br., 1H, H2), 7.81 (s br., 1H, H7), 
7.18 (s br., 8H, BPh4-), 6.92 (s br., 8H, BPh4-), 6.79 (s br., 5H, BPh4-, NH), 6.15 (s, 1H, 
Hcymene), 6.05-6.01 (m, 3H, Hcymene), 3.57 (s br., 2H, Hpropyl), 2.43 (s br., 1H, Hcymene), 2.21 (s, 
3H, Hcymene), 1.70 (s br., 2H, Hpropyl), 0.97-0.86 (m, 9H, Hcymene & Hpropyl). 13C NMR (100.6 
MHz, DMSO d6, 20 °C): δ 164.1-162.6 (m, BPh4-), 162.5 (s, C9), 161.5 (s, C8), 161.0 (s, C6), 
156.1 (s, C5), 153.8 (s, C1), 140.1 (s, Ccymene), 135.5 (s br., C3, Ccymene & BPh4-), 129.0 (s, 
Ccymene), 125.3-125.3 (s br., BPh4-), 125.2 (s, C2), 121.5 (s br., Ccymene & BPh4-), 121.2 (s, C4), 
105.2 (s, C7), 43.7 (s, CPropyl), 30.3 (s, Ccymene), 21.9 (s, CPropyl), 21.6 (s, Ccymene), 21,5 (s, 
Ccymene), 18.3 (s, Ccymene), 11.2 (s, CPropyl). 
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[N-1-Butyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthenium(II)]tetra-
fluoroborate 36m-BPh4. The synthesis of 36m-BPh4 was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 250.0 mg (61%, brown 
solid). Anal. calcd forC47H50BClN4Ru: C, 68.99; H, 6.16; N, 6.85. Found: C, 68.92; H, 6.23; N, 
6.68. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.48 (d, JHH = 5.08 Hz, 1H, H1), 8.76 (d, JHH 
= 4.68 Hz, 1H, H8), 8.59 (d, JHH = 8.24 Hz, 1H, H4), 8.27 (t, JHH = 7.82 Hz, 1H, H3), 7.84 (t, 
JHH = 6.46 Hz, 1H, H2), 7.78 (d, JHH = 4.72 Hz, 1H, H7), 7.20 (s br., 8H, BPh4-), 6.93 (t, JHH = 
7.24 Hz, 8H, BPh4-), 6.78-6.81 (m, 5H, NH & BPh4-), 6.14 (d, JHH = 6.24 Hz, 1H, Hcymene), 6.03 
(s br., 2H, Hcymene), 5.99 (d, JHH = 6.28 Hz, 1H, Hcymene), 3.62 (t, JHH = 6.64 Hz, 2H, Hbutyl), 
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2.47-2.40 (m, 1H, Hcymene), 2.21 (s, 3H, Hcymene), 1.68-1.66 (m, 2H, Hbutyl), 1.43-1.38 (m, 2H, 
Hbutyl), 0.97 (t, JHH = 7.42 Hz, 3H, Hbutyl), 0.93 (d, JHH = 8.04 Hz, 3H, Hcymene), 0.86 (d, JHH = 
7.04 Hz, 3H, Hcymene). 13C NMR (100.6 MHz, DMSO d6, 20 °C): δ 164.1-162.6 (m, BPh4-), 
162.5 (s, C9), 161.5 (s, C8), 161.0 (s, C6), 156.1 (s, C5), 153.8 (s, C1), 140.1 (s, Ccymene), 135.5 
(s, C3, Ccymene & BPh4-), 128.9 (s, Ccymene), 125.1 (m, C2 & BPh4-), 121.5 (s, C4, Ccymene & 
BPh4-), 105.0 (s, C7), 41.7 (s, Cbutyl), 30.7 (s, Cbutyl), 30.3 (s, Ccymene), 21.6 (s, Ccymene), 21.5 (s, 
Ccymene), 19.6 (s, Cbutyl), 18.3 (s, Ccymene), 13.7 (s, Cbutyl). 
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[N-1-Octyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthenium(II)]tetra-
fluoroborate 36n-BPh4. The synthesis of 36n-BPh4was carried out as described in general 
synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and before 
concentrating the excess and formed salts were filtered off. Yield: 370.0 mg (85%, brown 
solid). Anal. calcd forC51H58BClN4Ru: C, 70.06; H, 6.69; N, 6.41. Found: C, 69.79; H, 6.77; N, 
6.42. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.48 (d, JHH = 5.08 Hz, 1H, H1), 8.76 (d, JHH 
= 4.68 Hz, 1H, H8), 8.60 (d, JHH = 8.24 Hz, 1H, H4), 8.28 (t, JHH = 7.64 Hz, 1H, H3), 7.85 (t, 
JHH = 6.44 Hz, 1H, H2), 7.79 (d, JHH = 5.08 Hz, 1H, H7), 7.19 (d, 8H, BPh4-), 6.93 (t, JHH = 
7.24 Hz, 8H, BPh4-), 6.81-6.77 (m, 5H, NH & BPh4-), 6.14 (d, JHH = 5.88 Hz, 1H, Hcymene), 6.03 
(s br., 2H, Hcymene), 5.99 (d, JHH = 6.24 Hz, 1H, Hcymene), 2.45-2.41 (m, 1H, Hcymene), 2.21 (s, 
3H, Hcymene), 1.68 (s br., 2H, Hoctyl), 1.35-1.28 (m, 12H, Hoctyl), 0.93 (d, JHH = 6.68 Hz, 3H, 
Hcymene), 0.87-0.85 (m, 6H, Hcymene, Hoctyl). 13C NMR (100.6 MHz, DMSO d6, 20 °C): δ 164.1-
162.6 (m, BPh4-), 162.1 (s, C9), 161.5 (s, C8), 161.0 (s, C6), 156.1 (s, C5), 153.8 (s, C1), 140.1 
(s, Ccymene), 135.5 (s, C3, Ccymene & BPh4-), 128.9 (s, Ccymene), 125.3-125.3 (m, BPh4-), 125.2 (s, 
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C2), 121.5 (s, C4, Ccymene & BPh4-), 105.1 (s, C7), 42.0 (s, Coctyl), 31.2 (s, Coctyl), 30.3 (s, Coctyl 
& Ccymene), 28.7 (s, Coctyl), 28.6 (s, Coctyl), 26.3 (s, Coctyl), 22.1 (s, Coctyl), 21.6 (s, Ccymene), 21.5 
(s, Ccymene), 18.3 (s, Ccymene), 14.0 (s, Coctyl).  
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[N-(S)-(+)-1-Phenylethyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthe-
nium(II)]tetrafluoroborate 36o-BPh4. The synthesis of 36o-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 0.34 g 
(0.39 mmol, 78%, green solid). Anal. calcd for C51H50BClN4Ru: C, 70.71; H, 5.82; N, 6.47. 
Found: C, 70.71; H, 5.82; N, 6.53. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.54 (d, JHH = 
5.2 Hz, 1H, H1), 9.49 (d, JHH = 5.2 Hz, 1H, H1'), 8.83 (d, JHH = 4.8 Hz, 1H, H8), 8.70 (d, JHH = 
4.8 Hz, 1H, H8'), 8.65 (t, JHH = 7.7 Hz, 2H, H4 & H4'), 8.32 (t, JHH = 7.8 Hz, 2H, H3 & H3'), 
7.90-7.85 (m, 3H, H2 & HPh), 7.83 (d, JHH = 4.9 Hz, 1H, H2'), 7.67 (d, JHH = 7.4 Hz, 2H, 
Hphenyl), 7.53-7.22 (m, 8H, H7, H7', HPh & HPh'), 7.20 (s br., 16H, BPh4- & BPh4-'), 6.92 (t, JHH 
= 7.3 Hz, 16H, BPh4- & BPh4-'), 6.85 (d, JHH = 8.7 Hz, 1H, NH), 6.78 (t, JHH = 7.1 Hz, 8H, 
BPh4- & BPh4-'), 6.64 (d, JHH = 7.2 Hz, 1H, NH'), 6.33 (d, JHH = 6.0 Hz, 1H, Hcymene), 6.15 (d, 
JHH = 6.0 Hz, 1H, Hcymene'), 6.08 (d, JHH = 6.0 Hz, 1H, Hcymene), 5.96 (d, JHH = 6.0 Hz, 1H, 
Hcymene'), 5.86 (t, JHH = 6.3 Hz, 2H, Hcymene & Hcymene'), 5.79 (d, JHH = 6.0 Hz, 1H, Hcymene), 5.53 
(d, JHH = 6.0 Hz, 1H Hcymene'), 5.46-5.23 (m, 2H, C10 & C10'), 2.49-2.45 (m, 1H, Hcymene), 
2.30-2.20 (m, 4H, Hcymene' & Hcymene), 2.07 (s, 3H, Hcymene'), 1.78 (d, J HH= 6.9 Hz, 3H, H11), 
1.63 (d, JHH = 6.8 Hz, 3H, H11'), 0.96 (d, JHH = 6.8 Hz, 3H, Hcymene), 0.89 (d, JHH = 6.9 Hz, 3H, 
Hcymene'), 0.79 (dd, JHH = 6.7, 2.6 Hz, 6H, Hcymene & Hcymene'). 13C NMR (100.6 MHz, DMSO 
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d6, 20 °C): δ 164.1, 163.6 (s, C9 & C9'), 163.1, 162.6 (s, C8 & C8'), 161.6, 161.4 (s, C6 & 
C6'), 161.3 (dd, JHH = 36.2, 12.6 Hz, BPh4- & BPh4-'), 156.3 (s, C5 & C5'), 153.7 (s, C1 & C1'), 
143.4, 142.3 (s, Cphenylethyl & Cphenylethyl'), 140.2 (s br., Ccymene & Ccymene'), 135.53 (s br., C3, C3', 
Ccymene, Ccymene', BPh4- & BPh4-'), 129.1 (s br., Ccymene & Ccymene'), 129.0, 128.9 (s, Cphenyl & 
Cphenyl'), 128.4, 128.0 (s, Cphenyl & Cphenyl'), 127.0, 126.6 (s, Cphenyl & C phenyl'), 126.6, 125.6 (s, 
C2 & C2'), 125.3 (dd, JHH = 5.3, 2.6 Hz, BPh4- & BPh4-'), 121.5 (m, C4 & C4'), 108.5, 108.3 (s, 
C7 & C7'), 104.9-104.1 (m, Ccymene, Ccymene', BPh4- & BPh4-'), 87.1, 86.6, 85.6, 84.6, 84.1, 83.7, 
83.6 (s, Ccymene & Ccymene'), 51.8, 51.6 (s, C10 & C10'), 30.4, 30.2 (s, Ccymene & Ccymene'), 22.9, 
21.6 (s, C11 & C11'), 21.6, 21.1 (s, Ccymene & Ccymene'), 21.4, 20.6 (s, Ccymene & Ccymene'), 18.3, 
18.0 (s, Ccymene & Ccymene').  
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[N-(R)-(+)-1-Phenylethyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthe-
nium(II)]tetrafluoroborate 36p-BPh4. The synthesis of 36p-BPh4 was carried out as 
described in general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the 
solution and before concentrating the excess and formed salts were filtered off. Yield: 320.0 
mg (74%, green solid). Anal. calcd forC51H50BClN4Ru: C, 70.71; H, 5.82; N, 6.47. Found: C, 
68.65; H, 6.01; N, 6.24. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.53, (d, JHH = 5.3 Hz, 1H, 
H1), 9.48 (d, JHH = 5.3 Hz, 1H, H1'), 8.81 (d, JHH = 4.9 Hz, 1H, H8), 8.68 (d, JHH = 4.8 Hz, 1H, 
H8'), 8.62 (t, JHH = 7.8 Hz, 2H, H4 & H4'), 8.29 (t, JHH = 7.8 Hz, 2H, H3 & H3'), 7.91-7.83 (m, 
4H, H2 & HPh), 7.81 (d, JHH = 4.9 Hz, 1H, H2'), 7.67 (d, JHH = 7.4 Hz, 2H, HPh), 7.53-7.22 (m, 
8H, H7, H7' , HPh & HPh'), 7.18 (s br., 16H, BPh4- & BPh4-'), 6.92 (t, JHH = 7.3 Hz, 16H, BPh4- 
& BPh4-'), 6.85 (d, JHH = 8.7 Hz, 1H, NH), 6.79 (t, JHH = 7.1 Hz, 8H, BPh4- & BPh4-'), 6.64 (d, 
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JHH = 7.3 Hz, 1H, NH), 6.31 (d, JHH = 6.1 Hz, 1H, HCymene), 6.13 (d, JHH = 6.1 Hz, 1H, 
HCymene), 6.06 (d, JHH = 6.1 Hz, 1H, HCymene), 5.94 (d, JHH = 6.1 Hz, 1H, HCymene), 5.84 (t, JHH = 
7.2 Hz, 2H, HCymene), 5.77 (d, JHH = 6.1 Hz, 1H, HCymene), 5.51 (d, JHH = 6.0 Hz, 1H, HCymene), 
5.45-5.24 (m, 2H, H10 & H10'), 2.45 (m, 1H, HCymene), 2.27-2.19 (m, 4H, HCymene), 2.07 (d, JHH 
= 8.7 Hz, 3H, HCymene), 1.78 (d, JHH = 6.9 Hz, 3H, H11), 1.63 (d, JHH = 6.8 Hz, 3H, H11'), 0.95 
(d, JHH = 6.9 Hz, 3H, HCymene), 0.90 (t, JHH = 8.2 Hz, 3H, HCymene), 0.78 (dd, JHH = 6.8, 2.8 Hz, 
6H, HCymene). 13C NMR (100.6 MHz, DMSO d6, 20 °C): δ 161.4 (dd, JHH = 35.9, 15.8 Hz, 
BPh4- & BPh4-'), 164.1, 163.6 (s, C9 & C9'), 163.2, 162.7 (s, C8 & C8'), 161.6, 161.5 (s, C6 & 
C6'), 156.3 (s, C5 & C5'), 153.7 (s, C1 & C1'), 143.5, 142.4 (s, Cphenylethyl & Cphenylethyl'), 140.3 
(s br., Ccymene & Ccymene'), 135.57 (s br., C3, C3', Ccymene, Ccymene', BPh4- & BPh4-'), 129.1 (s br., 
Ccymene & Ccymene'), 129.1, 128.5 (s, Cphenyl & Cphenyl'), 128.5, 128.0 (s, Cphenyl & C phenyl'), 127.0, 
126.7 (s, Cphenyl & C phenyl'), 126.7, 125.6 (s, C2 & C2'), 125.3 (dd, JHH = 5.4, 2.6 Hz, BPh4- & 
BPh4-'), 121.6 (m, C4, C4', Ccymene, Ccymene', BPh4- & BPh4-'), 108.6, 108.4 (s, C7 & C7'), 87.2, 
86.7, 85.6, 84.7, 84.1, 83.8, 83.7 (s, Ccymene & Ccymene'), 51.8, 51.6 (s, C10 & C 10’), 30.4, 30.2 
(s, Ccymene & Ccymene'), 22.9, 21.7 (s, C11 & C11'), 21.2 (s, Ccymene & Ccymene'), 21.5, 20.6 (s, 
Ccymene & Ccymene'), 18.3, 18.1 (s, Ccymene & Ccymene').  
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[N-Isopropyl-4-(2-pyridinyl)pyrimidin-2-amin(chlorido)(η6-p-cymene)ruthenium(II)]-
tetrafluoroborate 36q-BPh4. The synthesis of 36q-BPh4 was carried out as described in 
general synthesis but 154.0 mg of NaBPh4 salt (0.45 mmol) were also added to the solution and 
before concentrating the excess and formed salts were filtered off. Yield: 230.0 g (57%, brown 
solid). Anal. calcd for C46H48BClN4Ru: C, 68.70; H, 6.02; N, 6.97. Found: C, 68.50; H, 6.21; 
 Experimental 
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N, 7.13. 1H NMR (400.1 MHz, DMSO d6, 20 °C): δ 9.49 (d, JHH = 5.08 Hz, 1H, H1). 8.76 (d, 
JHH = 4.68 Hz, 1H, H8), 8.58 (d, JHH = 7.80 Hz, 1H, H4), 8.25 (t, JHH = 7.62 Hz, 1H, H3), 7.84 
(t, JHH = 6.26 Hz, 1H, H2), 7.79 (d, JHH = 4.68 Hz, 1H, H7), 7.23 (d, 8H, BPh4-), 6.95 (t, JHH = 
7.04 Hz, 8H, BPh4-), 6.81 (t, JHH = 6.84 Hz, 4H, BPh4-), 6.34 (s, 1H, NH), 6.15 (d, JHH = 5.88 
Hz, 1H, Hcymene), 6.04-5.99 (m, 2H, Hcymene), 5.79 (d, JHH = 5.88 Hz, 1H, Hcymene), 4.34-4.29 (m, 
1H, Hisopropyl), 2.46-2.39 (m, 1H, Hcymene), 2.20 (s, 3H, Hcymene), 1.49 (d, JHH = 6.24 Hz, 3H, 
Hisopropyl), 1.25 (d, JHH = 6.64 Hz, 3H, Hisopropyl), 0.93-0.88 (m, 6H, Hcymene). 13C NMR (100.6 
MHz, DMSO d6, 20 °C): δ 164.1-162.6 (m, BPh4-), 161.7 (s, C9), 161.4 (s, C8), 161.1 (s, C6), 
156.2 (s, C5), 153.8 (s, C1), 140.1 (s, Ccymene), 135.5 (s br., C3, Ccymene & BPh4-), 129.0 (s, 
Ccymene), 125.3 (s br., BPh4-), 125.2 (s, C2), 121.5 (s br., C4, Ccymene & BPh4-), 108.0 (s, C7), 
44.1 (s, Cisoropyl), 30.3 (s, Ccymene), 21.7 (s, Ccymene), 21.3 (s, Ccymene), 21.9 (s, Cisoropyl), 21.8 (s, 
Cisoropyl), 18.2 (s, Ccymene). 
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[4,4'-Bipyrimidine-2,2'-diamine(chlorido)(η6-p-cymene)ruthenium(II)]tetrafluoroborate 
37-BPh4. The synthesis of 37 was carried out as described in general synthesis but 154.0 mg of 
NaBPh4 salt (0.45 mmol) were also added to the solution and before concentrating the excess 
and formed salts were filtered off. Yield: 224.1 mg (96%, red solid). Anal. calcd for 
C42H42BClN6Ru + 0.25 CH2Cl2: C, 63.48; H, 5.36; N, 10.51. Found: C, 63.35; H, 5.30; N, 
10.38. 1H NMR (600.1 MHz, DMSO-d6, 20 °C): δ 8.74 (d, JHH = 4.7 Hz, 2H, H3), 7.77 (d, JHH 
= 4.7 Hz, 2H, H2), 7.17 (s br., 8H, HPh), 6.92 (t, JHH = 7.3 Hz 8H, HPh), 6.78 (t, JHH = 7.1 Hz, 
4H, HPh), 6.15 (d, JHH = 6.1 Hz, 2H, Hcymene), 6.02 (d, JHH = 6.1 Hz 2H, Hcymene), 2.31 (m, 1H, 
Hcymene), 2.24 (s, 3H, Hcymene), 0.87 (d, JHH = 6.8 Hz, 6H, Hcymene). 13C NMR (150.9 MHz, 
190 
 
DMSO-d6, 20 °C): δ 164.5 (s, C4), 163.9-162.9 (q, CPh), 162.0 (s, C3), 160.9 (s, C1), 135.6 (s, 
CPh), 125.4 (s, CPh), 121.6 (s, CPh), 109.4 (s, C2), 107.4 (s, Ccymene), 103.2 (s, Ccymene), 85.9 (s, 
Ccymene), 81.9 (s, Ccymene), 30.0 (s, Ccymene), 21.6 (s, Ccymene), 18.2 (s, Ccymene). 
5.4.2 Palladium Complexes 
5.4.2.1 Palladium Complexes with Bidendate Ligands 
  General synthesis of the Pd(NN)Cl2 type complexes. A solution of the ligand (0.5 
mmol) in CH2Cl2 (5 ml) was added dropwise to a solution of 191 mg of 
bis(benzonitrile)palladium(II) chloride (0.5 mmol) in CH2Cl2 (20 ml). After stirring for 20 h at 
room temperature the solution was concentrated and the product was precipitated by adding 
Et2O (10 ml). The product was filtered and washed with Et2O twice and dried under vacuum. 
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2-Amino-4-(pyridin-2-yl)pyrimidine(dichlorido)palladium(II) 39a. Yield: 78.0 mg (90%, 
yellow solid). Anal. calcd for C9H8Cl2N4Pd: C, 30.93; H, 2.31; N, 16.03. Found: C, 30.93; H, 
2.54; N, 15.82. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.21 (d, JHH = 5.87 Hz, 1H, H1), 
9.00 (s br., 1H, NH2), 8.70 (d, JHH = 4.89 Hz, 1H, H8), 8.56 (d, JHH = 8.32 Hz, 1H, H4), 8.36-
8.8.30 (m, 2H, H3
 
& NH2), 7.83 (t, JHH = 6.85 Hz, 1H, H2), 7.65 (d, JHH = 4.89 Hz, 1H, H7). 
13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 163.9 (s, C9), 162.5 (s, C6), 161.8 (s, C8), 152.3 
(s, C5), 150.0 (s, C1), 141.2 (s, C3), 127.9 (s, C4), 124.9 (s, C2), 107.2 (s, C7). 
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2-Amino-6-(1-phenyl)-4-(pyridin-2-yl)pyrimidine)(dichlorido)palladium(II) 39b. Yield: 
211.0 mg (99%, yellow solid). Anal. calcd for C15H12Cl2N4Pd: C, 42.33; H, 2.84; N, 13.16. 
Found: C, 42.93; H, 2.68; N, 12.72. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.22 (d, JHH = 
4.89 Hz, 1H, H1), 9.01 (s br., 1H, NH2), 8.88 (d, JHH = 8.32 Hz, 1H, H4), 8.40-8.32 (m, 4H, 
H3, NH2 & H11), 8.22 (s, 1H, H7), 7.84 (t, JHH = 6.36 Hz, 1H, H2), 7.66-7.58 (m, 3H, H12 & 
H13). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 166.8 (s, C8), 163.7 (s, C6), 163.4 (s, C9), 
157.0 (s, C5), 150.0 (s, C1), 141.1 (s, C3), 134.6 (s, C10), 132.6 (s, C13), 129.0 (s, C12), 127.9 
(s, C4 & C11), 125.2 (s, C2), 103.8 (s, C7). 
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2-Amino-6-(1-naphtyl)-4-(pyridin-2-yl)pyrimidine)(dichlorido)palladium(II) 39c. Yield: 
226.0 mg (95%, yellow solid). Anal. calcd for C19H14Cl2N4Pd: C, 47.98; H, 2.97; N, 11.78. 
Found: C, 44.96; H, 3.24; N, 11.35. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.25 (d, JHH = 
5.87 Hz, 1H, H1), 9.09 (s br., 1H, NH2), 8.73 (d, JHH = 7.82 Hz, 1H, H4), 8.47 (s br., 1H, NH2), 
8.36-8.28 (m, 2H, H3 & Hnaphthyl), 8.17 (d, JHH = 8.32 Hz, 1H, Hnaphthyl), 8.07-8.05 (m, 1H, 
Hnaphthyl), 8.01 (s, 1H, H7), 7.88 (d, JHH = 6.35 Hz, 1H, Hnaphthyl), 7.81 (t, JHH = 5.87 Hz, 1H, 
H2), 7.7-7.5 (m, 3H, Hnaphthyl). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 170.3 (s, C8), 
163.6 (s, C6), 162.9 (s, C9), 156.9 (s, C5), 150.0 (s, C1), 141.1 (s, C3), 134.2-125.2 (12s, C2, 
C4 & Cnaphthyl), 108.5 (s, C7). 
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2-Amino-6-(3-methoxyphenyl)-4-(pyridin-2-yl)pyrimidine)(dichlorido)palladium(II) 39d. 
Yield: 191.0 mg (84%, yellow solid). Anal. calcd for C16H14Cl2N4OPd: C, 42.18; H, 3.10; N, 
12.30. Found: C, 42.10; H, 3.54; N, 12.55. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.22 (d, 
JHH = 4.89 Hz, 1H, H1), 8.94 (s br., 1H, NH2), 8.87 (d, JHH = 7.82 Hz, 1H, H4), 8.39-8.32 (m, 
3H, H3 & H11), 8.22 (s br., 1H, NH2), 8.17 (s, 1H, H7), 7.82 (t, JHH = 6.36 Hz, 1H, H2), 7.16 
(d, JHH = 8.81 Hz, 2H, H12), 3.88 (s, 1H. H14). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 
166.0 (s, C13), 163.6, 163.0, 162.9 (3s, C9, C6 & C8), 157.1 (s, C5), 149.9 (s, C1), 141.0 (s, 
C3), 129.8 (s, C11), 127.7 (s, C4), 126.8 (s, C10), 124.9 (s, C2), 114.4 (s, C12), 103.1 (s, C7), 
55.6 (s, C14). 
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2-Amino-6-(3-buthoxyphenyl)-4-(pyridin-2-yl)pyrimidine)(dichlorido)palladium(II) 39e. 
Yield: 202.0 mg (81%, yellow solid). Anal. calcd for C19H20Cl2N4OPd: C, 45.85; H, 4.05; N, 
11.26. Found: C, 45.52; H, 4.27; N, 11.07. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.20 (d, 
JHH = 5.38 Hz, 1H, H1), 8.92 (s br., 1H, NH2), 8.85 (d, JHH = 7.82 Hz, 1H, H4), 8.35 (t, JHH = 
7.34 Hz, 1H, H3), 8.30 (d, JHH = 8.8 Hz, 1H, H11), 8.17 (s br., 1H, NH2), 8.12 (s, 1H, H7), 
7.80 (t, JHH = 6.36 Hz, 1H, H2), 7.11 (d, JHH = 8.8 Hz, 2H, H12), 4.09 (t, JHH = 6.36 Hz, 2H, 
H14), 1.77-1.72 (m, 2H, H15), 1.49-1.40 (m, 2H, H16), 0.95 (t, JHH = 7.34 Hz, 3H, H17). 13C 
NMR (100.6 MHz, DMSO-d6, 20 °C): δ 166.0 (s, C13), 163.6, 162.8, 162.5 (3s, C9, C6 & C8), 
157.1 (s, C5), 149.6 (s, C1), 141.0 (s, C3), 129.8 (s, C11), 127.6 (s, C4), 126.6 (s, C10), 124.9 
(s, C2), 114.8 (s, C12), 103.1 (s, C7), 67.6 (s, C14), 30.7 (s, C15), 18.7 (s, C16), 13.7 (s, C17). 
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2-Amino-6-(tbutyl)-4-(pyridin-2-yl)pyrimidine)(dichlorido)palladium(II) 39f. Yield: 170.0 
mg (84%, orange solid). Anal. calcd for C13H16Cl2N4OPd: C, 38.49; H, 3.98; N, 13.81. Found: 
C, 38.48; H, 4.09; N, 13.75. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 9.18 (d, JHH = 5.38 
Hz, 1H, H1), 8.89 (s br., 1H, NH2), 8.75 (d, JHH = 7.82 Hz, 1H, H4), 8.31 (t, JHH = 7.83 Hz, 
1H, H3), 8.16 (s br., 1H, NH2), 7.79 (t, JHH = 6.36 Hz, 1H, H2), 7.68 (s, 1H, H7), 1.32 (s, 9H, 
H11). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 182.3 (s, C8), 163.3 (s, C6), 162.3 (s, C9), 
156.9 (s, C5), 149.9 (s, C1), 141.0 (s, C3), 127.6 (s, C4), 124.9 (s, C2), 104.1 (s, C7), 38.1 (s, 
C10), 28.5 (s, C11). 
5.4.2.2 Palladium Complexes with Tridendate Ligands 
General method of synthesis of the Pd(NNC)Cl type complexes. To a solution of 0.5 
mmol bis(benzonitrile)palladium(II)chloride in 10 ml of dichloromethane a solution of 0.5 
mmol of the ligand in 10 ml dichloromethane was added dropwise. The reaction mixture was 
stirred at room temperature over night. The precipitated product was filtered and washed with 
dichloromethane. The product can be crystallized from DMSO. 
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N-Phenyl-κC2-4-(pyridine-2-yl-κN1)pyrimidin-κN3-2-amine(chlorido)palladium(II) 40a. 
Yield: 360.0 mg (93%, orange solid). Anal. calcd for C15H11ClN4Pd + 0.33CH2Cl2: C, 44.14; 
H, 2.80; N, 13.43. Found: C, 44.58; H, 2.90; N, 13.73. 1H NMR (400.1 MHz, DMSO-d6, 20 
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°C): δ 11.10 (s br., 1H, NH), 9.33 (d, JHH = 4.69 Hz, 1H, H1), 9.00 (d, JHH = 4.69 Hz, 1H, H8), 
8.67 (d, JHH = 7.82 Hz, 1H, H4), 8.37 (d, JHH = 8.19 Hz, 1H, H12), 8.28 (t, JHH = 7.04 Hz, 1H, 
H3), 7.99 (d, JHH = 5.08 Hz, 1H, H7), 7.88 (t, JHH = 6.26 Hz, 1H, H2), 7.19 (d, JHH = 7.43 Hz, 
1H, H13), 7.04 (t, JHH = 7.04 Hz, 1H, H15), 6.71 (t, JHH = 7.04 Hz, 1H, H14). 13C NMR (100.6 
MHz, DMSO-d6, 20 °C): δ 162.1 (s, C6), 161.1 (s, C8), 152.5 (s, C5), 150.0 (s, C9), 149.2 (s, 
C1), 140.3 (s, C10), 139.8 (s, C3), 136.6 (s, C14), 128.0 (s, C2), 125.0 (s, C11), 124.5 (s, C12), 
123.9 (s, C4), 120.6 (s, C13), 116.2 (s, C15), 108.8 (s, C7). 
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N-(4-Fluorophenyl-κC2)-4-(pyridine-2-yl-κN1)pyrimidin-κN3-2-amine(chlorido)palla-
dium(II) 40b. Yield: 380.0 mg (94%, orange solid). Anal. calcd for C15H10ClFN4Pd + DMSO: 
C, 42.08; H, 3.32; N, 11.55. Found: C, 41.80; H, 3.42; N, 11.46. 1H NMR (400.1 MHz, 
DMSO-d6, 20 °C): δ 11.03 (s br., 1H, NH), 9.18 (d, JHH = 5.04 Hz, 1H, H1), 8.90 (d, JHH = 
4.70 Hz, 1H, H8), 8.56 (d, JHH = 8.21 Hz, 1H, H4), 8.21-8.17 (m, 1H, H3), 8.04 (dd, JHH = 
11.4, 2.9 Hz, 1H, H12), 7.87 (d, JHH = 4.69 Hz, 1H, H7), 7.79-7.77 (m, 1H, H2), 7.13 (dd, JHH 
= 3.13, 5.48 Hz, 1H, H15), 6.84-6.79 (m, 1H, H14). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): 
δ 162.0 (s, C6), 161.2 (s, C8), 156.2 (d, JCF = 240 Hz, C13), 152.6 (s, C5), 150.0 (s, C9), 149.2 
(s, C1), 139.8 (s, C3), 133.5 (s, C10), 128.0 (s, C2), 126.5 (d, JCF = 5.0 Hz, C11), 124.9 (d, JCF 
= 20.6 Hz, C12), 123.9 (s, C4), 116.8 (d, JCF = 7.7 Hz, C15), 112.0 (d, JCF = 23.4 Hz, C14), 
108.7 (s, C7). 
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 N-(4-Chlorophenyl-κC2)-4-(pyridine-2-yl-κN1)pyrimidin-κN3-2-amine(chlorido)palla-
dium(II) 40c. Yield: 370.0 mg (88%, orange solid). Anal. calcd for C15H10Cl2N4Pd + 0.33 
CH2Cl2: C, 40.71; H, 2.36; N, 12.39. Found: C, 40.95; H, 2.41; N, 12.70. 1H NMR (400.1 
MHz, DMSO-d6, 20 °C): δ 11.19 (s br., 1H, NH), 9.27 (d, JHH = 5.08 Hz, 1H, H1), 9.00 (d, JHH 
= 5.08 Hz, 1H, H8), 8.66 (d, JHH = 8.22 Hz, 1H, H4), 8.32-8.26 (m, 2H, H3 & H12), 7.99 (d, 
JHH = 4.70 Hz, 1H, H7), 7.88 (t, JHH = 6.26 Hz, 1H, H2), 7.17-7.15 (m, 1H, H15), 7.09-7.06 
(m, 1H, H14). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 162.1 (s, C6), 161.3 (s, C8), 152.6 
(s, C5), 150.1 (s, C9), 149.3 (s, C1), 139.9 (s, C3), 138.6 (s, C13), 135.9 (s, C10), 128.0 (s, 
C2), 126.4 (s, C11), 124.7 (s, C12), 124.0 (s, C4), 123.9 (s, C14), 117.3 (s, C15), 109.1 (s, C7). 
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N-(4-Methoxyphenyl-κC2)-4-(pyridine-2-yl-κN1)pyrimidin-κN3-2-amine(chlorido)palla-
dium(II) 40d. Yield: 400 mg (95%, red solid). Anal. calcd for C16H13ClN4OPd: C, 45.85; H, 
3.13; N, 13.37. Found: C, 45.30; H, 3.30; N, 13.15. 1H NMR (400.1 MHz, DMSO-d6, 20 °C): δ 
11.02 (s br., 1H, NH), 9.33 (d, JHH = 4.7 Hz, 1H, H1), 8.95 (d, JHH = 4.69 Hz, 1H, H8), 8.66 (d, 
JHH = 8.22 Hz, 1H, H4), 8.28 (t, JHH = 8.33 Hz, 1H, H3), 8.00 (d, JHH = 2.74 Hz, 1H, H12), 
7.91-7.86 (m, 2H, H7 & H2), 7.14 (d, JHH = 9 Hz, 1H, H15), 6.69 (dd, JHH = 2.74, 5.87 Hz, 1H, 
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H14), 3.68 (s, 3H, H16). 13C NMR (100.6 MHz, DMSO-d6, 20 °C): δ 161.9 (s, C6), 160.9 (s, 
C8), 152.6 (s, C5), 152.0 (s, C10), 149.7 (s, C9), 149.2 (s, C1), 139.7 (s, C3), 130.6 (s, C13), 
127.9 (s, C2), 125.8 (s, C11), 124.1 (s, C12), 123.8 (s, C4), 116.4 (s, C15), 111.5 (s, C14), 
108.2 (s, C7), 54.9 (s, C16). 
N
N N
NH
1
2
3
4
5
6 7 8
9
PdCl
10
11
12
13
14
15
C
N
 
4-(4-(Pyridin-2-yl-κN1)pyrimidin-κN3-2-ylamino)benzonitrile-κC2(chlorido)palladium(II) 
40e. Yield: 370.0 mg (90%, yellow solid). Anal. calcd for C16H10ClN5Pd + DMSO: C, 43.92; 
H, 3.28; N, 14.23. Found: C, 44.04; H, 3.33; N, 14.47. 1H NMR (400.1 MHz, DMSO-d6, 20 
°C): δ 11.51 (s br., 1H, NH), 9.29 (d, JHH = 4.7 Hz, 1H, H1), 9.08 (d, JHH = 4.69 Hz, 1H, H8), 
8.71-8.69 (m, 2H, H4 & H12), 8.31-8.29 (m, 1H, H3), 8.10 (d, JHH = 4.7 Hz, 1H, H7), 7.90-
7.88 (m, 1H, H2), 7.47 (d, JHH = 8.22 Hz, 1H, H15), 7.29 (d, JHH = 8.22 Hz, 1H, H14). 13C 
NMR (100.6 MHz, DMSO-d6, 20 °C): The complex was not soluble enough, so the 13C NMR 
spectrum could not be measured. 
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7 Index 
7.1 Crystal Structure Data 
7.1.1 Crystal Data and Structure Refinement for 9 
Empirical formula   C27H27N3O2 
Formula weight   425.52 
Crystal colour and habit   yellow needle 
Crystal size (mm)   0.28 x 0.11 x 0.07 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 9.1667(2) Å  α = 90o 
   b = 15.0261(3) Å  β= 99.078(2)o 
   c = 16.8345(4) Å  γ = 90o 
Volume (Å3)   2289.74(9) 
Z   4 
Calculated density (Mg/m3)   1.234 
Absorption coefficient (mm-1) 0.624 
F(000)   904 
Theta-range for data collection (o) 3.97/62.62 
Index ranges   -10 ≤ h ≤ 10, -17 ≤ k ≤ 17, -18 ≤ l ≤ 19 
Reflections collected   16200 
Independent reflections   3656 (Rint = 0.0269) 
Completeness to theta = 62.62o 99.6 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
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Max. and min. transmission   1.00000 and 0.54119 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   3656/0/294 
Goodness-of-fit on F2   1.024 
Final R indices [I>2σ(I)]   R1 = 0.0325, wR2 = 0.0874 
R indices (all data)   R1 = 0.0413, wR2 = 0.0909 
Extinction coefficient   0.00165(19) 
Largest diff. peak and hole (e·Å-3) 0.140/-0.186 
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Notes on the refinement of 9. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. 
7.1.2 Crystal Data and Structure Refinement for 16 
Empirical formula   C36H26N2O2 
Formula weight   518.59 
Crystal colour and habit   colorless prism 
Crystal size (mm)   0.14 x 0.09 x 0.08 
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Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/n 
Unit cell dimensions   a = 8.2096(2) Å  α = 90o 
   b = 11.6997(2) Å              β = 91.195(2)o 
   c = 27.2887(4) Å  γ = 90o 
Volume (Å3)   2620.51(9) 
Z   4 
Calculated density (Mg/m3)   1.314 
Absorption coefficient (mm-1) 0.642 
F(000)   1088 
Theta-range for data collection (o) 4.11/62.69 
Index ranges   -9 ≤ h ≤ 7, -13 ≤ k ≤ 13, -31 ≤ l ≤ 31 
Reflections collected   22940 
Independent reflections   4188 (Rint = 0.0373) 
Completeness to theta = 62.69o 99.1 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.67762 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   4188/0/361 
Goodness-of-fit on F2   0.854 
Final R indices [I>2σ(I)]   R1 = 0.0335, wR2 = 0.0719 
R indices (all data)   R1 = 0.0500, wR2 = 0.0755 
Largest diff. Peak and hole (e·Å-3) 0.119/-0.203 
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Notes on the refinement of 16. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. 
7.1.3 Crystal Data and Structure Refinement for Guanidinium Salt 
Empirical formula  C18H44N6O4S 
Formula weight  440.65 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 11.5847(6) Å α= 90°. 
 b = 7.6008(4) Å β= 98.688(5)°. 
 c = 28.0681(15) Å γ = 90°. 
Volume 2443.1(2) Å3 
Z 4 
Density (calculated) 1.198 Mg/m3 
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Absorption coefficient 1.452 mm-1 
F(000) 968 
Crystal colour and habit Colorless prism 
Crystal size 0.14 x 0.06 x 0.04 mm3 
Theta range for data collection 3.19 to 62.64°. 
Index ranges -13<=h<=13, -8<=k<=7, -32<=l<=20 
Reflections collected 7080 
Independent reflections 1945 [R(int) = 0.0279] 
Completeness to theta = 62.64° 99.7 %  
Absorption correction Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission 1.00000 and 0.49315 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1945 / 49 / 153 
Goodness-of-fit on F2 1.104 
Final R indices [I>2σ(I)] R1 = 0.0330, wR2 = 0.0967 
R indices (all data) R1 = 0.0371, wR2 = 0.0984 
Extinction coefficient 0.00041(9) 
Largest diff. peak and hole 0.269 and -0.305 e.Å-3 
 
Definitions: 
 
R
F F
F
o c
o
1 =
−∑
∑
                                 
( )[ ]
( )[ ]wR
w F F
w F
o c
o
2
2 2 2
2 2
=
−∑
∑
              
 
220 
 
( )[ ]
( )GooF
w F F
n p
o c
=
−
−
∑
2 2
      n = number of reflections; p = number of parameters 
 
Notes on the refinement of guanidinium salt. 
All hydrogen atoms were placed in calculated positions and refined by using a riding model. 
7.1.4 Crystal Data and Structure Refinement for 17d 
Empirical formula   C16H14N4O 
Formula weight   278.31 
Crystal colour and habit   yellow needle 
Crystal size (mm)   0.41 x 0.15 x 0.11 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 12.3576(2) Å  α = 90o 
   b = 6.9698(1) Å   β = 96.270(1)o 
   c = 15.8623(2) Å  γ = 90o 
Volume (Å3)   1358.05(3) 
Z   4 
Calculated density (Mg/m3)   1.361 
Absorption coefficient (mm-1) 0.720 
F(000)   584 
Theta-range for data collection (o) 5.61/62.68 
Index ranges   -14 ≤ h ≤ 14, -7 ≤ k ≤ 7, -18 ≤ l ≤ 17 
Reflections collected   11721 
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Independent reflections   2150 (Rint = 0.0295) 
Completeness to theta = 62.68o 99.0 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.69702 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   2150/0/192 
Goodness-of-fit on F2   0.954 
Final R indices [I>2σ(I)]   R1 = 0.0331, wR2 = 0.0865 
R indices (all data)   R1 = 0.0411, wR2 = 0.0893 
Extinction coefficent   0.0029(4) 
Largest diff. Peak and hole (e·Å-3) 0.168/-0.159 
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Notes on the refinement of 17d. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. 
7.1.5 Crystal Data and Structure Refinement for 17f 
Empirical formula   C13H16N4 
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Formula weight   228.30 
Crystal colour and habit   colorless needle 
Crystal size (mm)   0.19 x 0.18 x 0.14 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 16.5007(2) Å  α = 90o 
   b = 9.0395(1) Å  β = 98.147(1)o 
   c = 16.9197(2) Å  γ = 90o 
Volume (Å3)   2498.24(5) 
Z   8 
Calculated density (Mg/m3)   1.214 
Absorption coefficient (mm-1) 0.599 
F(000)   976 
Theta-range for data collection (o) 5.28/62.70 
Index ranges   -13 ≤ h ≤ 18, -10 ≤ k ≤ 10, -19 ≤ l ≤ 19 
Reflections collected   18102 
Independent reflections   4003 (Rint = 0.0222) 
Completeness to theta = 62.70o 99.7 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.78505 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   4003/4/325 
Goodness-of-fit on F2   1.071 
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Final R indices [I>2σ(I)]   R1 = 0.0410, wR2 = 0.1185 
R indices (all data)   R1 = 0.0461, wR2 = 0.1214 
Largest diff. peak and hole (e·Å-3) 0.553/-0.276 
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Notes on the refinement of 17f. 
The hydrogen atoms H4A and H4B, H8A and H8B, which are bound to the nitrogen atoms N4 
and N8, respectively, were located in the difference Fourier synthesis, and were refined semi-
freely with the help of a distance restraint, while constraining their U-values to 1.2 times the 
U(eq) values of N4 and N8, respectively. All the other hydrogen atoms were placed in 
calculated positions and refined by using a riding model. 
7.1.6 Crystal Data and Structure Refinement for 17h 
Empirical formula   C15H20N4 
Formula weight   256.35 
Crystal colour and habit   colorless prism 
Crystal size (mm)   0.18 x 0.11 x 0.09 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
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Crystal system   Orthorhombic 
Space group   Pnma 
Unit cell dimensions   a = 12.0897(3) Å  α = 90o 
   b = 6.9231(2) Å  β = 90o 
   c = 16.5369(5) Å  γ = 90o 
Volume (Å3)   1384.11(7) 
Z   4 
Calculated density (Mg/m3)   1.230 
Absorption coefficient (mm-1) 0.593 
F(000)   552 
Theta -range for data collection (o) 4.53/62.64 
Index ranges   -13 ≤ h ≤ 13, -7 ≤ k ≤ 7, -18 ≤ l ≤ 18 
Reflections collected   7939 
Independent reflections   1206 (Rint = 0.0552) 
Completeness to theta = 62.64o 99.8 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.87531 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   1206/4/125 
Goodness-of-fit on F2   1.090 
Final R indices [I>2σ(I)]   R1 = 0.0347, wR2 = 0.1024 
R indices (all data)   R1 = 0.0443, wR2 = 0.1065 
Extinction coefficient   0.0019(6) 
Largest diff. peak and hole (e·Å-3) 0.185/-0.252 
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Notes on the refinement of 17h. 
The hydrogen atoms which are bound to C11 and C14, were located in the difference Fourier 
synthesis, and were refined semi-freely with the help of a distance restraint, while constraining 
their U-values to 1.5 times the U(eq) value of bonding C-atom. All the other hydrogen atoms 
were placed in calculated positions and refined by using a riding model. The methyl group 
C(15)H3- was treated as disorder on special position. 
7.1.7 Crystal Data and Structure Refinement for 33b 
Empirical formula   C43H48Cl2N5PRu 
Formula weight   837.80 
Crystal colour and habit   red prism 
Crystal size (mm)   0.19 x 0.14 x 0.06 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   I2/a 
Unit cell dimensions   a = 22.9187(2) Å  α = 90o 
   b = 12.84570(10) Å              β = 101.6280(10)o 
226 
 
   c = 27.3925(2) Å  γ = 90o 
Volume (Å3)   7899.03(11) 
Z   8 
Calculated density (Mg/m3)   1.409 
Absorption coefficient (mm-1) 5.127 
F(000)   3472 
Theta-range for data collection (o) 3.82/62.65 
Index ranges   -26 ≤ h ≤ 26, -13 ≤ k ≤ 14, -25 ≤ l ≤ 30 
Reflections collected   19278 
Independent reflections   6216 (Rint = 0.0244) 
Completeness to theta = 62.65o 98.2 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.49019 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   6216/387/581 
Goodness-of-fit on F2   1.008 
Final R indices [I>2σ(I)]   R1 = 0.0405, wR2 = 0.1182 
R indices (all data)   R1 = 0.0499, wR2 = 0.1232 
Largest diff. Peak and hole (e·Å-3) 1.239/-0.720 
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Notes on the refinement of 33b. 
All hydrogen atom positions were calculated in deal positions (riding model). And half of the 
molecule was severely disordered. 
7.1.8 Crystal Data and Structure Refinement for 33a 
Empirical formula   C35H32Cl2N5PRu 
Formula weight   725.60 
Crystal colour and habit   red prism 
Crystal size (mm)   0.19 x 0.17 x 0.06 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Triclinic 
Space group   P-1 
Unit cell dimensions   a = 13.0148(9) Å  α = 102.805(6)o 
   b = 14.8928(10) Å                β = 92.194(5)o 
   c = 16.8628(10) Å             γ = 93.225(5)o 
Volume (Å3)   3177.8(4) 
Z   4 
Calculated density (Mg/m3)   1.517 
Absorption coefficient (mm-1) 6.280 
F(000)   1480 
Theta-range for data collection (o) 3.41/62.92 
Index ranges   -14 ≤ h ≤ 14, -16 ≤ k ≤ 16, -18 ≤ l ≤ 19 
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Reflections collected   27114 
Independent reflections   9952 (Rint = 0.0352) 
Completeness to theta = 62.92o 97.0 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.41078 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   9952/0/793 
Goodness-of-fit on F2   0.985 
Final R indices [I>2σ(I)]   R1 = 0.0299, wR2 = 0.0787 
R indices (all data)   R1 = 0.0362, wR2 = 0.0823 
Largest diff. Peak and hole (e·Å-3) 0.880/-0.749 
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Notes on the refinement of 33a. 
All hydrogen atom positions were calculated in deal positions (riding model). 
7.1.9 Crystal Data and Structure Refinement for 33e 
Empirical formula   C47H52Cl6N5PRu 
Formula weight   1031.68 
 Index 
 
229 
 
Crystal colour and habit   red plate 
Crystal size (mm)   0.42 x 0.10 x 0.04 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 14.9916(3) Å  α = 90o 
   b = 18.2917(3) Å              β = 110.460(2)o 
   c = 18.7007(4) Å  γ = 90o 
Volume (Å3)   4804.64(16) 
Z   4 
Calculated density (Mg/m3)   1.426 
Absorption coefficient (mm-1) 6.323 
F(000)   2120 
Theta-range for data collection (o) 4.93/62.65 
Index ranges   -15 ≤ h ≤ 17, -20 ≤ k ≤ 20, -21 ≤ l ≤ 21 
Reflections collected   20732 
Independent reflections   7571 (Rint = 0.0450) 
Completeness to theta = 62.65o 98.4 % 
Absorption correction   Analytical 
Max. and min. transmission   0.801 and 0.323 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   7571/0/541 
Goodness-of-fit on F2   1.027 
Final R indices [I>2σ(I)]   R1 = 0.0535, wR2 = 0.1535 
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R indices (all data)   R1 = 0.0694, wR2 = 0.1595 
Largest diff. Peak and hole (e·Å-3) 2.900/-1.517 
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Notes on the refinement of 33e. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. 
7.1.10 Crystal Data and Structure Refinement for 35 
Empirical formula   C18H19Cl5N5Ru 
Formula weight   583.70 
Crystal colour and habit   brown plate 
Crystal size (mm)   0.20 x 0.13 x 0.03 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Triclinic 
Space group   P-1 
Unit cell dimensions   a = 8.0575(4) Å  α = 71.813(4)o 
   b = 10.4714(4) Å  β = 81.249(4)o 
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   c = 14.3250(7) Å  γ = 76.049(4)o 
Volume (Å3)   1110.51(9) 
Z   2 
Calculated density (Mg/m3)   1.746 
Absorption coefficient (mm-1) 11.381 
F(000)   582 
Tetha-range for data collection (o) 3.26/62.60 
Index ranges   -9 ≤ h ≤ 9, -11 ≤ k ≤ 12, -16 ≤ l ≤ 16 
Reflections collected   8213 
Independent reflections   3539 (Rint = 0.0252) 
Completeness to tetha = 62.60o 99.5 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.37481 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   3539/0/262 
Goodness-of-fit on F2   1.096 
Final R indices [I>2 σ(I)]  R1 = 0.0556, wR2 = 0.1596 
R indices (all data)   R1 = 0.0595, wR2 = 0.1626 
Largest diff. peak and hole (e·Å-3) 1.573/-1.549 
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Notes on the refinement of 35. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. 
7.1.11 Crystal Data and Structure Refinement for 36a 
Empirical formula   C21H28ClF6N4OPRu 
Formula weight   633.96 
Crystal colour and habit   red prism 
Crystal size (mm)   0.28 x 0.21 x 0.18 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 10.3715(1) Å  α = 90o 
   b = 15.0288(2) Å  β = 102.954(1)o 
   c = 16.0810(2) Å  γ = 90o 
Volume (Å3)   2442.77(5) 
Z   4 
Calculated density (Mg/m3)   1.724 
Absorption coefficient (mm-1) 7.452 
F(000)   1280 
Tetha-range for data collection (o) 4.08/62.64 
Index ranges   -11 ≤ h ≤ 11, -17 ≤ k ≤ 16, -18 ≤ l ≤ 18 
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Reflections collected   17462 
Independent reflections   3903 (Rint = 0.0274) 
Completeness to tetha = 62.64o 99.9 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.59416 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   3903/2/327 
Goodness-of-fit on F2   1.079 
Final R indices [I>2 σ(I)]  R1 = 0.0230, wR2 = 0.0589 
R indices (all data)   R1 = 0.0245, wR2 = 0.0596 
Largest diff. peak and hole (e·Å-3) 0.319/-0.618 
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Notes on the refinement of 36a. 
The hydrogen atoms H4A and H4B, which are bound to the nitrogen atom N4, were located in 
the difference Fourier synthesis, and were refined semi-freely with the help of a distance 
restraint, while constraining their U-values to 1.2 times the U(eq) value of N4. All the other 
hydrogen atoms were placed in calculated positions and refined by using a riding model. 
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One EtOH molecule was co-crystallized with the target complex. 
7.1.12 Crystal Data and Structure Refinement for 36b 
Empirical formula   C49H46BClN4Ru 
Formula weight   838.23 
Crystal colour and habit   yellow prism 
Crystal size (mm)   0.20 x 0.13 x 0.08 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/n 
Unit cell dimensions   a = 13.5219(1) Å  α  = 90o 
   b = 21.5269(2) Å  β  = 90.424(1)o 
   c = 14.0468(1) Å  γ  = 90o 
Volume (Å3)   4088.70(6) 
Z   4 
Calculated density (Mg/m3)   1.362 
Absorption coefficient (mm-1) 4.002 
F(000)   1736 
Tetha-range for data collection (o) 3.76/62.64 
Index ranges   -15 ≤ h ≤ 15, -22 ≤ k ≤ 24, -16 ≤ l ≤ 14 
Reflections collected   31505 
Independent reflections   6538 (Rint = 0.0241) 
Completeness to tetha = 62.64o 99.8 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.66444 
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Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   6538/2/514 
Goodness-of-fit on F2   1.034 
Final R indices [I>2 σ(I)]  R1 = 0.0200, wR2 = 0.0529 
R indices (all data)   R1 = 0.0225, wR2 = 0.0535 
Largest diff. peak and hole (e·Å-3) 0.227/-0.360 
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Notes on the refinement of 36b. 
 
The hydrogen atoms H4A and H4B, which are bound to the nitrogen atom N4, were located in 
the difference Fourier synthesis, and were refined semi-freely with the help of a distance 
restraint, while constraining their U-values to 1.2 times the U(eq) value of N4. All the other 
hydrogen atoms were placed in calculated positions and refined by using a riding model. 
7.1.13 Crystal Data and Structure Refinement for 36f 
Empirical formula   C53H65BClN4O1.5Ru 
Formula weight   929.42 
Crystal colour and habit   yellow prism 
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Crystal size (mm)   0.40 x 0.17 x 0.13 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 15.2326(1) Å  α = 90o 
   b = 13.8012(1) Å  β = 107.188(1)o 
                           c = 24.5075(2) Å  σ = 90o 
Volume (Å3)   4922.07(6) 
Z   4 
Calculated density (Mg/m3)   1.254 
Absorption coefficient (mm-1) 3.392 
F(000)   1956 
Tetha-range for data collection (o) 3.04/62.65 
Index ranges   -14 ≤ h ≤ 17, -15 ≤ k ≤ 15, -27 ≤ l ≤ 17 
Reflections collected   40936 
Independent reflections   7866 (Rint = 0.0225) 
Completeness to tetha= 62.65o 99.7 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.68249 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   7866/40/580 
Goodness-of-fit on F2   1.042 
Final R indices [I>2 σ(I)]  R1 = 0.0244, wR2 = 0.0647 
R indices (all data)   R1 = 0.0264, wR2 = 0.0655 
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Largest diff. peak and hole (e·Å-3) 0.414/-0.335 
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Notes on the refinement of 36f. 
The hydrogen atoms H4A and H4B, which are bound to the nitrogen atom N4, were located in 
the difference Fourier synthesis, and were refined semi-freely with the help of a distance 
restraint, while constraining their U-values to 1.2 times the U(eq) value of N4. All the other 
hydrogen atoms were placed in calculated positions and refined by using a riding model. One 
target molecule was co-crystallized with 1.5 Et2O, one of which was disordered. 
7.1.14 Crystal Data and Structure Refinement for 36g 
Empirical formula  C48H49BCl4N4Ru 
Formula weight  935.59 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 9.3478(2) Å α = 90°. 
 b = 24.5559(5) Å β = 90.376(2)°. 
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 c = 19.0534(5) Å γ = 90°. 
Volume 4373.49(17) Å3 
Z 4 
Density (calculated) 1.421 Mg/m3 
Absorption coefficient 5.446 mm-1 
F(000) 1928 
Crystal colour and habit             orange prism 
Crystal size 0.11 x 0.09 x 0.05 mm3 
Theta range for data collection 2.94 to 62.72° 
Index ranges -10<=h<=9, -28<=k<=28, -21<=l<=21 
Reflections collected 47086 
Independent reflections 7017 [R(int) = 0.0534] 
Completeness to theta = 62.72° 99.9 %  
Absorption correction              Multiscan 
Max. and min. transmission 1.00000 and 0.47266 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7017 / 0 / 526 
Goodness-of-fit on F2 0.955 
Final R indices [I>2sigma(I)] R1 = 0.0253, wR2 = 0.0583 
R indices (all data) R1 = 0.0373, wR2 = 0.0697 
Largest diff. peak and hole 0.420 and -0.456 e.Å-3 
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Notes on the refinement of 36g. 
All hydrogen atoms were placed in calculated positions and refined by using a riding model. 
7.1.15 Crystal Data and Structure Refinement for 36h 
Empirical formula   C49H54BClN4Ru 
Formula weight   846.29 
Crystal colour and habit   yellow prism 
Crystal size (mm)   0.25 x 0.09 x 0.05 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/c 
Unit cell dimensions   a = 14.6567(3) Å  α = 90o 
   b = 9.6078(2) Å  β = 100.226(2)o 
   c = 33.5405(6) Å  γ = 90o 
Volume (Å3)   4648.10(16) 
Z   4 
Calculated density (Mg/m3)   1.209 
Absorption coefficient (mm-1) 3.521 
F(000)   1768 
Tetha-range for data collection (o) 3.06/62.63 
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Index ranges   -16 ≤ h ≤ 15, -9 ≤ k ≤ 11, -38 ≤ l ≤ 38 
Reflections collected   24700 
Independent reflections   7402 (Rint = 0.0367) 
Completeness to tetha= 62.63o 99.7 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.40065 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   7402/0/513 
Goodness-of-fit on F2   0.946 
Final R indices [I>2sigma(I)]   R1 = 0.0310, wR2 = 0.0771 
R indices (all data)   R1 = 0.0390, wR2 = 0.0797 
Largest diff. peak and hole (e·Å-3) 0.402/-0.581 
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Notes on the refinement of 36h. 
All the hydrogen atoms were placed in calculated positions and refined by using a riding 
model. Because of the existence of severely disordered solvents, most possibly Et2O, 
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SQUEEZE process integrated in PLATON has been used. And the detailed information has 
also been posted in the final CIF file. 
7.1.16 Crystal Data and Structure Refinement for 36j 
Empirical formula   C45H46BClN4Ru 
Formula weight   790.19 
Crystal colour and habit   orange needle 
Crystal size (mm)   0.18 x 0.12 x 0.11 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Monoclinic 
Space group   P21/n 
Unit cell dimensions   a = 13.0910(2) Å  α = 90o 
   b = 11.8941(1) Å  β = 95.960(1)o 
   c = 25.6986(3) Å  γ  = 90o 
Volume (Å3)   3979.79(8) 
Z   4 
Calculated density (Mg/m3)   1.319 
Absorption coefficient (mm-1) 4.076 
F(000)   1640 
Tetha-range for data collection (o) 3.46/62.74 
Index ranges   -15 ≤ h ≤ 14, -13 ≤ k ≤ 13, -29 ≤ l ≤ 22 
Reflections collected   31463 
Independent reflections   6363 (Rint = 0.0237) 
Completeness to tetha = 62.74o 99.5 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
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Max. and min. transmission   1.00000 and 0.77087 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   6363/0/474 
Goodness-of-fit on F2   1.041 
Final R indices [I>2 sigma (I)] R1 = 0.0218, wR2 = 0.0562 
R indices (all data)   R1 = 0.0240, wR2 = 0.0570 
Largest diff. peak and hole (e·Å-3) 0.292/-0.597 
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Notes on the refinement of 36j. 
All hydrogen atoms were placed in calculated positions and refined by using a riding model. 
7.1.17 Crystal Data and Structure Refinement for 36k 
Empirical formula  C48H50BClN4Ru 
Formula weight  830.25 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P21/c 
 Index 
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Unit cell dimensions a = 12.2710(1) Å α = 90°. 
 b = 14.9669(1) Å β = 95.163(1)°. 
 c = 22.3485(2) Å γ = 90°. 
Volume 4087.85(6) Å3 
Z 4 
Density (calculated) 1.349 Mg/m3 
Absorption coefficient 3.994 mm-1 
F(000) 1728 
Crystal colour and habit Brown plate 
Crystal size 0.18 x 0.07 x 0.03 mm3 
Theta range for data collection 3.56 to 62.65°. 
Index ranges -13<=h<=14, -17<=k<=16, -25<=l<=22 
Reflections collected 32737 
Independent reflections 6515 [R(int) = 0.0336] 
Completeness to theta = 62.65° 99.6 %  
Absorption correction Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission 1.00000 and 0.58561 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6515 / 0 / 499 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0245, wR2 = 0.0652 
R indices (all data) R1 = 0.0293, wR2 = 0.0665 
Largest diff. peak and hole 0.536 and -0.388 e.Å-3 
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Notes on the refinement of 36k. 
All hydrogen atoms were placed in calculated positions and refined by using a riding model. 
7.1.18 Crystal Data and Structure Refinement for 36l 
Empirical formula  C47H50BCl3N4Ru 
Formula weight  889.14 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 12.89110(10) Å α = 90°. 
 b = 14.90500(10) Å β = 98.3670(10)°. 
 c = 22.7354(2) Å γ = 90°. 
Volume 4321.93(6) Å3 
Z 4 
Density (calculated) 1.366 Mg/m3 
Absorption coefficient 4.925 mm-1 
F(000) 1840 
 Index 
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Crystal size 0.16 x 0.08 x 0.06 mm3 
Crystal colour and habit Red prism 
Theta range for data collection 3.47 to 62.67°. 
Index ranges -14<=h<=12, -17<=k<=16, -26<=l<=25 
Reflections collected 33782 
Independent reflections 6916 [R(int) = 0.0299] 
Completeness to theta = 62.67° 99.8 %  
Absorption correction Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission 1.00000 and 0.36187 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6916 / 1 / 512 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0292, wR2 = 0.0796 
R indices (all data) R1 = 0.0346, wR2 = 0.0815 
Largest diff. peak and hole 0.679 and -0.944 e.Å-3 
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Notes on the refinement of 36l. 
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The hydrogen atom H4N, which is bound to the nitrogen atom N4, was located in the 
difference Fourier synthesis, and was refined semi-freely with the help of a distance restraint, 
while constraining its U-value to 1.2 times the U(eq) values of the corresponding nitrogen 
atom. All the other hydrogen atoms were placed in calculated positions and refined by using a 
riding model. 
7.1.19 Crystal Data and Structure Refinement for 38 
Empirical formula   C12H20N6O6RuS3  
Formula weight   541.59 
Crystal colour and habit   red prism 
Crystal size (mm)   0.14 x 0.11 x 0.09 
Temperature (K)   150(2) 
Wavelength (Å)   1.54184 
Crystal system   Orthorhombic 
Space group   Pbcn 
Unit cell dimensions   a = 13.1591(2) Å  α = 90o 
   b = 10.5891(1) Å  β = 90o 
   c = 13.5448(2) Å  γ = 90o 
Volume (Å3)   1887.37(4) 
Z   4 
Calculated density (Mg/m3)   1.906 
Absorption coefficient (mm-1) 10.250 
F(000)   1096 
Tetha-range for data collection (o) 5.36/62.66 
Index ranges   -15 ≤ h ≤ 15, -9 ≤ k ≤ 12, -15 ≤ l ≤ 15 
 Index 
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Reflections collected   11302 
Independent reflections   1513 (Rint = 0.0253) 
Completeness to tetha = 62.66o 99.9 % 
Absorption correction   Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission   1.00000 and 0.01465 
Refinement method   Full-matrix least-squares on F2 
Data/restraints/parameters   1513/0/168 
Goodness-of-fit on F2   1.129 
Final R indices [I>2 sigma (I)] R1 = 0.0189, wR2 = 0.0502 
R indices (all data)   R1 = 0.0201, wR2 = 0.0507 
Largest diff. peak and hole (e·Å-3) 0.232/-0.533 
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Notes on the refinement of 38. 
All hydrogen atoms were located in the difference Fourier synthesis, and then were refined 
with individual isotopic displacement parameters. 
7.1.20 Crystal Data and Structure Refinement for 40a 
Empirical formula  C17H17ClN4OPdS 
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Formula weight  467.26 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 11.3161(2) Å α = 90° 
 b = 20.3112(4) Å β = 97.815(2)° 
 c = 7.6539(1) Å γ = 90° 
Volume 1742.86(5) Å3 
Z 4 
Density (calculated) 1.781 Mg/m3 
Absorption coefficient 11.233 mm-1 
F(000) 936 
Crystal colour and habit red needle 
Crystal size 0.32 x 0.15 x 0.14 mm3 
Theta range for data collection 3.94 to 62.62°. 
Index ranges -13<=h<=13, -21<=k<=23, -8<=l<=5 
Reflections collected 10892 
Independent reflections 2777 [R(int) = 0.0293] 
Completeness to theta = 62.62° 99.8 %  
Absorption correction Multiscan 
Max. and min. transmission 1.00000 and 0.61247 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2777 / 1 / 232 
Goodness-of-fit on F2 1.189 
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Final R indices [I>2sigma(I)] R1 = 0.0229, wR2 = 0.0636 
R indices (all data) R1 = 0.0258, wR2 = 0.0745 
Extinction coefficient 0.00230(13) 
Largest diff. peak and hole 0.509 and -0.854 e.Å-3 
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Notes on the refinement of 40a. 
The hydrogen atom H4N, which is bound to the nitrogen atom N4, was located in the 
difference Fourier synthesis, and was refined semi-freely with the help of a distance restraint, 
while constraining its U-value to 1.2 times the U(eq) value of N4. All the hydrogen atoms were 
placed in calculated positions and refined by using a riding model. 
7.1.21 Crystal Data and Structure Refinement for 40b 
Empirical formula  C18H19ClN4O2PdS 
Formula weight  497.28 
Temperature  150(2) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 9.0633(2) Å α = 90°. 
 b = 16.6341(3) Å β = 109.739(2)°. 
250 
 
 c = 13.2038(3) Å γ = 90°. 
Volume 1873.64(7) Å3 
Z 4 
Density (calculated) 1.763 Mg/m3 
Absorption coefficient 10.534 mm-1 
F(000) 1000 
Crystal colour and habit red prism 
Crystal size 0.26 x 0.07 x 0.06 mm3 
Theta range for data collection 4.44 to 62.62°. 
Index ranges -10<=h<=9, -19<=k<=18, -14<=l<=15 
Reflections collected 13076 
Independent reflections 3004 [R(int) = 0.0304] 
Completeness to theta = 62.62° 99.8 %  
Absorption correction Semi-empirical from equivalents (Multiscan) 
Max. and min. transmission 1.00000 and 0.39813 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3004 / 1 / 250 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0211, wR2 = 0.0521 
R indices (all data) R1 = 0.0230, wR2 = 0.0527 
Largest diff. peak and hole 0.316 and -0.677 e.Å-3 
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Notes on the refinement of 40d. 
The hydrogen atom H4N, which is bound to the nitrogen atom N4, was located in the 
difference Fourier synthesis, and was refined semi-freely with the help of a distance restraint, 
while constraining its U-value to 1.2 times the U(eq) value of N4. All the other hydrogen 
atoms were placed in calculated positions and refined by using a riding model. 
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7.2 DFT calculations 
 Quantum chemical calculations on the cations 36a+, 36j+ and 36g+ and of HCl were 
performed with the program Gaussian03 [1] using the B3LYP gradient corrected exchange-
correlation functional in combination with the 6-31G* basis set for C, H, N, Cl and the 
Stuttgart/Dresden ECP basis set for Ru (see ref. [2] in the manuscript). Full geometry 
optimizations were carried out in C1 symmetry using analytical gradient techniques and the 
resulting structures were confirmed to be true minima by diagonalization of the analytical 
Hessian Matrix. The starting geometries for the calculations of the cations A+, B+, and C+ were 
taken from solid state structures of appropriate compounds. Different orientations of the 
cymene ligand were not evaluated. This may lead to small variations of the calculated energies. 
7.2.1 Calculation of HCl 
SCF Done:  E(RB+HF-LYP) =  -460.795694055     A.U. after    1 cycles 
Low frequencies ---   -0.0047   -0.0047   -0.0047   78.8246   78.8246 2930.0342 
Zero-point correction=                           0.006675 (Hartree/Particle) 
 Thermal correction to Energy=                    0.009036 
 Thermal correction to Enthalpy=                  0.009980 
 Thermal correction to Gibbs Free Energy=        -0.011218 
 Sum of electronic and zero-point Energies=           -460.789019 
 Sum of electronic and thermal Energies=              -460.786658 
                                                 
[1]  Gaussian 03, Revision E.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. 
Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. 
Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. 
Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. 
Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. 
Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, 
K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, 
M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, 
A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. 
L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. 
Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and J. A. Pople, Gaussian, Inc., Wallingford CT 
(2004). 
[2]  a) C. Lee, W. Yang, R. G. Parr, Phys. Rev. B 1988, 37, 785-789; b) A. D. Becke, Phys. Rev. 1988, A38, 
3098-3100; c) B. Miehlich, A. Savin, H. Stoll, H. Preuss, Chem. Phys. Lett. 1989, 157, 200-206; d) P. C. 
Hariharan, J. A. Pople, Theoret. Chim. Acta 1973, 28, 213-222; e) D. Andrae, U. Haeussermann, M. Dolg, 
H. Stoll, H. Preuss, Theor. Chem. Acc. 1990, 77, 123-141. 
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 Sum of electronic and thermal Enthalpies=            -460.785714 
 Sum of electronic and thermal Free Energies=         -460.806912 
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7.2.2 Calculations of cation 36a+ 
 
Calculated geometries of 36a+ leading to C-H activation. The calculation results are given 
below. 
 
 Index 
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Calculated heats of formation (Hf, solid lines), enthalpies (H, dashed lines) and Gibbs 
energies (G, dotted lines) leading to the elimination of HCl from 36a+. 
 
Geometry A 
SCF Done:  E(RB+HF-LYP) =  -1511.31596928     A.U. after   11 cycles 
Low frequencies ---   -0.0019   -0.0014    0.0009    5.5565    7.0455    
Zero-point correction=                           0.384382 (Hartree/Particle) 
 Thermal correction to Energy=                    0.408229 
 Thermal correction to Enthalpy=                  0.409174 
 Thermal correction to Gibbs Free Energy=         0.331402 
 Sum of electronic and zero-point Energies=          -1510.931587 
 Sum of electronic and thermal Energies=             -1510.907740 
 Sum of electronic and thermal Enthalpies=           -1510.906796 
 Sum of electronic and thermal Free Energies=        -1510.984568 
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Geometry TS1 
SCF Done:  E(RB+HF-LYP) =  -1511.26049449     A.U. after   11 cycles 
Low frequencies ---  -46.0545   -7.0925    0.0010    0.0018    0.0022     
 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.382193 (Hartree/Particle) 
 Thermal correction to Energy=                    0.406403 
 Thermal correction to Enthalpy=                  0.407347 
 Thermal correction to Gibbs Free Energy=         0.327102 
 Sum of electronic and zero-point Energies=          -1510.878302 
 Sum of electronic and thermal Energies=             -1510.854092 
 Sum of electronic and thermal Enthalpies=           -1510.853148 
 Sum of electronic and thermal Free Energies=        -1510.933392 
 
Geometry B 
SCF Done:  E(RB+HF-LYP) =  -1511.27720975     A.U. after    1 cycles 
Low frequencies ---   -8.5946    0.0011    0.0012    0.0019    5.8451     
Zero-point correction=                           0.383121 (Hartree/Particle) 
 Thermal correction to Energy=                    0.407499 
 Thermal correction to Enthalpy=                  0.408443 
 Thermal correction to Gibbs Free Energy=         0.329634 
 Sum of electronic and zero-point Energies=          -1510.894089 
 Sum of electronic and thermal Energies=             -1510.869711 
 Sum of electronic and thermal Enthalpies=           -1510.868766 
 Sum of electronic and thermal Free Energies=        -1510.947576 
 
Geometry TS2 
SCF Done:  E(RB+HF-LYP) =  -1511.23929634     A.U. after    1 cycles 
Low frequencies --- -396.9974   -4.9530   -0.0004    0.0013    0.0013     
 ******    1 imaginary frequencies (negative Signs) ******  
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Zero-point correction=                           0.376562 (Hartree/Particle) 
 Thermal correction to Energy=                    0.400973 
 Thermal correction to Enthalpy=                  0.401917 
 Thermal correction to Gibbs Free Energy=         0.322867 
 Sum of electronic and zero-point Energies=          -1510.862734 
 Sum of electronic and thermal Energies=             -1510.838323 
 Sum of electronic and thermal Enthalpies=           -1510.837379 
 Sum of electronic and thermal Free Energies=        -1510.916429 
Geometry C 
SCF Done:  E(RB+HF-LYP) =  -1511.24275769     A.U. after    3 cycles 
Low frequencies ---    0.0001    0.0012    0.0015    5.2357    6.6925    
Zero-point correction=                           0.378403 (Hartree/Particle) 
 Thermal correction to Energy=                    0.403811 
 Thermal correction to Enthalpy=                  0.404756 
 Thermal correction to Gibbs Free Energy=         0.323397 
 Sum of electronic and zero-point Energies=          -1510.864355 
 Sum of electronic and thermal Energies=             -1510.838946 
 Sum of electronic and thermal Enthalpies=           -1510.838002 
 Sum of electronic and thermal Free Energies=        -1510.919360 
 
Geometry TS3 
SCF Done:  E(RB+HF-LYP) =  -1511.23624180     A.U. after   19 cycles 
Low frequencies ---  -25.1010   -9.9084   -5.9022   -0.0018   -0.0018     
 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.376878 (Hartree/Particle) 
 Thermal correction to Energy=                    0.402673 
 Thermal correction to Enthalpy=                  0.403617 
 Thermal correction to Gibbs Free Energy=         0.316982 
 Sum of electronic and zero-point Energies=          -1510.859364 
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 Sum of electronic and thermal Energies=             -1510.833569 
 Sum of electronic and thermal Enthalpies=           -1510.832624 
 Sum of electronic and thermal Free Energies=        -1510.919260 
 
Geometry D 
SCF Done:  E(RB+HF-LYP) =  -1050.44183852     A.U. after    1 cycles 
Low frequencies ---   -3.3682    0.0005    0.0005    0.0006    4.0179    
Zero-point correction=                           0.369493 (Hartree/Particle) 
 Thermal correction to Energy=                    0.392095 
 Thermal correction to Enthalpy=                  0.393039 
 Thermal correction to Gibbs Free Energy=         0.316423 
 Sum of electronic and zero-point Energies=          -1050.072345 
 Sum of electronic and thermal Energies=             -1050.049743 
 Sum of electronic and thermal Enthalpies=           -1050.048799 
 Sum of electronic and thermal Free Energies=        -1050.125415 
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7.2.3 Calculations of cation 36j+ 
 
Calculated geometries of 36j+ leading to C-H activation. The calculation results are given 
below. 
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Calculated heats of formation (Hf, solid lines), enthalpies (H, dashed lines) and Gibbs 
energies (G, dotted lines) leading to the elimination of HCl from 36j+  
 
Geometry A 
SCF Done:  E(RB+HF-LYP) =  -1589.91791235     A.U. after    1 cycles 
Low frequencies ---   -0.0009    0.0011    0.0022    3.3602    5.5602    
Zero-point correction=                           0.440704 (Hartree/Particle) 
 Thermal correction to Energy=                    0.467647 
 Thermal correction to Enthalpy=                  0.468591 
 Thermal correction to Gibbs Free Energy=         0.384637 
 Sum of electronic and zero-point Energies=          -1589.477208 
 Sum of electronic and thermal Energies=             -1589.450265 
 Sum of electronic and thermal Enthalpies=           -1589.449321 
 Sum of electronic and thermal Free Energies=        -1589.533275 
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Geometry TS1 
SCF Done:  E(RB+HF-LYP) =  -1589.87864391     A.U. after    1 cycles 
Low frequencies ---  -42.1364   -2.7747   -0.0015   -0.0010    0.0013     
 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.438572 (Hartree/Particle) 
 Thermal correction to Energy=                    0.465988 
 Thermal correction to Enthalpy=                  0.466932 
 Thermal correction to Gibbs Free Energy=         0.378714 
 Sum of electronic and zero-point Energies=          -1589.440072 
 Sum of electronic and thermal Energies=             -1589.412656 
 Sum of electronic and thermal Enthalpies=           -1589.411711 
 Sum of electronic and thermal Free Energies=        -1589.499929 
 
Geometry B 
SCF Done:  E(RB+HF-LYP) =  -1589.89737080     A.U. after    1 cycles 
Low frequencies ---  -13.2204   -9.4610   -5.0836   -0.0015   -0.0005   - 
Zero-point correction=                           0.439247 (Hartree/Particle) 
 Thermal correction to Energy=                    0.466971 
 Thermal correction to Enthalpy=                  0.467916 
 Thermal correction to Gibbs Free Energy=         0.380245 
 Sum of electronic and zero-point Energies=          -1589.458124 
 Sum of electronic and thermal Energies=             -1589.430399 
 Sum of electronic and thermal Enthalpies=           -1589.429455 
 Sum of electronic and thermal Free Energies=        -1589.517126 
 
Geometry TS2 
SCF Done:  E(RB+HF-LYP) =  -1589.85703645     A.U. after    1 cycles 
Low frequencies --- -356.8770   -8.3221   -5.1598   -0.0023   -0.0020   - 
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 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.433202 (Hartree/Particle) 
 Thermal correction to Energy=                    0.460846 
 Thermal correction to Enthalpy=                  0.461790 
 Thermal correction to Gibbs Free Energy=         0.374448 
 Sum of electronic and zero-point Energies=          -1589.423834 
 Sum of electronic and thermal Energies=             -1589.396190 
 Sum of electronic and thermal Enthalpies=           -1589.395246 
 Sum of electronic and thermal Free Energies=        -1589.482588 
 
Geometry C 
SCF Done:  E(RB+HF-LYP) =  -1589.85949379     A.U. after    1 cycles 
Low frequencies ---   -8.5904   -5.0578   -0.0013   -0.0005    0.0006     
Zero-point correction=                           0.434920 (Hartree/Particle) 
 Thermal correction to Energy=                    0.463413 
 Thermal correction to Enthalpy=                  0.464357 
 Thermal correction to Gibbs Free Energy=         0.374765 
 Sum of electronic and zero-point Energies=          -1589.424573 
 Sum of electronic and thermal Energies=             -1589.396081 
 Sum of electronic and thermal Enthalpies=           -1589.395137 
 Sum of electronic and thermal Free Energies=        -1589.484729 
 
Geometry TS3 
SCF Done:  E(RB+HF-LYP) =  -1589.85508271     A.U. after    1 cycles 
Low frequencies ---  -27.2579   -7.9043   -4.6512   -0.0010    0.0008     
 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.433662 (Hartree/Particle) 
 Thermal correction to Energy=                    0.462329 
 Thermal correction to Enthalpy=                  0.463273 
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 Thermal correction to Gibbs Free Energy=         0.371535 
 Sum of electronic and zero-point Energies=          -1589.421421 
 Sum of electronic and thermal Energies=             -1589.392754 
 Sum of electronic and thermal Enthalpies=           -1589.391810 
 Sum of electronic and thermal Free Energies=        -1589.483548 
 
Geometry D 
SCF Done:  E(RB+HF-LYP) =  -1129.06138969     A.U. after    1 cycles 
Low frequencies ---   -0.0004   -0.0002    0.0005    3.3181    7.6402     
Zero-point correction=                           0.425996 (Hartree/Particle) 
 Thermal correction to Energy=                    0.451775 
 Thermal correction to Enthalpy=                  0.452720 
 Thermal correction to Gibbs Free Energy=         0.368457 
 Sum of electronic and zero-point Energies=          -1128.635393 
 Sum of electronic and thermal Energies=             -1128.609614 
 Sum of electronic and thermal Enthalpies=           -1128.608670 
 Sum of electronic and thermal Free Energies=        -1128.692933 
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7.2.4 Calculations of cation 36g+ 
 
Calculated geometries of 36g+ leading to C-H activation. The calculation results are given 
below. 
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Calculated heats of formation (Hf, solid lines), enthalpies (H, dashed lines) and Gibbs 
energies (G, dotted lines) leading to the elimination of HCl from 36g+. 
 
Geometry A 
SCF Done:  E(RB+HF-LYP) =  -1667.34386736     A.U. after   10 cycles 
Low frequencies ---  -12.2086   -0.0022   -0.0013   -0.0003    5.6055     
Zero-point correction=                           0.477635 (Hartree/Particle) 
 Thermal correction to Energy=                    0.505326 
 Thermal correction to Enthalpy=                  0.506270 
 Thermal correction to Gibbs Free Energy=         0.420205 
 Sum of electronic and zero-point Energies=          -1666.866232 
 Sum of electronic and thermal Energies=             -1666.838541 
 Sum of electronic and thermal Enthalpies=           -1666.837597 
 Sum of electronic and thermal Free Energies=        -1666.923662 
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Geometry TS1 
SCF Done:  E(RB+HF-LYP) =  -1667.30356205     A.U. after    1 cycles 
Low frequencies ---  -40.9446   -1.3930    0.0015    0.0022    0.0024     
 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.475965 (Hartree/Particle) 
 Thermal correction to Energy=                    0.503717 
 Thermal correction to Enthalpy=                  0.504661 
 Thermal correction to Gibbs Free Energy=         0.415856 
 Sum of electronic and zero-point Energies=          -1666.827597 
 Sum of electronic and thermal Energies=             -1666.799845 
 Sum of electronic and thermal Enthalpies=           -1666.798901 
 Sum of electronic and thermal Free Energies=        -1666.887706 
 
Geometry B 
SCF Done:  E(RB+HF-LYP) =  -1667.32317386     A.U. after    1 cycles 
Low frequencies ---   -7.2257   -0.0004    0.0004    0.0016    0.4847   Zero-point correction=                           
0.476861 (Hartree/Particle) 
 Thermal correction to Energy=                    0.504837 
 Thermal correction to Enthalpy=                  0.505781 
 Thermal correction to Gibbs Free Energy=         0.417916 
 Sum of electronic and zero-point Energies=          -1666.846313 
 Sum of electronic and thermal Energies=             -1666.818337 
 Sum of electronic and thermal Enthalpies=           -1666.817393 
 Sum of electronic and thermal Free Energies=        -1666.905258 
 
Geometry TS2 
SCF Done:  E(RB+HF-LYP) =  -1667.28247706     A.U. after    1 cycles 
Low frequencies --- -350.4000   -6.0964   -4.1291   -0.0020   -0.0014   - 
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 ******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.470632 (Hartree/Particle) 
 Thermal correction to Energy=                    0.498678 
 Thermal correction to Enthalpy=                  0.499622 
 Thermal correction to Gibbs Free Energy=         0.411361 
 Sum of electronic and zero-point Energies=          -1666.811845 
 Sum of electronic and thermal Energies=             -1666.783799 
 Sum of electronic and thermal Enthalpies=           -1666.782855 
 Sum of electronic and thermal Free Energies=        -1666.871116 
 
Geometry C 
SCF Done:  E(RB+HF-LYP) =  -1667.28473447     A.U. after    1 cycles 
Low frequencies ---   -5.8963   -0.0026   -0.0012   -0.0011    4.8874     
Zero-point correction=                           0.472488 (Hartree/Particle) 
 Thermal correction to Energy=                    0.501262 
 Thermal correction to Enthalpy=                  0.502207 
 Thermal correction to Gibbs Free Energy=         0.412697 
 Sum of electronic and zero-point Energies=          -1666.812246 
 Sum of electronic and thermal Energies=             -1666.783472 
 Sum of electronic and thermal Enthalpies=           -1666.782528 
 Sum of electronic and thermal Free Energies=        -1666.872038 
 
Geometry TS3 
SCF Done:  E(RB+HF-LYP) =  -1667.28042733     A.U. after   12 cycles 
Low frequencies ---  -25.0881   -5.3180   -0.0021   -0.0020    0.0010     
******    1 imaginary frequencies (negative Signs) ******  
Zero-point correction=                           0.471042 (Hartree/Particle) 
 Thermal correction to Energy=                    0.500104 
 Thermal correction to Enthalpy=                  0.501048 
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 Thermal correction to Gibbs Free Energy=         0.407772 
 Sum of electronic and zero-point Energies=          -1666.809385 
 Sum of electronic and thermal Energies=             -1666.780323 
 Sum of electronic and thermal Enthalpies=           -1666.779379 
 Sum of electronic and thermal Free Energies=        -1666.872655 
 
Geometry D 
SCF Done:  E(RB+HF-LYP) =  -1206.48684254     A.U. after    1 cycles 
Low frequencies ---  -10.3552   -0.9775   -0.0007   -0.0004   -0.0001     
Zero-point correction=                           0.463104 (Hartree/Particle) 
 Thermal correction to Energy=                    0.489386 
 Thermal correction to Enthalpy=                  0.490330 
 Thermal correction to Gibbs Free Energy=         0.403983 
 Sum of electronic and zero-point Energies=          -1206.023738 
 Sum of electronic and thermal Energies=             -1205.997456 
 Sum of electronic and thermal Enthalpies=           -1205.996512 
 Sum of electronic and thermal Free Energies=        -1206.082860 
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7.2.5 Heats of formation 
 
Calculated heats of formation (Hf) of the geometries leading to the elimination of HCl from 
the cations 36a+ (black), 36j+ (red), 36g+ (green), [(η6-cymene)Ru(Cl)(4-phenylpyrimidine)]+ 
(blue) and [(η6-cymene)Ru(Cl)(bipy)]+ (orange).  
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Calculated reaction enthalpies (Hr) of the geometries leading to the elimination of HCl 
from the cations 36a+ (black), 36j+ (red), 36g+ (green), [(η6-cymene)Ru(Cl)(4-
phenylpyrimidine)]+ (blue) and [(η6-cymene)Ru(Cl)(bipy)]+ (orange).  
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Calculated Gibbs enthalpies (Gr) of the geometries leading to the elimination of HCl from 
the cations 36a+ (black), 36j+ (red), 36g+ (green), [(η6-cymene)Ru(Cl)(4-phenylpyrimidine)]+ 
(blue) and [(η6-cymene)Ru(Cl)(bipy)]+ (orange).  
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 Hiermit bestatige ich, dass ich die vorliegende Arbeit gemas der Promotionsordnung 
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